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Abstract 
In low GC Gram-positive bacteria, the phenomenon of carbon catabolite repression is 
dependent on a metabolite-activated bifunctional protein kinase/phosphorylase.  In 
Clostridium acetobutylicum ATCC 824, the hprK gene encodes the bifunctional protein 
kinase/phosphorylase that is dependent on fructose 1,6-bisphosphate for activity.  
However, a putative glpX class II gene that might encode for fructose 1,6-
bisphosphatase is located upstream of hprK and to date this is a unique gene 
arrangement.  Therefore, the product of the putative glpX gene might have a vital role in 
regulating the activity of bifunctional protein kinase/phosphorylase by hydrolysing 
fructose 1,6-bisphosphate which is needed for the kinase activity.  In the present work, 
experimental evidence is presented that the putative glpX gene encodes a fructose 1,6-
bisphosphatase which can hydrolyse fructose 1,6-bisphosphate to fructose 6-phosphate 
and  phosphate.  FBPase activity was first demonstrated by cloning and transforming 
the glpX gene into an E. coli fbp mutant which cannot grow on gluconeogenic substrates 
such as glycerol.  The transformed glpX gene was able to complement the fbp mutation 
of E. coli for growth on glycerol. GlpX was overexpressed as a GST-fusion protein and 
purified, and activity was demonstrated using fructose 1,6-bisphosphate as substrate.   
Activity was assayed at pH 8.0, and in the presence of Mn
2+
, but the enzyme was 
inhibited completely by 1 mM phosphate.  A putative fbp class III gene was also 
overexpressed and the encoded protein was purified as a GST-fusion product in order to 
compare Fbp with GlpX.  To our knowledge, this is the first study that was able to 
purify a Fbp class III enzyme.  The Fbp protein showed almost the same behaviour 
towards inhibitors compared to GlpX, but had a considerably higher specific activity 
than GlpX under the conditions of the experiments.  The glpX gene was shown by RT-
PCR to be transcribed together with hprK on the same mRNA during growth on 
glucose, and this indicates that glpX is unlikely to be a gluconeogenic gene.  The results 
suggest that GlpX may play a novel and specific role in regulating the kinase activity 
activity of bifunctional protein kinase/phosphorylase and carbon catabolite repression in 
C. acetobutylicum.  
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Chapter 1: 
1 General introduction 
                                                                                                            General introduction 
2 
1.1 Clostridium acetobutylicum 
The taxonomy of the Clostridium acetobutylicum is Bacteria; Firmicutes; Clostridia; 
Clostridiales; Clostridiaceae; Clostridium. It is a rod-shaped, Gram positive, obligate 
anaerobe that cannot grow in the presence of oxygen, and is capable of producing 
endospores under environmental stress conditions (Vos et al., 2009).  C. acetobutylicum 
belongs to a large genus that includes several important pathogens such as C. botulinum 
which produces the most neurotoxin proteins that cause botulism illness, C. perfringens, 
C. difficile, and C. tetani (Montecucco and Molgó, 2005).  Also within the same genus 
is C. thermocellum which is capable of converting cellulosic substrate into ethanol 
(Ram and Seenayya, 2005). C. acetobutylicum was once known as the Weizmann 
organism, named after chemist Chaim Weizmann who originally utilised the bacteria to 
produce acetone, butanol and ethanol (ABE) in a large scale fermentation (Jones and 
Woods, 1986).  The strain C. acetobutylicum ATCC 824 was isolated from garden soil 
in Connecticut in 1924, and has the ability to ferment a wide range of biomass.  This 
strain has now been shown to be related to the Weizmann strain (Nolling et al., 2001).  
The genome of the solvent-producing bacterium C. acetobutylicum ATTC 824 consists 
of a 4-Mbp chromosome and a megaplasmid (around 200 kbp in size) that carries the 
genes involved in the production of solvent, hence, this plasmid was named pSOL1 
(Nolling et al.,  2001).    
 
1.2 The history of acetone-butanol-ethanol (ABE) fermentation 
The first butanol production from a microbial fermentation was reported in 1861 by 
Louis Pasteur (Pasteur, 1862). The shortage of natural rubber in the early 20
th
 century 
stimulated an interest in producing butanol due to synthetic rubber was needed in 
manufacturing of automobile tyres (Gabriel, 1928). This problem stimulated the 
research of many scientists - one of them the chemist Chaim Weizmann, who isolated 
and studied many microorganisms between 1912 and 1914. One of the isolates was C. 
acetobutylicum (Jones and Woods, 1986).  The First World War changed the future of 
the ABE fermentation. The smokeless gun powder (cordite) was required in large 
quantities for the production of munitions, and vast quantities of acetone were required 
for the manufacture process (Killeffer, 1927; Gabriel, 1928; Jones and Woods, 1986).  
Also, the automobile industry needed a lacquer, and butanol was the best solvent for the 
production of lacquer.  The acetone production during World War II was needed again 
for military use (Jones and Woods, 1986).   
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In 1945 one-tenth of the acetone and two-thirds of the butanol in the USA were still 
produced in USA by fermentation (Rose, 1961).  However due to many political, 
economical and scientific reasons around the 1950’s the large scale fermentation for 
solvent production began to decline.  
Several of the major drawbacks that played an important role in the decline of the ABE 
fermentation industry were firstly, the destructive problem of bacteriophage infection of 
the bioreactors, which could cause the production of ABE to be cut by half for the year 
(Jones and Woods, 1986).  Secondly, solvent toxicity, especially butanol which is very 
toxic for bacteria even at low concentrations (1-2% v/v).  This resulted in low final 
product concentrations, and subsequently high solvent recovery costs.  Thirdly, the 
growing cost of biomass substrates and finally, the ever expanding petrochemical 
industry began to produce solvents at competitive prices compared to fermentatively 
produced ABE (Hasting, 1971). 
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1.3 Revival of ABE fermentation 
As a result of the dramatic price increase of petrochemicals, interest in the ABE 
fermentation process has been revived, which has encouraged the development of new 
technologies to produce fuels from cheap, secure and renewable resources.  The USA 
aims to increase the production of biofuels by three fold by 2025 (Hansen et al., 2005).  
There has been much research conducted on many fronts (such as in clostridial genetics, 
bioreactor technology and identification of cheap, renewable feedstocks) to enable the 
ABE fermentation to once again become economically competitive against fossil fuel 
(Jones and Woods, 1986). On the molecular front, many of the genomes of 
solventogenic clostridia have been sequenced such as C. beijerinckii NCIMB 8052,     
C. beijerinckii BA101, and C. acetobutylicum ATCC 824 (Nolling et al., 2001),            
C. beijerinckii BA101, a mutant strain which is derived from C. beijerinckii NCIMB 
8052, is a hyper-butanol producing strain, that can tolerate butanol better than the 
parental strain, and also butanol production is increased by 100% (Qureshi and 
Blaschek, 2001).   
Ingenious bioreactor design, which can remove ABE during the fermentation, has 
mitigated the problems caused by solvent toxicity (Nakas et al., 1983).  Many substrates 
have been identified which can replace molasses and grains, including, microalgae 
Dunaliella which can be utilized, with the addition of 4% glycerol, by C. pasteurianum 
with the production of 16 g/L of solvents (Nakas et al., 1983).  Bioinformatics analysis 
of C. acetobutylicum ATCC 824 identified 11 genes encoding for proteins that are 
involved in cellulose utilization (Nolling et al., 2001).  Whey, which is a by-product of 
the dairy industry, can be used as an economical fermentation feedstock for solvent-
producing clostridia such as C. acetobutylicum (Qureshi and Maddox, 2005). Also, 
uptake of lactose which is the major sugar in whey has been confirmed to be catalyzed 
by a phosphotransferase system (PTS) (see section  1.6) (Yu et al., 2007).  Crude 
glycerol which is the by-product of the biodiesel industry can be used as an alternative 
substrate. This low quality crude glycerol contains a mixture of contaminated glycerol, 
water, methanol, free fatty acids, and both organic and inorganic salts (Thomson and He 
2006).   
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Glycerol is produced in huge quantities during the production of biodiesel. 10 lbs of 
crude glycerol is made from every 100 lbs of biodiesel generated from vegetable oils 
and animal fats (Thompson and He, 2006).   Due to the low price, crude glycerol is very 
competitive with other sugars that are used in biofuel production by microbial 
fermentation (Yazdani and Gonzalez, 2007). Up to date, there is no economical viable 
use for the crude glycerol and it cannot be used in cosmetics and pharmaceutical 
industries due to the purification process not being economical (Dobson et al., 2011).  
However, in the USA the price of crude glycerol is constantly decreasing from US 
$0.20 / lb in 2001 to US $0.01 / lb in 2006 which makes it in the  future a most 
promising, economically viable biological fermentation substrate (Dasari, 2007).  
Around 50% of the production cost of biofuels is due to the cost of the fermentation 
substrate, hence, if crude glycerol can be used the total production cost of the biofuel 
would be lower (Willke and Vorlop, 2008; Dobson et al., 2011).  
 Several organisms are able to grow in glycerol, however, the best microorganisms that 
able to grow in glycerol and produce a valuable product belong to the genus 
Clostridium. Recent study indicates that a newly isolated Clostridium butyricum 
AKR102a from soil was able to grow in low-quality crude glycerol and produce 1,3-
propanediol (1,3-PD) which can be used in cars as a coolant (Ringel et al., 2011). When 
the strain was grown in crude glycerol, 76.2 g/L of 1,3-PD was produced making it the 
best non-engineered strain able to produce a valuable product in such a large quantity 
(Wilkens et al., 2011).   It has also been reported that C. acetobutylicum was able to co-
utilize glucose and glycerol (Vasconcelos et al., 1993).  Carlos et al, 2003 reported that 
C. acetobutylicum can grow on crude glycerol in the presence of glucose and produce 
the same amount of solvents as when grown on pure glycerol in the presence of glucose.  
A continuous culture of C. acetobutylicum over 70 days was able to produce 0.34 
mol/mol of butanol with overall butanol productivity of 0.42 g/L/h with no sign of 
degeneration (loss of pSOL1 plasmid leads the cells to not produce solvents) (Carlos et 
al, 2003).  Biodiesel is produced in many EU countries, with Germany the largest 
producer and consumer of this biofuel with the annual production exceeding 2.5 billion 
liters. However, these countries have severe problems in disposal of the excessive crude 
glycerol generated from this industry and also the disposal process is quite expensive 
(Silva et al., 2009).  Therefore, establishing a biobutanol industry together with 
biodiesel leads not only to increase the profit, but also solves the disposal problem. 
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1.4 Biofuels 
Biofuels are fuels produced from biomass (Demirbas, 2007).  Biomass is a term which 
can refer to any organic biological material, however in this context, biomass usually 
refers to matter such as crops, wood and waste residues produced by farming, the food 
and drink processing industry and so forth.  This biomass can be used for the production 
of renewable energy. Lignocellulose, which is the most abundant biomass on the Earth, 
is mainly composed of three sugars, glucose, arabinose, and xylose (Xiao et al., 2011).  
Crop waste and forestry residues are examples of lignocellulosic biomass which does 
not compete with animal feedstock and food industry (Weber et al., 2010).  Biomass 
usually needs to be degraded into manageable mono or disaccharides before microbial 
conversion into solvents or biofuels can occur, and thermochemical, enzymatic (or a 
combination of the two) pretreatment is usually employed (Brodeur et al., 2011).  
Biofuel is the most promising alternative energy that will achieve the aims of reducing 
CO2 emissions and the dependence on fossil fuel, also production and the trade of 
biofuel can create new jobs and support the economy of the developing countries 
(Groom et al., 2008).  
There are two main types of liquid biofuel used for transport fuel: 
 Biodiesel is derived from biological sources such as animal fats and vegetable 
oil. It has low emissions and is readily biodegradable, compared with 
petrodiesel.  The term biodiesel was introduced by the National Soy Diesel 
Development Board in USA during 1992.  Biodiesel can be used in the current 
diesel engine with moderate or no modification to it.  However, there are some 
problems associated with the use of biodiesel in the current diesel engine, for 
example, high viscosity and gum formation which at the end damages the diesel 
engine (Ramadhas et al., 2003).   
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 Bioalcohols, for example bioethanol produced by yeasts, are already being used 
in Brazil, the USA and some European countries on a large scale, and have 
potential to be one of the leading renewable biofuels in the coming 20 years due 
to the increase in crude oil price.  Bioethanol is produced from sugar cane in 
Brazil and from corn in USA, however this biomass stream can also be utilised 
for human and animal nutrition, which causes these feedstocks to be subject to 
erratic price fluctuations and become a target for the growing food versus fuel 
movement (Hägerdal, 2006).  
 
Biobutanol, which is butanol that is derived from biomass, is produced by the 
solventogenic clostridia such as C. acetobutylicum.  The World market for 
butanol is currently 350 million gallons per year.  The USA alone consumes 220 
million gallons per year (Shapovalov and Ashkinazi, 2008). It is mainly used as 
solvent and an intermediate in chemical production (Lee et al., 2008).     
However, Butanol has several advantages as a transport fuel over ethanol.  
Butanol has a higher energy content compared to ethanol, it blends better with 
gasoline at any concentration, and it can be used in current cars without any 
modification to the engine.  It also evaporates six times less than ethanol, is not 
corrosive compared to ethanol, hence, can be distributed by pipelines.  (Dürre, 
2007; Shapovalov and Ashkinazi, 2008). 
 
1.5 The physiology and biochemistry of the ABE process 
The solvent-producing clostridia have two main metabolic phases.  The initial growth 
phase - the acidogenic phase - produces hydrogen, carbon dioxide, acetate, and butyrate 
(Figure  1.1).  Production of the acids results in a decrease of the pH of the medium.  
The second phase of the fermentation is the solventogenic phase, in which the acetate 
and butyrate are taken up from the medium then converted into solvents, and this 
subsequently results in an increase of the pH of the medium (Davies and Stephenson, 
1941; Johnson et al., 1931; Reilly et al., 1920; Rose, 1961). 
The build-up of large amounts of acetic and butyric acids puts the cell in danger by 
dissipating the proton gradient across the cytoplasmic membrane.  As a result, the cells 
stop the formation of acids and shift towards the production of neutral solvents, the 
acids being mostly reassimilated and converted to acetone, butanol and ethanol (Dürre, 
2002). 
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Figure ‎1.1:  Biochemical Pathways in C. acetobutylicum 
Figure adapted from Jones & Woods, 1986. Reactions which predominate during the 
acidogenic phase and the solventogenic phase of the fermentation are shown by thin 
and thick arrows, respectively.  Enzymes are indicated by letters as follows: (A) 
glyceraldehyde 3-phosphate dehydrogenase; (B) pyruvate-ferredoxin oxidoreductase; 
(C) NADH-ferredoxin oxidoreductase; (D) NADPH-ferredoxin oxidoreductase; (E) 
NADH-rubredoxin oxidoreductase; (F) hydrogenase; (G) phosphate acetyltransferase 
(phosphotransacetylase);  
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(H) acetatekinase; (I) thiolase (acetyl-CoA acetyltransferase); (J) 3-hydroxybutyryl-
CoA dehydrogenase; (K) crotonase; (L) butyryl-CoAdehydrogenase; 
(M)phosphatebutyltransferase (phosphotransbutyrylase); (N) butyrate kinase; (O) 
acetaldehyde dehydrogenase; (P) ethanol dehydrogenase; (Q) butyraldehyde 
dehydrogenase; (R) butanol dehydrogenase; (S) acetoacetyl-CoA:acetate/butyrate:CoA 
transferase; (T) acetoacetate decarboxylase; (U) phosphoglucomutase; (V) ADP-
glucose pyrophosphorylase; (W) granulose (glycogen) synthase; (X) granulose 
phosphorylase. 
 
Under certain conditions C. acetobutylicum can convert pyruvate into lactate.  Lactic 
acid is not produced under normal conditions, but this occurs when the hydrogenase 
activity is inhibited by carbon monoxide or the microbe runs out of iron (Jones and 
Woods, 1986).  This pathway only operates as an alternative pathway in order to allow 
the continuation of NADH oxidation and energy generation.  In the acidogenic pathway, 
butyrate and acetate are produced from butyryl-CoA and acetyl-CoA which results in 
the production of ATP at end of the pathway. 
There are four main enzymes responsible for the formation of acids; phosphate 
acetyltransferase, and acetate kinase, encoded by pta and ack genes, for the production 
of acetic acid, and phosphate butyryl-transferase and butyrate kinase encoded by ptb 
and buk genes for the production of butyrate (Jones and Woods, 1986).  In the 
acidogenic phase the highest amount of hydrogen production occurs, concurrent with a 
high rate of glucose consumption.  The first decrease of hydrogen production is 
associated with a reduction in the metabolic activity and cell growth in the culture.  
Thus in this stage, the decrease in the hydrogen production is due to the reduction in the 
metabolic rate rather than inhibition of hydrogenase activity (Kim and Zeikus, 1985). 
The start of the solventogenic phase coincides with a fall in the pH of the medium 
which is linked to accumulation of acids. The addition of butyrate and acetate to a 
culture of C. acetobutylicum at pH 5.0 was reported to accelerate the induction of 
solventogenesis (Bernhauer and Kurschner, 1935; Reilly et al., 1920), which was 
followed by a decrease in the growth rate and hydrogen production.  The acetate and 
butyrate uptake only occurs when the sugars in the medium have been depleted.   
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The genes that are required for solvent production in C. acetobutylicum are aad, ctfA, 
ctfB, and adc which are located on a 192 kbp megaplasmid pSOL1.  C. acetobutylicum 
may lose pSOL1 resulting in the loss of the ability to produce solvents.  Strains that 
have lost the plasmid are said to have degenerated (Scotcher and Bennett, 2005).  
Solvent production serves as a detoxification process in response to the accumulation of 
acids which result in conditions that reduce the cells growth rate (Hartmanis et al., 
1984).  The shift from acidogenic phase to solventogenic phase is accompanied by a 
change in the production ratios of hydrogen and CO2 (a decrease in hydrogen 
production and an increase in CO2 production. In the solventogenic phase, the cell 
metabolism continues until the concentration of solvents reaches an inhibitory point 
which is usually around 20 g/L. The most toxic solvent is butanol, and the solvent 
production is inhibited when the concentration of butanol reaches 13 g/L. Recent studies 
have confirmed that growth is completely inhibited by the addition of 12 to 16 g/L of 
butanol. However, the addition of ethanol and acetone to the medium reduces the 
growth by 50% at a concentration of 40 g/L and growth was totally inhibited at a 
concentration of 70 g of acetone and 50 g to 60 g of ethanol per litre (Leung and Wang, 
1981; Jeanine and Antonio, 1983).  
Butanol toxicity is related to the hydrophobic property of this molecule. The main effect 
of this compound appears to be the disruption of the phospholipid bilayer of the cell 
membrane which results in an increase in membrane fluidity.  Furthermore, a recent 
study has observed an increase in the ratio of saturated to unsaturated fatty acids in the 
membranes both from solventogenic phase cells and vegetative cells grown in the 
presence of butanol (Schneck et al., 1984).  Hence, this increase in the saturated fatty 
acids in the membrane is due to the physiological response of the cell to tolerate the 
effect of increased membrane fluidity, which is similar to the response of cells grown at 
high temperature.  Butanol tolerance could be enhanced by the addition of saturated 
fatty acids to the medium which results in an increase in the content of saturated fatty 
acids in the membrane.  Also, a decrease in fermentation temperature may increase the 
butanol tolerance during the solventogenic phase (Rogers, 1984). 
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1.6 The carbohydrate phosphotransferase system (PTS) 
Transport from the environment to inside the cell is the first step in any sugar 
metabolism pathway and the PTS system is the main sugar transport system in many 
Gram positive and Gram negative microorganisms (Postma et al., 1993; Deutscher et 
al., 2006).  In 1964, this system was firstly reported in E. coli by Kundig et al. (1964). 
The PTS is a predominant transport system in many facultative and obligate anaerobic 
bacteria and involves the uptake and phosphorylation of a large number of carbon 
sources.  Although its main function is as a transport system, it can also be involved in 
movement towards carbon sources (chemotaxis), and the regulation of gene expression 
(Deutscher et al., 2006; Postma et al., 1993).  All the PTS systems that have been 
reported catalyze the following process:   
  
P-enolpyruvate (inside cell) + carbohydrate (outside cell)  
         
pyruvate (inside cell) + 
carbohydrate-P (inside cell).          
   
Sugar uptake in clostridia relies heavily but not completely on the 
phosphoenolpyruvate-dependent PTS (Figure  1.2). The main mechanism of 
carbohydrate transport in C. acetobutylicum and C. beijerinckii is the PTS (Mitchell and 
Tangney, 2005).  Many sugars such as sucrose, maltose, glucose, lactose and fructose 
have been reported to be PTS substrates in C. acetobutylicum and the genes of these 
systems have been characterised (Tangney and Mitchell, 2000; Tangney et al., 2001;  
Tangney and Mitchell, 2005; Yu et al., 2007).  As in many bacteria, the expression of 
PTS genes is induced by their substrates and they are subject to carbon catabolite 
repression (CCR) by glucose.  Neither sucrose nor maltose can be utilized by the 
growing bacteria when cultured in the presence of glucose (Tangney and Mitchell, 
2007).  
  
PTS
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Figure ‎1.2: The Phosphoenolpyruvate dependent phosphotransferase system 
Organisation of the phosphoenolpyruvate dependent phosphoTransferase system 
(PEP: PTS).  Figure adapted from Mitchell and Tangney, 2005.  Enzyme I and heat 
stable histidine-phosphorylatable protein (HPr) are the general PTS proteins for all 
PTS’s.  The substrate specific enzyme II can have highly variable domain structure, 
present as a single polypeptide or individual proteins.  A phosphate (~p) is donated 
from PEP to enzyme I, HPr, enzyme II, and then the sugar.  
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The PTS is composed of a multiprotein phosphoryl transfer chain. The first two 
proteins, enzyme I (EI) and HPr are soluble proteins that are involved in the 
phosphorylation of all of the PTS carbohydrates in any microorganism; hence, they 
have been called the general PTS proteins (Deutscher et al., 2006; Tangney and 
Mitchell, 2005; Postma et al., 1993).  Bioinformatics analysis has revealed that most of 
the EIs from Gram-positive and Gram-negative bacteria show strong identity and 
consist of around 570 amino acids with size about 63 kDa (Kuang-Yu and Saier Jr, 
2002).  EI is phosphorylated in the presences of Mg
2+
 at a conserved histidine site which 
is located in the N-terminal region (His-189) in E. coli (Weigel et al., 1982).  Moreover, 
several studies reported Mg
2+
 is needed for EI phosphorylation, but is not needed for 
transfer of the phosphate from EI to the conserved His-15 in HPr (Weigel et al., 1982; 
Chauvin et al., 1996).  The C terminal of the enzyme which contains the PEP binding 
site is needed for dimerization of EI.  Only dimer can be phosphorylated by PEP, which 
may imply that monomer to dimer transition is involved in regulation of the enzyme 
activity (Chauvin et al., 1996).  
 
HPr, which is the heat stable histidine-phosphorylatable protein and EI are encoded by 
the genes ptsH and ptsI, respectively.  The other PTS proteins are the substrate-specific 
enzyme II (EII) domains, which might exist separately or connected within a single 
polypeptide chain (Tangney and Mitchell, 2007).  These domains are referred to as the 
EIIA, EIIB, and EIIC, whereas a small number of systems were reported to have an 
extra EIID domain such as the fructose PTS system in B. subtilis (Martin-Verstraete et 
al., 1990; and Reizer, 1992).  The first two domains IIA and IIB are hydrophilic and 
both contain sites for phosphorylation, whereas IIC and IID are membrane bound 
proteins and their function is to translocate the substrate.  The EIIC domain is more 
hydrophobic than the IID (Saier Jr and Reizer, 1992; Postma et al., 1993). 
The clostridial system consists of functional proteins equivalent to those in other 
bacteria.  Hence, the soluble part of the C. beijernckii NCIMB 8052 PTS complemented 
the membranes prepared from Bacillus subtilis, C. pasteurainum and E. coli for glucose 
phosphorylation (Tangney and Mitchell, 2005).   
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Also, clostridial extracts restored the PTS activity of the extracts prepared from ptsI and 
ptsH mutants of B. subtilis, Staphylococcus aureus and E. coli (Saier and Reizer, 1992; 
Tangney and Mitchell, 2005). The phosphotransferase system (PTS) has been show to 
play a main role in bacterial CCR through HPr (Zeng and Burne, 2010; Deutscher et al., 
2006). 
1.7 Elements of Carbon Catabolite Repression (CCR) 
More than a century ago, it was reported that growth on glucose can decrease the 
activity of specific enzymes in yeast and bacteria.  This event became known as the 
glucose effect. The first description of this phenomenon was by Dienert in 1900 in 
France.  He reported that Saccharomyces cerevisiae cells that had been adapted to 
galactose, lost this adaptation directly after they were exposed to glucose or fructose 
(Dienert, 1900).  Another study was done in Wageningen, Netherlands by Sohngen and 
Coolhaas, who measured the influence of temperature on the glucose effect in S. 
cerevisiae (Sohngen and Coolhaas, 1924).  At the beginning of the 1940s, Jacques 
Monod studied B. subtilis and E. coli and concluded that “in each organism, a specific 
hierarchy existed for the utilization of carbon sources, with glucose usually being in the 
top of it” (Monod, 1942).  Later, it was found that the preferred carbon sources such as 
glucose, fructose and sucrose could repress the synthesis of the enzymes that are needed 
for the transport and metabolism of less favourable carbon sources.  This observable 
fact became known as carbon catabolite repression (CCR) (Deutscher et al., 2006). 
When the preferred sugar in a culture is depleted, cells begin to synthesize the necessary 
enzymes for the transport and metabolism of the less favourable sugar, and usually 
show a lag phase before they can resume growth again.  Therefore, the glucose effect 
phenomenon reported in the 1900s can be considered as carbon catabolite repression.  
Carbon catabolite repression can be defined as the inhibitory effect of a particular sugar 
in the growth medium on gene expression or the activity of enzymes involved in the 
catabolism of other sugars (Deutscher et al., 2006).  CCR can be mediated by various 
mechanisms, which can repress the transcription of catabolic genes via specific or 
global regulators (Deutscher, 2008). The main CCR mechanism in firmicutes is 
mediated by the global regulator catabolite control protein A (CcpA) as will be 
explained later in greater detail.         
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1.8 CCR in Gram negative bacteria 
 A major global regulator in E. coli is the cyclic AMP receptor protein (CRP), also 
called the catabolite activator protein (CAP) which is a homodimeric transcription 
protein with each monomer composed of two functional domains.  The first domain is 
located in the N-terminal region which contains a cAMP binding site and the second 
domain is located in the C-terminal which contains a specific DNA binding site (Cheng 
and Lee, 1998; Busby and Ebright, 1999; Li and Lee, 2011).  CRP activates 
transcription at many promoters in the presence of cAMP by binding to specific 
palindromic sequence of 22 bp located in or upstream of the promoter (Busby and 
Ebright, 1999; Lawson et al., 2004).  In absence of glucose, cAMP is present at a high 
concentration which stimulates CRP binding to the specific CRP-site to activate 
transcription.  However, under glucose growth conditions, cAMP is present at a low 
level, hence, no transcriptional activation occurs (Lawson et al., 2004; Crasnier-
Mednansky et al., 1997). 
The catabolite repressor /activator (Cra) protein is another global regulator that mediates 
the central metabolic pathways in Gram negative bacteria (Chavarría et al., 2011).  Cra 
was initially known as the fructose repressor (FruR) for repressing of the genes that are 
involved in fructose metabolism, however, more studies reported that FruR is not 
specific for repressing fructose utilizing genes but has a global regulator function which 
can repress or activate many catabolic genes.  Therefore, it was termed Cra (Ramseier et 
al., 1993; Shimada et al., 2010; Chavarría et al., 2011).   Cra belongs to the GalR-LacI 
family of proteins which contain two domains, an N-terminal helix-turn-helix domain 
which recognises a specific imperfect palindromic DNA sequence of around 12 bp and 
binds to it, and a second C-terminal domain which is the inducer binding domain by 
which fructose 1,6-bisphosphate (FBP) and fructose 1-phosphate bind to the protein 
(Saier Jr and Ramseier, 1996; Shimada et al., 2010).  
Repression and activation of the catabolic genes are dependent on the location of the 
Cra-binding sites.  Therefore, activation occurs when the Cra-binding site is located 
within or downstream of the promoter, but, gene repression occurs when the Cra-
binding site is located upstream of the promoter (Saier Jr and Ramseier, 1996). 
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Cra is regulated by FBP and/ or fructose 1-phosphate (effectors) via stimulating 
dissociation of Cra from the Cra-binding sites.  As a result, the genes that are associated 
with a Cra-binding site located upstream of the promoter are activated by Cra and since 
the effector binds to Cra, this leads to displacement of the protein from the Cra-binding 
site, hence, these genes are subject to catabolite repression. Whereas, the genes are 
associated with a Cra-binding site that is located within or downstream of the promoter 
are repressed by Cra and when the effector binds to Cra, this leads to displacement of 
the protein from the Cra-binding site, and hence these genes are subject to catabolite 
activation (Saier Jr and Ramseier, 1996).  
To date, it is unclear why the cell has two different global regulators, Cra and CRP, for 
controlling carbon metabolism (Shimada et al., 2010).  However, recent studies indicate 
the crp gene encoding for CRP is under the control of the Cra regulator which makes it 
the true global regulator in Gram negative bacteria (Shimada et al., 2010; Chavarría et 
al., 2011).    
                                           
1.9 CCR in Gram positive bacteria 
Catabolite control protein A ( CcpA) is the the global regulator that controls the central 
metabolic pathways in Gram positive bacteria (Singh et al., 2008).  It also can regulate 
genes that are involved in sporulation, toxin production and biofilm formation (Varga et 
al., 2004; Varga et al., 2008; Antunes et al., 2010).  Like Cra in Gram negative bacteria,   
CcpA belongs to the GalR-LacI family (Shimada et al., 2010; Deutscher et al., 2008).  
CCR occurs when HPr of the PTS is phosphorylated at a serine site (P-Ser-HPr) by HPr 
kinase which forms a complex (P-Ser-HPr-CcpA) that binds to a specific DNA site in 
the presence of FBP (Figure ‎1.3) (Deutscher et al., 2008).  Moreover, B. subtilis 
contains a homologous protein to HPr termed Crh which can be involved in CCR 
(Figure ‎1.3).  All these elements of CCR are explained below in greater detail. 
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Figure ‎1.3: Model of catabolite activation or repression in B. subtilis. 
Figure adapted from Lorca et al., 2005.  Proposed sensory transduction pathway by 
which exogenous glucose is believed to activate the CcpA transcription factor to 
promote catabolite repression (CR) or catabolite activation (CA) by binding to a 
catabolite responsive element (cre) in the control region of a target gene.  (i) Proteins 
primarily involved are the glucose phosphotransferase system, including enzyme I, 
HPr, and IIBCA
Glc
, (ii) glycolytic enzymes, (iii) the ATP-dependent fructose 1,6-
bisphosphate (FBP)-dependent HPr/Crh kinase/phosphatase HprK, and the two HPr 
and Crh protein targets of HprK that independently bind to CcpA to activate it for 
binding to cre sites.  
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1.9.1 HPr and Crh  
The general PTS protein HPr is the central processing unit in the regulation of carbon 
metabolism in the low GC Gram positive bacteria. HPr is a small protein consisting of 
about 90 amino acids only (9 to 10 kDa) (Postma et al., 1993). HPr can be 
phosphorylated at either His-15 by enzyme I and PEP or Ser-46 by ATP.  As a result, 
four different forms exist; HPr (dephosphorylated form), HPr phosphorylated at either 
His-15 (P-His-HPr) or Ser-46 (P-Ser-HPr), and the double phosphorylated HPr 
(Deutscher et al., 2006). The active-site histidyl residue (His-15) in HPr which 
participates in the PTS is located in the N-terminal region, and the region around the 
histidyl residue is conserved in most bacteria (Deutscher et al., 1986; Deutscher et al., 
2006).   In the B. subtilis sequencing project, a gene was identified that encodes a 
protein that shares 45% sequence identity to HPr.  It  was therefore termed catabolite 
repression HPr-like protein (Crh) (Martin-Verstraeter et al., 1999; Galinier and Haiech 
et al., 1997).  To date, Crh has been found only in bacillus spp. has the same regulatory 
site (Ser-46) as HPr which is involved in carbon catabolite repression.  However, His-15 
that is involved in sugar transport is replaced by glutamine in Crh, thus it cannot 
participate in sugar transport  (Galinier et al., 1997; Schumacher  et al., 2006). 
Martin-Verstraete et al, (1999) reported that HPr can completely substitute for Crh 
deletion in carbon catabolite repression of the lev operon which encodes for a fructose-
specific PTS and levanase that catalyse metabolism of fructose polymers.  However, 
Crh can only partly substitute for HPr deletion.  However, specific function for Crh in 
B. subtilis has been described by Warner et al, (2000).  They reported that the Mg-
citrate transporter (CitM) of B. subtilis, which is the main citrate uptake transporter 
during growth on citrate as the sole carbon source, is exclusively regulated by Crh 
during growth on gluconeogenic substrates such as succinate and glutamate (Warner et 
al., 2000).  CitM transports citrate or isocitrate into the cell in complex with divalent 
cations such as Mg, Zn, and Mn, hence it is termed the Mg-citrate transporter (Warner 
et al., 2000). 
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1.9.2 HPrK/P 
The metabolism of several carbon sources affects the activity of HPrK/P which is a 
bifunctional protein kinase/ phosphorylase, that reacts to changes of the concentration of 
FBP, ATP, pyrophosphate (PPi), and inorganic phosphate (Pi) (Hogema, et al., 1998).  
The phosphorylation of HPr at Ser-46 requires the HPrK/P protein kinase and ATP 
(Deutscher and Saier Jr, 1983).  The substitution of Ser-46 with alanine, tyrosine, or 
aspartate in B. subtilis HPr prevented the FBP-stimulated ATP-dependent 
phosphorylation of HPr (Eisermann et al., 1988).  Also, mutation at this site affected the 
PEP-dependent phophorylation at His-15 (Reizer et al., 1989).  FBP is needed to 
stimulate HPrK/P to phosphorylate either HPr or Crh in B. subtilis (Jault et al., 2000).  
HPrK/P kinase activity was identified in several Gram positive bacteria more than 28 
years ago.  However, the hprK  gene was discovered only during the B. subtilis 
sequencing project (Jault et al., 2000; Deutscher and Saier Jr, 1983).  When the 
concentrations of FBP and ATP increase, the kinase activity of HPrK/P is predominant; 
on the other hand, the phosphorylase activity becomes  predominant when the 
concentration of Pi increases (Kravanja et al., 1999; Jault et al., 2000).  HPrK/P can 
dephosphorylate P-Ser-HPr in presence of inorganic phosphate producing PPi.  The 
dephosphorylation is stimulated by Pi, and due to P-Ser-HPr dephosphorylation being a 
reversible mechanism, hence PPi can substitute for ATP as the phosphoryl donor for 
HPr at high concetration (Figure ‎1.3) (Deutscher et al., 1985; Nessler et al., 2002; 
Kravanja et al., 1999).  Kravanja et al, (1999) reported that the kinase activity of 
HPrK/P was inhibited at high concentration of Pi (50 mM) present under starvation 
conditions, however, a drop in the concentraction of Pi (4 mM) was detected after 
adding glucose to the medium which led to restoration of the kinase activity of HPrK/P.  
Therefore, the HPrK/P protein plays a vital rule in adjusting the level of P-His-HPr and 
P-Ser-HPr according to the nutritional state of the cell (Kravanja et al. 1999) (Figure 
‎1.3).   
Jault et al, (2000) showed that when the FBP concentration increases, HPrK/P was 
strongly stimulated to phosphorylate HPr at Ser-46.  Therefore, there is a correlation 
between FBP concentration and HPrK/P stimulation.  Also, it has been shown that FBP 
(20 mM) stimulates the kinase activity of B. subtilis and C. acetobutylicum HPrK/P and 
the kinase activity is stronger when low concentrations of ATP (0.4 mM) are used (Jault 
et al., 2000; Tangney et al., 2003).   
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The intracellular concentrations of ATP, Pi, PPi and FBP are determined by whether the 
bacteria are utilizing a favoured sugar or not (Deutscher et al., 2006).  B. subtilis cells 
grown on glucose were found to contain more FBP (14.1 mM) and PPi (6 mM) than 
cells grown on less favourable substrate such as succinate which was found to contain 
only 1.4 mM for FBP and 1.2 mM for PPi (Blencke et al., 2003; Poncet et al., 2004; 
Singh et al., 2008).  This explains why about 65% of the HPr in B. subtilis grown on 
glucose is present as P-Ser-HPr and the rest is present as HPr, P-His-HPr, and the 
doubly phosphorylated HPr (Singh et al., 2008).  However, when succinate is the sole 
carbon source, the majority of the protein is in the form of HPr, together with a small 
amount of P-His-HPr. Therefore, the two antagonistic activities of HPrK/P and the 
percentage of various form of HPr are regulated mainly by these metabolites (Moreno et 
al., 2001; Singh et al., 2008).  HPrK/P kinase activity in the presence of less than 1 mM 
FBP was very low, however, higher FBP concentrations in the assay reaction mix led to 
an increase in the HPrK/P kinase activity (Jault et al., 2000; Singh et al., 2008).  A few 
mM of FBP can overcome the inhibition of the kinase activity of HPrK/P excreted by 
Pi, hence, the major physiological function of FBP may be to stop the inhibition of 
HPrK/P by Pi (Kravanja et al. 1999; Brochu and Vadeboncoeur, 1999).   
In the firmicutes, the hprK gene, which encodes the bifunctional enzyme HPr K/P, is 
frequently the first within an operon, and the second gene encodes a prolipoprotein 
diacylglycerol transferase (lgt) which may be involved in metabolism and membrane 
anchoring.  This association of these two genes may indicate that the functions of the 
two enzymes are related but until now there is no experimental evidence to support the 
assumption (Deutscher et al., 2006).  However, in clostridia the lgt and hprK genes are 
located in different places in the genome.  In the case of C. acetobutylicum, hprK is 
preceded by the glpX gene which appears to encode a fructose 1.6 bisphosphatase 
(Tangney et al., 2003). 
No Gram negative bacteria have been identified which possess the HPrK/P kinase, even 
though their HPr proteins possess Ser-46 and share 45% overall sequence identity to 
HPr`s from the Gram positive bacteria (Deutscher and Engelmann, 1984).   
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However, the difference around the Ser-46 region is responsible for the failure of 
HPrK/P kinase from Gram positive organisms to phosphorylate the E. coli HPr 
(Deutscher and Saier, 1983; Reizer et al., 1989). The replacement of the amino acids 
next to Ser-46 in the Mycoplasma capricolum HPr with the equivalent amino acids of E. 
coli, resulted in poor phosphorylation with ATP (Zhu et al., 1998). 
 
1.9.3 CcpA 
CcpA is the catabolite control protein A which belongs to the GalR–LacI regulatory 
protein family as mentioned before (Deutscher et al., 2006).  It has a helix-turn-helix at 
the N-terminal which is responsible for DNA recognition and binding to a specific site 
called cre (catabolite responsive element) which is found in the promoter region of 
catabolic operons.  The C-terminal of CcpA is engaged in the recognition of the 
phosphoserine and binding to P-Ser-HPr complex in the presences of FBP (Jones et al., 
1997 and Loll et al., 2007).  CcpA either by activation or repression is needed in order 
to maximize the efficiency of energy and carbon metabolism in the cell (Fujita, 2009).  
CcpA regulates the expression of around 400 genes which is about 10% of the B. 
subtilis genome (Nessler et al., 2003).  In B. subtilis, CcpA (global regulator) and XylR 
(specific regulator) are required for full glucose repression of the xyl operon, however, 
only CcpA is needed for  full fructose repression (Dahl and Hillen, 1995).  CcpA can 
act as a repressor or activator depending on the location of the cis acting catabolite 
responsive element (cre) which is a 14 bp palindromic sequence, reported by Weickert 
and Chambliss (1990).  The cre consensus sequence is: TGWAANC*GNTNWCA, 
where the star signs (*) indicates the centre of the palindrome, W is adenine or thymine, 
and N is any base (Weickert and Chambliss, 1990).  Therefore, repression occurs when 
the cre site is located within or downstream of the promoter, but, gene activation occurs 
when the cre site is located upstream of the promoter (Henkin, 1996).  In B. megaterium 
and B. subtilis, the ccpA gene is expressed in a constitutive manner and this does not 
depend on the growth conditions.  Instead, CcpA is controlled at a post translational 
level (Hueck et al., 1995; Henkin, 1996).  Also, CcpA controls the efficiency and 
optimizes the catabolism of glucose through repression of alternative metabolism 
pathways (Van der Voort et al., 2008).   
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Moreno et al, (2001) reported that CcpA can mediate gene repression or activation in a 
glucose independent manner.  Computer analysis can identify the putative cre sites that 
are involved in catabolite repression but fails to identify cre sites that are involved in 
catabolite activation.  CcpA binds to cre sites as a dimer in a tetrameric protein complex 
in the presence of either co-factors HPr-P-Ser or Crh-P-Ser (Moreno et al., 2001). 
The amounts of CCR elements such as HPrK/P, CcpA, HPr, and Crh in the cell are not 
affected by the presence of different carbon sources (Singh et al., 2008).  Fructose 1,6 
bisphosphate is needed to stimulate the interaction between CcpA and HPr-P-Ser and is 
needed to enhance binding of the CcpA-HPr-P-Ser complex to cre sites (Henkin, 1996; 
Presecan-Siedel et al., 1999; Antunes et al., 2010).  Kim et al, (2005) reported that 
interaction between CcpA and RNA polymerase is needed in order to inhibit the 
transcription of the amyE gene.  Actually, a cre site (centered at +4.5) is overlapping 
with the amyE promoter area, but CcpA would not prevent RNA polymerase from 
binding to the promoter (Kim et al., 2005).  Also CcpA cannot bind to cre sites in the 
absence of HPr-P-Ser (Kim et al., 1998).  Some operons have more than one cre site, 
for example, the xyl operon has 3 cre sites. The major one is centered at +130.5, and 
two supplementary sites are located at -35.5 and +219.5 (Kim et al., 2005).  When 
CcpA binds to the major cre site that is located downstream of the xyl operon 
transcriptional start site, the CcpA would not behave as roadblock (inhibit the 
elongation) instead, it inhibits the initiation of transcription.  These results suggest that 
CcpA has a regulatory function other than simply binding to cre sites (Blencke et al., 
2003; Lorca et al., 2005).  Not all putative cre sites that have been identified have been 
shown to be functional (Van der Voort et al., 2008; Miwa et al., 2000).  Actually, most 
of the genes that are activated by CcpA appear to lack a cre site and this indicates that 
the catabolite repression mechanism is unable to elicit catabolite activation by CcpA 
due to the absence of the cre sites (Blencke et al., 2003; Lorca, et al., 2005). 
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1.10  Elements of carbon catabolite repression in clostridia 
The ptsH gene which encodes for HPr has been identified in the C. acetobutylicum 
genome sequence, and when cloned into an E. coli ptsH mutant, the clostridial gene 
complemented the mutation.  The alignment of the HPr amino acid sequence of low GC 
Gram positive bacteria with HPr of C. acetobutylicum showed that the sequence around 
the His-15 site which participates in PTS transport was conserved (Tangney et al., 
2003), whereas the region around the Ser-46 site, which is involved in CCR and is well 
conserved in HPr proteins from other Gram-positive bacteria, is not conserved in C. 
acetobutylicum HPr (Tangney et al., 2003). This protein can, however, be 
phosphorylated at Ser-46 by HPrK/P kinase in an ATP-dependent matter, and this 
activity is stimulated by FBP (Figure  1.4).  Moreover, the clostridial HPrK/P kinase can 
phosphorylate the purified HPr from B. subtilis in the presence of FBP.  Thus, it is 
suggested that the carbon catabolite repression model of low GC Gram positive bacteria 
also applies to C. acetobutylicum (Tangney et al., 2003; Tangney and Mitchell, 2005). 
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Figure ‎1.4: The model of the phosphotransferase system (PTS) mediated by the 
catabolite repression in C. acetobutylicum based on B. subtils model.   
The PTS is a transport system that has a vital role in CCR in low GC Gram positive 
microorganisms. When glucose is present, a high intracellular level of FBP will 
stimulate HPrK/P to phosphorylate the HPr at serine-46 site.  This modified HPr forms 
a complex with the catabolite control protein A (CcpA).  The complex binds to specific 
sequences called catabolite responsive elements (cre) and the transcription of a target 
gene is repressed.  However, under unpreferred nutritional conditions such as starvation 
or grown on gluconeogenic substrate, the concentration of inorganic phosphate 
increases, and phosphorylase activity of HprK/P becomes predominant. Figure adapted 
from Durre (2005).   
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Until now, HPrK/P kinase activity has been observed only in one species of Clostridium 
which is C. acetobutylicum, whereas, PTS activity has been reported in several species 
of Clostridium (Tangney et al., 2003).  A putative ptsH gene has been identified in the 
genome of three species of Clostridium, C. perfringens, C. tetani, and C. beijerinckii. 
Surprisingly, the ptsH gene is not followed by ptsI in the three species nor in C. 
acetobutylicum which means that ptsH and ptsI are not in an operon, which is unusual 
(Tangney and Mitchell, 2005).  However, this situation has also been reported in some 
other bacteria such as Mycoplasma capricolum and Streptomyces coelicolor (Zhu et al., 
1993).  As for C. acetobutylicum, analysis of the completed genomes of C. perfringens, 
C. tetani, and C. beijerinckii reveals that there is only one gene encoding for HPr and 
that there is no HPr-like protein Crh found in these bacteria (Tangney and Mitchell, 
2005).  
Bioinformatic analysis has shown a putative C. acetobutylicum HPrK/P and this protein 
has a signature sequence that is involved in the interaction with HPr and also a Walker 
A box which is involved in ATP binding.  The hprK gene is located downstream of an 
open reading frame encoding a putative fructose 1,6-bisphosphatase (GlpX) (Tangney et 
al., 2003).  To date, this gene arrangement has not been observed in any other low GC 
Gram positive bacterium, since as mentioned previously the hprK gene is usually linked 
to the lgt gene encoding prolipoprotein diacylglyceryl transferase (Tangney et al., 
2003). 
A putative gene, termed regA, encoding a CcpA-like protein in C. saccharobutylicum 
was cloned into a B. subtilis ccpA mutant and was found to complement the mutation 
(Davison et al., 1995).  This suggested that the RegA protein is actually CcpA.  Genes 
encoding putative CcpA protiens have been identified in three other species of 
Clostridium; C. acetobutylicum, C. tetani, and C. prefringens and all these proteins 
contain an N-terminal DNA recognition binding domain (Tangney and Mitchell, 2005). 
Putative cre sites have been identified in the promoter region of nearly all the pts 
operons in species of Clostridium that have been studied.  As an example, a cre site has 
been identified in both the sucrose (scr) and lactose (lac) operons of C. acetobutylicum. 
These operons are induced by sucrose and lactose respectively, and both are repressed 
by glucose (Tangney and Mitchell, 2000; Yu et al., 2007).  Ren et al. (2010) have 
recently characterized and then disrupted the ccpA gene in C. acetobutylicum ATCC 
824 in order to generate a strain that is able to utilize a mixture of sugars such as xylose 
and glucose simultaneously.   
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However, the growth of the mutant strain (ccpA) was impaired with very low 
consumption of glucose and xylose compared to the wild type.  Also, acid 
reassimilation by the mutant was inhibited which resulted in high acid accumulation.  
To solve the problem of the resulting low pH, calcium carbonate was added to the 
medium. As a result the mutant strain was able to grow on glucose and xylose.  
Transcriptional analysis revealed that the expression level of the ctfAB operon was very 
low in the ccpA mutant strain compare to the wild type (Ren et al., 2010).  This 
indicates that CcpA could be acting as a catabolite activator in C. acetobutylicum ATCC 
824.   
1.11 Fructose 1,6-bisphosphatase  
Gluconeogenesis is a vital metabolic pathway that is undertaken to produce glucose 
when bacteria grow on non-carbohydrate substrates such as glycerol, amino acids, 
organic acids or fatty acids (Figure ‎1.5) (Brown et al., 2009).  Under gluconeogenic 
growth conditions, fructose 1,6-bisphosphatase (FBPase) is a key enzyme which 
produces fructose 6-phosphate and orthophosphate from the hydrolysis of fructose 1,6-
bisphosphate. However, under glycolytic conditions, the reverse of the reaction is 
catalyzed by 6-phosphofructokinase to produce fructose 1,6-bisphosphate from fructose 
6-phosphate at the expense of ATP (Brown et al.,  2009: Rittmann et al.,  2003 :Jules et 
al., 2009). 
Five different classes of FBPase enzyme have been identified and classified based on 
their primary structure.  The classes I, II, and III have been reported in bacteria, class IV 
in archaea, and class V in both domains of the thermophilic prokaryotes.  However, 
only FBPase class I enzymes have been found in eukaryotes (Brown et al., 2009: Hines 
et al., 2006).  These five classes of FBPases require divalent cations for activity (Mn
2+
, 
Zn
2+
, Mg
2+
) (Brown, et al., 2009; Donahue et al., 2000).  The classes I, III, IV, and V 
are all termed Fbpase, However, class II has been termed GlpX (Brown, et al., 2009; 
Donahue et al., 2000).  Most microorganisms appear to have more than one FBPase 
enzyme, to date, no bacteria have the combination of class I and class III FBPases, 
however, the combinations of classes I and II and classes II and III were reported 
(Donahue et al., 2000; Kuznetsova et al., 2011).  All the resolved crystal structures of 
class I, II, IV and V have the same α-β-α-β-α secondary structure which explains why 
they have the same function despite differences in primary structure (Brown, et al., 
2009; Hines et al., 2006; Nishimasu et al., 2004; Johnson et al., 2001). 
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Figure ‎1.5: Pathway of gluconeogenesis.  Adapted from Berg et al., (2002).   
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1.11.1 Fbpase class I 
The Fbp class I has been identified in both eukaryotes and some prokaryotes. In 
mammals, the FBPase enzyme is a tetramer and can be inhibited by AMP and fructose 
2,6-bisphosphate. In E. coli, the class I FBPase is strongly inhibited by AMP, however, 
no inhibition was detected after the addition of fructose 2,6-bisphosphate, and the 
enzyme is activated at least 3-fold by PEP and sulphate. The enzyme requires Mg
2+ 
for 
activity (Brown et al., 2009; Hines et al., 2006).  The FBPase protein in E. coli is the 
main FBPase which is involved in gluconeogenesis and this explains why a ∆fbp strain 
cannot grow on gluconeogenesis substrates such as glycerol (Donahue et al., 2000). 
      
1.11.2 Fbpase class II (GlpX) 
 
1.11.2.1 In E. coli  
GlpX was first identified in E. coli as being encoded by one of the genes in the glpFKX 
operon involved in glycerol utilization.  The glpFKX operon encodes for a glycerol 
facilitator (glpF), glycerol kinase (glpK), and an enzyme of unidentified function (glpX) 
(Donahue et al., 2000).  Brown et al, (2009) reported that another gene also encodes for 
a FBPase class II enzyme (yggF).  The activity of both GlpX and YggF enzymes were 
strongly inhibited by inorganic phosphate and the resolved 3 dimensional structure of 
the GlpX complex with phosphate confirmed that the inorganic phosphate molecule 
binds to the active site of the enzyme which explains why the enzyme was strongly 
inhibited.  However, other effectors such as ADP, AMP and PEP each at 1 mM had no 
significant effect on the activity of either enzyme (Brown et al., 2009).  GlpX and YggF 
proteins are homodimers of subunits of 36 and 34.3 kDa respectively.  Both GlpX and 
YggF enzymes show maximal activity at pH 7.5-8.0 and Mn
2+ 
was the required divalent 
cation for the activity of both enzymes.  However, GlpX has higher activity and affinity 
for FBP which leads to three times higher catalytic efficiency compared to YggF.  In the 
GlpX structure, the active site is located in the large cavity between the two protein 
domains where many conserved residues are located (Brown et al., 2009). 
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1.11.2.2 In Corynebacterium glutamicum 
C. glutamicum is a Gram positive, high GC content bacterium which plays an important 
role in industrial amino acid production (Rittmann et al, 2003; Kalinowski et al, 2003). 
This bacterium has only a class II FBPase which is a homotetramer of subunits of 35.5 
kDa and shares 44% identity with E. coli GlpX (Rittmann et al., 2003).  The optimal pH 
to assay the activity was 7.7 and Mn
2+ 
was required for activity.  FBPase activity was 
completely inhibited by 90 µM AMP, and activity was reduced to 50% after adding 360 
µM PEP, 140 µM LiCl, 1.6 mM phosphate and 1.2 mM fructose 1-phosphate.  This 
gene was named fbp, even though the enzyme belongs to class II FBPases (Rittmann et 
al., 2003). The C. glutamicum FBPase class II shows similar behaviour to the 
mammalian FBPase in terms of inhibition by AMP (Hines et al., 2006; Rittmann et al., 
2003).  This enzyme is an abundant protein and its synthesis does not depend on the 
growth conditions. An fbp mutant could not grow on gluconeogenic substrates which 
indicate that this is the major FBPase in C. glutamicum (Rittmann et al., 2003).  PTS EI, 
HPr and EII permeases have been identified for uptake of sugars such as fructose and 
glucose/mannose, but no HPrK/P kinase was identified and also the HPr lacks the 
conserved Ser-46 which indicates that the carbon catabolite repression is different in 
this high GC content Gram positive bacterium from that in the low GC content Gram 
positive bacteria such as B. subtilis and C. acetobutylicum  (Rittmann et al., 2003). 
 
1.11.2.3 In Mycobacterium tuberculosis  
There is only one major FBPase class II encoded by the Rv1099c gene in this bacterium, 
and the enzyme shares 43% identity to E. coli GlpX (Movahedzadeh et al., 2004; Gutka 
et al., 2011).  The optimal pH for enzyme activity is 7.3 and Mg
2+ 
was required for 
activity. AMP, citrate, Li
+
, PEP and ADP were tested as potential effectors.  No 
inhibition was seen in the presence of any of these metabolites up to 1 mM except for 
Li
+
 which inhibited the activity by 50% at 0.2 mM, and by more than 90% at 2.5 mM 
indicating that this enzyme belongs to the Li
+
-sensitive phosphatases (Movahedzadeh et 
al., 2004; Gutka et al., 2011). 
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1.11.2.4 In Bacillus species 
GlpX in B. subtilis is encoded by the ywjI gene and the enzyme shares 54% identity 
with GlpX from C. glutamicum and requires Mn
2+ 
for activity (Jules et al., 2009).  The 
GlpX activity was completely inhibited by addition of 1 mM PEP.  A ∆ywjI strain was 
able to grow on gluconeogenic substrates such as glycerol and malate.  GlpX in B. 
subtilis is a constitutive enzyme with expression which is not dependent on 
gluconeogenic or glycolytic conditions (Jules et al., 2009).  Van der Voort et al, 2008 
reported that B. cereus has two glpX genes.  One of them (ywjl) was affected by the 
deletion of ccpA which led to relief of glucose repression and this might indicate that 
ywjl is involved in gluconeogenesis.  However, the second glpX was not affected by 
deletion of ccpA and the presence of glucose (Van der Voort et al., 2008). 
 
1.11.3 Fbpase class III 
The first and only FBPase belonging to class III has been reported in B. subtilis (Fujita 
et al., 1998).  The enzyme is encoded by a monocistronic yydE gene and the expression 
of this gene depends on the growth phase rather than growth conditions (Fujita et al., 
1998).  Like the glpX mutant, an fbp mutant was able to grow on gluconeogenic 
substrates such as glycerol indicating that each enzyme can compensate for the absence 
of the other (Jules et al., 2009).  The GlpX activity was completely inhibited by 
additional of 1 mM PEP, however Fbp activity was increased by 30-fold after adding 1 
mM PEP which indicates that GlpX and Fbp are both regulated by PEP (Jules et al., 
2009).  Like glpX, fbp was expressed at a constant level independent of the growth 
conditions (Jules et al., 2009; Fujita et al., 1998). 
 
1.11.4 Fbpase class IV and V  
The Fbpase class IV was first identified in Methanocaldococcus jannaschii which is 
anaerobic archaeon that produces methane as a by-product (Bult et al., 1996).  The 
MJ0109 protein can act as both inositol monophosphatase (IMPase) and FBPase (Stec 
et al., 2000).  The first class V FBPase was reported in the sulphur-reducing 
hyperthermophilic euryarchaeon Thermococcus kodakaraensis to be encoded by the 
fbpTK gene.  The enzyme showed substrate specificity for FBP only, indicating that this 
is the true FBPase, unlike the bifunctional class IV IMPase/FBPase enzyme.  
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The expression of the fbpTK gene was strongly repressed under glycolytic conditions 
and a  fbpTK mutant was unable to grow under gluconeogenic conditions even though 
impTK was constitutively expressed (Rashid et al., 2002).  The activity of FbpTK was 
detected without any divalent cations, but was enhanced 5-fold by the addition of 20 
mM Mg
2+
, and 4-fold by the addition of 1 mM Mn
2+
.  Also, Zn
2+
 increased the activity 
at 1 mM but Ca
2+
 and Ni
2+
 had no effect on the activity and the optimal pH was 8.0 
(Rashid  et al., 2002).  A recent study reported that class V FBPase is a bifunctional 
fructose 1,6 bisphosphate aldolase/phosphatase (FBP A/P) enzyme (Say and Fuchs, 
2010; Fushinobu et al., 2011).  Fructose 1,6-bisphosphate aldolase (FBP aldolase) is an 
enzyme that catalyzes FBP under glycolytic growth conditions into dihydroxyacetone 
phosphate and glyceraldehyde 3-phosphate (aldo cleavage step).  However, under 
gluconeogenic growth conditions the same enzyme catalyzes the reverse step which is 
aldol condensation of dihydroxyacetone phosphate and glyceraldehyde 3-phosphate to 
produce FBP (Siebers et al., 2001; Berry and Marshall, 1993).  Two different classes of 
FBP aldolase have been identified and classified based on their primary structure.  The 
aldolase activity of FBP A/P only has irreversible step of aldol condensation of 
dihydroxyacetone phosphate and glyceraldehyde 3-phosphate to produce FBP.   
Bioinformatics have shown that analysis for all the archaeal genomes sequenced encode 
a bifunctional FBP A/P, although the mechanism by which FBP A/P exhibits its dual 
activity remains unclear (Say and Fuchs, 2010; Fushinobu et al., 2011).     
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1.12 Project aim 
Interest in the putative GlpX of C. acetobutylicum started when Tangney et al, (2003) 
stated that the putative hprK gene, which is a vital gene in carbon catabolite repression, 
is followed by an open reading frame that might encode for a class II GlpX enzyme. 
This unique gene arrangement has not been reported in any other low GC Gram positive 
up to date, which might indicate that the putative GlpX enzyme plays a vital and unique 
role in regulating the FBP-dependent HPrK/P kinase activity (Figure  1.4) and thus in 
regulating carbon catabolite repression in C. acetobutylicum ATCC 824.  For these 
reasons, GlpX needs to be characterized at the biochemical and genetic levels.  In 
addition, the unique profile of the gene arrangement should be characterised in terms of 
gene expression.  Moreover, bioinformatic analysis revealed a putative class III fbp gene 
in C. acetobutylicum which is an orthologue to the class III fbp gene in B. subtils.  
Therefore, this gene and the encoded enzyme should be characterized and compared to 
the putative class II GlpX in order to know the physiological roles of both proteins.  The 
overall aim of this project is to isolate by cloning, characterise and compare the 
physiological function of glpX and fbp genes in the solventogenic C. acetobutylicum 
ATCC 824, and also to investigate the significance of the hprK-glpX unique gene 
arrangement in the bacterium.   
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Chapter 2: 
2 General materials and methods 
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2.1 Bacterial strains, growth conditions, primer and vector details 
C. acetobutylicum ATCC 824 strain was obtained from Dr P. Soucaille of the Institut 
National des Sciences Appliquées-DGBA, Toulouse, France, and was originally 
obtained from American Type Culture Collection, Rockville, Maryland, USA.  The E. 
coli strains JB103, JB108, JLD2402, JLD2403, JLD2404, and JLD2405 were obtained 
from Dr T. J. Larson of the Virginia Polytechnic Institute and State University, 
Blacksburg, USA. For TOPO cloning, the E. coli strain Mach1
™
-T1
R 
was acquired from 
Invitrogen, Carlsbad, CA.  For Gateway cloning the E. coli strains One Shot
®
 
OmniMAX™ 2-T1R (Invitrogen, Carlsbad, CA) and Rosetta™ 2(DE3) (Novagen 
Madison, WI) were used.  The E. coli strains for Ligation Independent Cloning (LIC) 
were acquired from Novagen.  Bacterial strains were stored at -70°C in the appropriate 
glycerol media.  Details of the E. coli strains used in this study are listed in Table  2.1.  
Plasmids were stored at -20°C in nuclease free water (Qiagen, Valencia,  
CA).  Details of the plasmids used in this study are listed in Table  2.2. 
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 Table ‎2.1: Details of E. coli strains used in this study and their genotypes  
E. coli strain Genotype Source 
TOP10F` 
F´{lacIqTn10(TetR)}mcrAΔ(mrr-hsdRMS-mcrBC)  
Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu)7697 
galU galK rpsL endA1 nupG 
Invitrogen 
 
Mach1
™
-T1
R  
  
 
F
- 
φ80(lacZ)ΔM15 ΔlacX74 hsdR(r
K
-m
K
+
) ΔrecA1398 endA1 
tonA 
Invitrogen 
 
JB108 
 
BL21 (DE3) zjg920::Tn10 Δfbp287 
 
Donahue et al., 2000 
 
JLD2402 
 
TL524 glpX::spcr Δfbp287 zjg-920::Tn10 
 
Donahue et al., 2000 
 
JLD2403 
 
TL524 glpX::spcr fbp+ zjg-920::Tn10 
 
Donahue et al., 2000 
 
JLD2404 
 
TL524 glpX+ Δfbp287 zjg-920::Tn10 
 
Donahue et al., 2000 
 
JLD2405 
 
TL524 glpX+ fbp+ zjg-920::Tn10 
 
Donahue et al., 2000 
 
JB103 
 
F
–
 araD139 Δ(lacZYA-argF)U169 rpsL150 deoC1 relA1 
ptsF25 flbB5301 thiA1zjg-920::Tn10 Δfbp287(λ lacIq tetR+ 
spcR) 
Lutz & Bujard, 1997 
 
One Shot® 
OmniMAX™ 
2-T1R 
F
–
 [proAB+ lacIq lacZΔM15 Tn10(TetR) Δ(ccdAB)] mcrA 
Δ(mrr-hsdRMS-mcrBC)φ80(lacZ)ΔM15Δ(lacZYA-argF) 
U169 endA1 recA1 supE44 thi-1 gyrA96 relA1 tonA panD 
Invitrogen  
 
 
Rosetta™ 
2(DE3) 
F
–
 ompT hsdSB(rB
–
 mB
–
) gal dcm (DE3) pRARE23 (CamR) 
 
Novagen 
 
NovaBlue 
GigaSingles™ 
F'[proA
+
B
+ 
lacI
q
ZΔM15::Tn10 (Tc
R
)]endA1 hsdR17(rK12– 
mK12+) supE44 thi-1 recA1 gyrA96 relA1 lac 
Novagen 
 
BL21(DE3) 
pLysS 
F– ompT hsdSB(rB– mB–) gal dcm (DE3) pLysS (CamR) 
 
Novagen 
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Table ‎2.2: Plasmids used in this study 
Plasmid + cloned gene Code assigned to clones after transformation  
pCR2.1-TOPO + glpX pM1B, pM1W, and pM2W 
pDONR™221 + glpX pMAX-glpX-1, pMAX-glpX-8, and pMAX-glpX-10 
pDONR™221 + fbp pMAX-fbp-1, pMAX-fbp-2 
pET-60-DEST + glpX pRosetta-glpX-6 and pRosetta-glpX-7 
Pet-41 Ek/LIC + glpX pNova-glpX-3 and pNova-glpX-4 
Pet-41 Ek/LIC + fbp pNova-fbp-3 and pNova-fbp-4 
 
2.1.1 E. coli strain growth conditions  
Luria-Bertani (LB) and M9 glycerol or glucose minimal medium were used to grow 
these strains. The compositions of these media are shown in Table ‎2.3.  Media were 
autoclaved at 121°C and ampicillin or tetracycline or kanamycin was added to the 
media as required after cooling to 55°C (Table  2.4).  All the strains were grown at 37°C.  
 
Table ‎2.3: Growth media composition 
M9 minimal medium: 0.4 % (w/v) glycerol (per litre) 
M9 salts (see below) 100 ml 
Glycerol  4 g  
0.1M MgSO4 10 ml 
0.01M CaCl2 10 ml 
dH2O to 1000 ml 
M9 Minimal medium: 0.2 % (w/v) glucose (per litre) 
M9 salts 100 ml 
Glucose 2 g  
0.1M MgSO4 10 ml 
0.01M CaCl2 10 ml 
dH2O to 1000 ml 
M9 Salts (per litre) 
Na2HPO4 60 g 
KH2PO4 30 g  
NaCl 5 g 
NH4Cl 10 g 
dH2O to 1000 ml 
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Luria-Bertani (LB) medium (per litre) 
Tryptone 10 g 
Yeast extract 5 g  
NaCl 5 g 
 
Table ‎2.4: List of antibiotics  
Full name Abbreviation Final concentration  
Ampicillin +Amp (100 µg/ml) 
Tetracycline +Tet (10 µg/ml) 
Kanamycin +Kan (30 µg/ml) 
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2.1.2 Primer sequences 
The sequences of the forward and reverse primers used in this study to amplify specific 
fragments of DNA are presented in Table  2.5.  All primers were obtained from Eurofins 
MWG Operon UK, except for RT-PCR control primers which were obtained from 
Novagen.  The extra overhang sequences for Gateway and LIC cloning primers are 
underlined.   
  
Table ‎2.5: Primer details  
Designated 
name 
Sequence‎(5’‎– 3’) 
TOPOglpX Fwd: ACTTTAGGACACTATAGCGC 
Rev: TACCTGCATTTACTATCCCC 
TOPOfbp Fwd: ACTTTAGGACACTATAGCGC 
Rev: TACCTGCATTTACTATCCCC 
GATEglpX Fwd: GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGTTTGATAATGATATATATCC 
Rev: GGGGACCACTTTGTACAAGAAAGCTGGGTTTTCTACCACTAATTTACTTTT 
GATEfbp Fwd: GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGCTATTAGAAAGTAAC 
Rev: GGGGACCACTTTGTACAAGAAAGCTGGGTAACTTTTTACAAATTCCTT 
LICfbp Fwd: GACGACGACAAGATGCTATTAGAAAGTAACACCA 
Rev: GAGGAGAAGCCCGGTACTTTTTACAAATTCCTTAATAAG 
LICglpX Fwd: GACGACGACAAGATGTTTGATAATGATATATCC 
Rev: GAGGAGAAGCCCGGTTTCTACCACTAATTTACTTTT 
RNAhprK Fwd: TATACGTCCAGGGAGGAATG 
Rev: CCTTGGAAATAACCTTCGGC 
RNAglpX 
 
Fwd: TGCAGCTACAGCAATAACAG 
Rev: CAAACTGTAGTCCTGGTCTG 
RT-PCR 
control 
Fwd: TCCACCACCCTGTTGCTGTA 
Rev: ACCACAGTCCATGCCATCAC 
T7 promoter Fwd: TAATACGACTCACTATAGGG 
- 
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2.1.3 Growth conditions for C. acetobutylicum ATCC 824 
C. acetobutylicum was maintained as a spore suspension in sterile water at 4°C.  Two 
ml of spore suspension was transferred into a sterile test tube and heated-shocked at 
80°C for 10 minutes and transferred into 20 ml of Reinforced Clostridial Medium 
(RCM) which was prepared according to the manufacturer’s instructions (OXOID LTD, 
England).  To prepare the starter culture, the inoculated RCM was then incubated in an 
anaerobic cabinet at 37°C overnight under N2:H2:CO2 (80:10:10) mixed gas atmosphere.  
Five ml of starter culture was then transferred into 100 ml of Clostridial Basal Medium 
(CBM) [casein hydrolysate, 4 g; MgSO4.7H2O, 0.2 g; FeSO4.7H2O, 10 mg; 
MnSO4.4H2O, 10 mg; α-aminobenzoic acid, 1 mg; thiamine-HCl, 1 mg; d-biotin, 2 µg; 
KH2PO4, 0.5 g; 5 mM of glucose in 1 L of dH2O] and incubated at 37°C under the same 
anaerobic conditions.  The cells were harvested by transferring them into 1.5 ml 
microcentrifuge tube, centrifuged at 18000 xg in room temperature for 10 minutes and 
the supernatant was discarded and the cell pellet was kept at -70°C. 
 
2.2 Chromosomal DNA extraction from C. acetobutylicum ATCC 824 
The chromosomal DNA was extracted by using a DNA Isolation Kit for Gram-positive 
bacteria (Gentra
®
, Cat# D-6000A) with some modifications in the protocol.  Cell 
Suspension Solution (300 µl) was added to the C. acetobutylicum cell pellet that was 
prepared as described above, and then the cell pellet was pipetted up and down until the 
cells were suspended.  Lytic Enzyme Solution (1.5 µl) was added to the mix and 
vortexed for 30 seconds, and then incubated on the shaking incubator at 100 rpm for 30 
minutes at 37°C. The reaction mix was centrifuged again at 18000 xg for 1 minute and 
the supernatant was discarded.   
 
Cell Lysis Solution (300 µl) was added to the cell pellet, to break open the cells and 
release the DNA, and then gently pipetted up and down to lyse the cells, 1.5 µl of 
RNase A Solution was added to the lysed cells, and incubated in a shaking incubator at 
100 rpm for 1 hour at 37°C.  Protein Precipitation Solution (100 µl) was added to the 
reaction mix and vortexed for 30 seconds and centrifuged at 18000 xg for 3 minutes, a 
white pellet containing the precipitated proteins was then formed.  The supernatant 
containing the DNA was transferred into a sterile 1.5 ml microcentrifuge tube 
containing 300 µl of 100% isopropanol, vortexed for 30 seconds, and then centrifuged 
at 18000 xg for 1 minute.   
 
                                                                                            General materials and methods 
40 
The supernatant was discarded and the pellet which contained the genomic DNA was 
resuspended again in 300 µl of 70% (v/v) ethanol, vortexed for 30 seconds, and then 
centrifuged at 18000 xg for 1 minute.  The supernatant was discarded and the pellet was 
hydrated in 60 µl of DNA Hydration solution, then incubated for 1 hour at 65°C and the 
purified genomic DNA was stored at -20°C. 
 
2.3 Polymerase Chain Reaction (PCR) for TOPO™ TA cloning 
C. acetobutylicum ATCC 824 chromosomal DNA was purified to be used as DNA 
template in the PCR reaction.  The total volume of the PCR reaction was 50 µl which 
consisted of; 1 µl of chromosomal DNA, 1 µl of each of the TOPO forward and reverse 
primers for both glpX and fbp genes, 10 µl of 5 × PCR buffer [100 Mm of dNTPs, 20 
µl; 10 × Buffer (Stratagene
®
, Cat# 600400), 230 µl; dH2O, 250 µl]   and 36.5 µl of 
deionised water.  After the first denaturation stage of 95°C for 5 minutes, 0.5 µl of 
Easy-A high fidelity PCR cloning enzyme (Stratagene
®
, Cat# 600400) was added to the 
PCR mixture.  The second stage was 30 cycles of 1 minute at 95°C, 1 minute at the 
appropriate annealing temperature and 3 minutes at 72°C.  The final stage was 10 
minutes at 72°C to complete primer extension.  
 
2.4 Gel electrophoresis 
To enable visualisation of nucleic acids, 5 µl of PCR product were mixed with 2 µl of 
DNA loading buffer (Bioline, Cat# BIO-37045).  Then 7 µl of the resultant mixture was 
loaded onto a 1% (w/v) agarose gel (containing 1 µl of Ethidium Bromide at 10 mg/ml) 
along with Hyperladder I (Bioline), as size standards and run at 60 V for 1 hour, and the 
DNA in the gels were visualised by UV light.  
 
2.5 TOPO™ cloning procedure 
A TOPO TA Cloning
®
 Kit (Invitrogen, Cat# K4500-01) was used to perform the 
cloning of both glpX and fbp genes.  Taq polymerase has a non-template dependent 
terminal transferase activity that adds a single deoxyadenosine (A) to the 3’ ends of the 
PCR product. The pCR2.1-TOPO vector possesses single overhanging 3’ 
deoxythymidine (T) residues.  This enables cloning of the PCR product into the 
pCR2.1-TOPO vector (appendix  7.4).  
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 Fresh PCR products (see section  2.3) (3 µl) were mixed with 1 µl water, 1 µl Salt 
Solution and 1 µl pCR2.1-TOPO vector (all provided from the TOPO kit).  The TOPO 
cloning reaction was incubated for 15 minutes at room temperature with the protocol 
carried out as per manufacturer’s instructions.  
2.6 Transformation of chemically competent E. coli 
A vial of Mach1
™
-T1
R
 competent
 
cells (Table ‎2.1) stored at -70°C was thawed on ice 
prior to use.  After thawing, 2 µl of TOPO cloning reaction was added into the vial and 
incubated for 10 minutes on ice and then the cells were heat-shocked for 30 seconds at 
42°C.  Immediately the vial was placed on ice for 2 minutes and then a 250 µl of S.O.C 
medium (provided from the TOPO kit) was added at room temperature.  The vial was 
incubated horizontally at 37°C on a shaking incubator at 170 rpm for 1 hour.  LB plates 
(Table ‎2.3) supplemented with 40 µl/plate of 40 µg/ml X-gal and (+Amp) were 
incubated for 1 hour at 37°C to pre-warm the plates.  Aliquots from the transformation 
mixture (50 µl or 100 µl) were then spread onto the surface of the agar.  The plates were 
incubated overnight at 37°C.  
 
2.7 Screening of clones  
 
2.7.1 PCR analysis 
White colonies contain an inserted gene which disrupts the lacZ gene fragment on the 
pCR2.1-TOPO vector.  Therefore the white colonies were tested for harbouring a 
plasmid containing the desired PCR insert.  This was done by transferring a colony, 
using a sterile toothpick, to 20 µl of dH2O in a 1.5 ml microcentrifuge tube and heating 
to 100°C in a heat block for 10 minutes.  The mixture was transferred to ice for 10 
minutes to cool down and then centrifuged at 18000 xg for 2 minutes.  After the 
centrifugation, the supernatant was used as the DNA template for a PCR reaction.  The 
PCR screening was carried out using the same primers that were used in the PCR 
amplification with 1 µl of the supernatant.  The reaction mix and conditions were the 
same as previously described in Section  2.3.  For determination of the orientation of the 
insert, the T7 promoter primer (Table  2.5) was used in conjunction with one of the 
TOPOglpX primers.  PCR products were visualised following electrophoresis in 1% 
(w/v) agarose gels in 1 × Tris-acetate-EDTA (TAE) buffer at 60 V. 
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2.7.2 Plasmid purification 
Plasmids were purified using the Qiagen Plasmid Midi Kit (Cat# 12145) as described in 
the manufacturer’s protocol.  A single colony of the cells containing the plasmid of 
interest was transferred to 10 ml of LB Broth supplemented with appropriate antibiotic 
and incubated overnight with shaking at 37°C.  Cell suspension (1 ml) was transferred 
into 100 ml of LB Broth supplemented with appropriate antibiotic and incubated again 
overnight with shaking at 37°C.  The cell suspension (50 ml) was then pelleted by 
centrifuging at 2700 x g for 10 minutes at 4°C.  The pellet was resuspended in 4 ml of 
Buffer P1 and vigorously shaken for 1 minute.  Lysis Buffer (4 ml, Buffer P2) was 
added to the resuspended pellet and mixed by inverting 6 times and incubated at room 
temperature for 5 minutes.   Then, 4 ml of chilled Buffer P3 was added to the mixture to 
stop the lysis reaction and incubated on ice for 15 minutes.  The reaction mixture was 
centrifuged at 20000 xg for 30 minutes at 4°C, the supernatant was transferred to 
another tube and centrifuged at 2700 xg for 10 minutes at 4°C and the supernatant was 
kept and the pellet discarded.  The purification column (QIAGEN-tip 100) was 
equilibrated by adding 4 ml of Buffer QBT to the purification column and allowing it to 
empty by gravity flow.  
  
The supernatant was applied to the purification column and allowed to move through 
the column by gravity flow and then the column was washed twice by applying 10 ml of 
Buffer QC.  The plasmid was eluted by adding 5 ml of Buffer QF and collected in a 15 
ml tube.  Isopropanol (3.5 ml) was added and centrifuged at 2700 xg for 1 hour at 4°C 
to precipitate the plasmid. The plasmid pellet was washed by the addition of 2 ml of 
70% (v/v) ethanol and centrifuged at 2700 xg for 30 minutes, after which the 
supernatant was discarded.  The pellet was resuspended in 50 µl of deionized water. The 
concetraction of plasmid DNA was quantified by comparing it to concentration of 
Hyperladder I (Bioline).  
 
2.7.3 DNA Sequencing  
All DNA sequencing was conducted commercially by Beckman Coulter Genomics.  
Plasmid DNA was sent in 20 µl of nuclease free dH2O at a concentration of 50 ng/µl. 
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2.7.4 Restriction analysis  
Colonies thought to possess a PCR insert, were grown in 100 ml LB Broth (+Amp).  
The Qiagen Plasmid Midi Kit was used to purify the recombinant plasmid.  After 
purification, 5 µl of the sample was electrophoresed in a 1%  (w/v) agarose gel in 1× 
TAE buffer at 60 V for 1 hour, to check whether the plasmid of interest was purified or 
not.  Separate digestion reactions using EcoRI (Fermentas, Cat# ER0271, cutting sites: 
5'...G↓A A T T C...3' and 3'...C T T A A↓G...5') and HindIII (Fermentas, Cat# ER0501, 
cutting sites: 5'...A↓A G C T T...3' and 3'...T T C G A↓A...5') restriction enzymes were 
performed to determine the orientation of the insert.  The reaction mixture (Table  2.6) 
was incubated at 37°C overnight before being visualised by electrophoresis.  The 
restriction digest sites of HindIII and EcoRI in the vector are shown in (Appendix  7.4). 
 
Table ‎2.6: Composition of the restriction digest mixture 
Substance Volume (µl) 
10 × buffer of EcoRI or HindIII 2 
Plasmid DNA  5 
Restriction digest enzyme 1 
dH2O 12 
Total volume 20 
 
2.7.5 Transformation of E. coli mutant strains 
The E. coli strains JB103, JB108, JLD2402, JLD2403, JLD2404, and JLD2405 were 
grown on Nutrient Agar.  Single colonies of these strains were transferred to 10 ml of 
LB supplemented with tetracycline (+Tet), and incubated on the shaking incubator at 
170 rpm overnight at 37°C.  After that, 1 ml of overnight culture was transferred into 
100 ml of LB (+Tet) and incubated at 37°C (170 rpm) for 4 hours until the OD600 
reached 0.6.  The culture (50 ml) was transferred into a 50 ml polypropylene tube and 
then incubated on ice for 10 minutes.  The cells were centrifuged at 1700 xg at 4°C for 
10 minutes.  The supernatant was discarded and the pellet was resuspended in 10 ml of 
ice-cold 0.1 M CaCl2 and again incubated on ice for 10 minutes.  The suspension was 
centrifuged again at 1700 xg at 4°C for 10 minutes and then the cells were resuspended 
in 2 ml of the same ice-cold 0.1M CaCl2.   
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Purified recombinant of interest plasmid (2.5-5 µl) was added to 200 µl of cell 
suspension using a chilled pipette tip and then mixed gently and incubated on ice for 10 
minutes.  After that, the reaction mixture was heat shocked for 2 minutes at 42°C in a 
water bath and placed on ice again for 5 minutes.  An 800 µl aliquot of LB broth was 
added to the mixture and incubated on the shaking incubator (100 rpm) at 37°C for 1 
hour.  After the incubation, 100 µl of the mixture were spread onto LB plates (+Amp 
and +Tet) and incubated again at 37°C overnight.  The colonies which formed were 
given a reference number and transferred onto M9 glucose (+Amp and +Tet), LB 
(+Amp and +Tet) and M9 glycerol (+Amp and +Tet) plates, incubated overnight at 
37°C and then PCR screened the same way as described in section  2.7.1.   
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2.7.6 Fructose 1,6-bisphosphatase assay 
A colony that contains a gene of interest was transferred using a sterile toothpick into 10 
ml LB broth (+Kan) and incubated overnight with shaking at 200 rpm at 37°C.  The 
overnight culture (1 ml) was transferred into 500 ml of Overnight Express
TM
 Instant LB 
medium and incubated overnight with shaking at 200 rpm at 37°C [ glycerol, 10 g; 
Overnight Express
TM
 Instant LB medium, 45 g in 1 L of dH2O]   (Novagen, Cat# 
71757).  The 500 ml culture was centrifuged at 1700 xg for 10 minutes at 4°C. The 
supernatant was discarded and the cell pellet was suspended in ice-cold 20 mM Tris-Cl 
(8 pH) and centrifuged again similar to the previous conditions.  The suspension was 
transferred into a 50 ml polypropylene tube and centrifuged at 1700 xg at 4°C for 10 
minutes.  The weight of the cell pellet was recorded before it was stored at -20°C.  The 
pellet was thawed on ice and resuspended in 50 mM Tris-Cl (pH8) containing 1 mM 
dithiothreitol (DTT) and 5 mM MgCl2 to reach a concentration of 3 ml/g pellet.  The 
cells were broken twice using a French Pressure Cell (SLM instruments, INC.) then 
centrifuged at 2700 xg for 10 minutes at 4°C.  Finally, the supernatant was transferred 
into 15 ml polypropylene tube and stored at -20°C.  The cell extracts were assayed 
spectrophotometrically, by using a Beckman Coulter DU 800 spectrophotometer  at 340 
nm at 37°C, for FBPase activity which involved measuring the production of fructose 6-
phosphate coupled to the reduction of NADP
+
 in the presence of glucose 6-phosphate 
dehydrogenase (G6PDH) (Sigma, 4.6 mg protein/ml; 715 units/mg protein, Cat# 
G8404-1KU) and phosphoglucose isomerase (PGI) (Sigma, 10.1 mg protein/ml; 547 
units/ mg protein, Cat# P5381-1KU) as follows: 
  
 
The formation of NADPH in the final step of the reaction was measured by the increase 
of the absorbance at 340 nm and FBPase specific activity is calculated using the molar 
extinction coefficient of NADPH which is 6.22 X 10
-3
 nmoles (Jules et al., 2009; 
Fraenkel et al., 1966; Babul et al., 1983)   as follows: 
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The activity of the coupling enzymes glucose 6-phosphate dehydrogenase and 
phosphoglucose isomerase were assayed in same way but instead of the FBP, 20 µl of 
F-6-P (500 mM) was added to the reaction mixture to check whether the enzymes were 
able to form NADPH.  The composition of the assay reaction mixture is shown in Table 
 2.7. 
 
Table ‎2.7: The composition of the fructose bisphosphatase assay reaction mixture 
Substance Volume (µl) 
1 M Tris-Cl pH8  50 
1 M MgCl2 10 
200 mM DTT  5 
0.1 mM EDTA 4 
50 mM Fbp  4 
50 mM NADP  4 
Coupling enzymes  1 of each 
Cell extract  50 
dH2O 871 
Total reaction volume 1000 
 
2.7.6.1 Microbuiret protien assay 
A microbuiret assay was used to measure the concentration of the protein present in the 
crude extract.  A serial standard was made using BSA as shown in Table 2.8, in 1 ml 
tube with the addition of 240 µl of 40% (w/v) NaOH.  After that, 680 µl of water and 63 
µl of 1% (w/v) CuSO4 .5 H2O were added to the mixture and then these were incubated 
in the 37°C water bath for 15 minutes.  The standard samples were read at 310 and 390 
nm to calculate the concentration of the standards for creating a calibration curve.  The 
concentration of protein in 10 µl of each crude extract sample was measured in same 
way but instead of BSA, which was used as standard, crude extract was used.  The 
protein concentration of crude extract was calculated by interpolation from the 
standards calibration curve (appendix  7.9).      
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Table ‎2.8: Different amounts of BSA and dH2O that were needed in the 1 ml assay 
mixture. 
BSA (10 mg/ml) µl dH2O µl 
20 0 
15 5 
10 10 
5 15 
0 20 
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2.8 Cloning of the glpX and fbp genes in the Gateway expression system 
The Gateway expression system (Invitrogen, Cat# 12535-029) is based on two cycles of 
bacteriophage lambda in E. coli.  The bacteriophage lambda can either enter, a lytic 
cycle which results in viral replication and destruction of the infected cell, or a 
lysogenic cycle in which it integrates itself into the host genomic DNA at a specific site. 
Also in the lysogenic cycle, the phage genome can either be transmitted into daughter 
cells or it can be induced to go back again to the lytic cycle from which the phage 
genome can be excised from the host genomic DNA.  This system consists of two 
reactions.  The first reaction is BP reaction, which is the integration process (lysogenic 
pathway) that facilitates recombination of attB-flanked PCR product with pDONR
™
 
vector to produce an attL-containing entry clone, and this reaction or pathway is 
catalyzed by bacteriophage lambda Integrase (Int) and E. coli Integration Host Factor 
(IHF) proteins (BP Clonase
™
 II enzyme mix).  The second reaction is the LR reaction 
which is the excision process (lytic pathway) that facilitates recombination of an entry 
clone with a destination vector, and this reaction or pathway is catalyzed by 
bacteriophage lambda Excisionase (Xis), Integrase (Int) and E. coli Integration Host 
Factor (IHF) proteins. 
 
2.8.1 BP cloning reaction 
Primers were designed to amplify C. acetobutylicum glpX and fbp genes flanked by 
attB1 and attB2 overhangs (Table ‎2.5), that can recombine with the donor vector 
(pDONR
™
221) at attP1 and attP2 sites to produce entry clones with two sites, attL1 and 
attL2.  Both glpX and fbp genes were amplified to produce attB-PCR products for the 
BP reaction as previously described in section 2.3.  The attB-PCR product (1 µl) was 
mixed with 1 µl of the donor vector (pDONR™221) and 6 μl Tris-EDTA (TE) buffer 
(pH 8.0) was added to the mixture, both provided with the kit.  The reaction was 
performed in a 1.5 ml microcentrifuge tube in room temperature.  The BP Clonase
™
 II 
enzyme  mix was removed from the freezer and left on ice 2 minutes for thawing, and 
then mixed by vortexing twice for 2 seconds, 2 µl of BP Clonase™ II enzyme mix was 
added to the reaction mixture and mixed by vortexing twice for 2 seconds.  The reaction 
mixture was incubated for 1 hour at room temperature, and after that 1 µl of proteinase 
K solution was added and incubated again for 10 minutes at 37°C. 
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2.8.2 Transformation of chemically competent cells 
One vial of One Shot
®
 OmniMAX
™
 2-T1R Chemically Competent E. coli (Invitrogen, 
Cat# 12535-029) was left on ice to thaw for 5 minutes and then 1 µl of BP reaction 
mixture was added to the One Shot
®
 OmniMAX
™
 2-T1R cells and mixed gently.  The 
vial was incubated on ice for 30 minutes and then heat shocked in a water bath for 30 
seconds at 42°C, and placed again on ice for 2 minutes.  S.O.C medium (250 µl) was 
added to the vial at room temperature, and incubated for 1 hour at 37°C, shaking 
horizontally at 200 rpm.  After that, 20 µl of the transformation mixture was spread onto 
LB plates (+Kan) and left in the incubator overnight at 37°C.  
 
2.8.3 LR reaction 
Plasmids of fbp and glpX were purified as described in section 2.7.2 using the Qiagen 
plasmid purification midi kit, and sent for sequencing to Eurofins MWG Operon.  The 
following reaction was performed in a 1.5 ml microcentrifuge tube at room temperature, 
1 µl of 150 ng purified plasmid (entry clone) was mixed with 1 µl of pET-60-DEST 
vector, and then 6 µl of TE buffer, pH 8.0 was added to the mixture.  The LR Clonase
™
  
II enzyme  mix was removed from the freezer and left on ice for 2 minutes for thawing, 
and then mixed by vortexing twice for 2 seconds, 2 µl of LR Clonase
™
 II enzyme mix 
was added to the reaction mixture and mixed by vortexing twice for 2 seconds.  The 
reaction mixture was incubated for 1 hour at room temperature, after that 1 µl of 
proteinase K solution was added and then incubated again for 10 minutes at 37°C. 
 
2.8.4 Transformation into expression host 
One vial of Rosetta
™
 2(DE3) Competent Cells (Novagen, Cat# 71397) was left on ice to 
thaw for 5 minutes and then 1 µl of LR reaction mixture was added to the Rosetta
™
 
2(DE3) Competent Cells and mixed gently.  The transformation was performed as 
described in section  2.8.2.   
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2.9 Cloning of glpX and fbp by Ligation-Independent Cloning (LIC)  
Novagen ligation-independent cloning (LIC) allows directional cloning of the insert 
with no need for ligation or restriction digest reaction.  This system uses the activity of 
the bacteriophage T4 DNA polymerase enzyme to make specific 15-base single 
stranded overhangs in the Ek/LIC vector.  Complementary overhangs in the insert must 
be present by adding suitable 5’ extension into the primers (Table  2.5).  To create 
specific vector compatible overhangs, purified insert DNA must be treated with T4 
DNA polymerase in the presence dATP.  Transformation into competent E. coli was 
carried out after cloning. 
 
2.9.1 LIC cloning reaction  
Primers LICglpX and LICfbp were designed for amplification of glpX and fbp genes 
flanked by specific 13-bases at the ends which were complementary to the overhangs in 
the Ek/LIC vector (Table ‎2.5).  Hot Start DNA Polymerase (KOD) (Novagen, Cat# 
71086-5) was used for amplification of both glpX and fbp genes from the purified C. 
acetobutylicum chromosomal DNA.  For reaction set up and cycle conditions see Table 
 2.9 and Table  2.10 respectively.  
 
Table ‎2.9: Hot start DNA polymerase reaction setup. 
Component  Volume‎(μl) 
10X Buffer for KOD Hot Start DNA Polymerase 5 
25 mM MgSO4 3 
dNTPs (2 mM each) 5 
PCR Grade Water 33 
10 pmol/μl Sense Primer  1 
10 pmol/μl Anti-Sense Primer  1 
Template DNA 1 
KOD Hot Start DNA Polymerase (1 U/μl) 1 
Total reaction volume 50 
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Table ‎2.10: Temperatures and times that were used for amplification by KOD Hot 
Start DNA Polymerase. 
Cycle  Temperature (°C) Time 
1-Polymerase activation 95  2 min 
2-Denature 95  20 s 
3-Annealing 
 
51 (fbp) 
56 (glpX) 
 10 s  (fbp) 
 10 s  (glpX) 
4-Extension 70 (glpX) 
70 (fbp) 
 20 s (glpX) 
 40 s (fbp) 
 Repeat steps 2–4 30 times 
 5-Final extension 70  3 min 
 
2.9.2 Purification and precipitation of PCR product  
After amplification, PCR products were purified to remove any contaminating DNA. 
Therefore, DNA extraction from agarose gel with Ultrafree
®
-DA kit (Millipore, Cat# 
42600) was used for purification of the PCR product.  PCR products (60 µl) were run in 
a modified TAE electrophoresis gel [40 mM Tris-acetate, pH 8.0, 0.1 mM Na2EDTA] 
for 1 hour alongside hyperladder I, and then the gel was placed on a UV box to locate 
the bands.  The bands were cut out using a blade and transferred into a Gel Nebulizer 
and the device was sealed with the cap attached to the vial, centrifuged at 6800 xg for 
10 minutes, and finally the supernatant which contained the DNA was captured in the 
vial and the Gel Nebulizer which contained the agarose gel was discarded. 
  
To inactivate the polymerase enzyme and remove dNTPs, isopropanol precipitation was 
used, 80 µl of gel extracted DNA was added to 80 µl of phenol-chloroform isoamyl 
alcohol, 24:1), mixed by vortexing for 1 minute, and centrifuged at 18000 xg for 1 
minute and then the supernatant mixed with an equal volume of chloroform to remove 
any residue of phenol, and centrifuged at 18000 xg for 5 minutes.  The top phase of the 
supernatant which contained the DNA was transferred into a new 1.5 ml tube, and 0.1 
volume of 3 M sodium acetate pH 5.2 and 1 volume isopropanol were added, mixed by 
vortexing and incubated at room temperature for 5 minutes to precipitate DNA.   
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After centrifugation at 18000 xg for 5 minutes, the supernatant was removed and the 
DNA pellet was washed with 70% (v/v) ethanol, spin at 18000 xg for 5 minutes, and 
then the DNA pellet was resuspended in 30 µl TE buffer [10 mM Tris-HCl, 0.1 mM 
EDTA pH 8.0] which was provided with the kit.  
 
2.9.3 T4 DNA Polymerase treatment of the purified PCR product 
To generate compatible overhangs on the purified PCR product, T4 DNA Polymerase 
(Novagen, Cat# 71086-5) was added to the reaction mix as shown in Table  2.11.  To 
start the reaction, the enzymes was added to the reaction mix, stirred with a pipette tip 
and incubated at room temperture for 30 minutes.  The enzyme was inactivated by 
incubating at 75°C for 20 minutes.  
Table ‎2.11: T4 DNA polymerase reaction setup. 
Component  Volume‎(μl) 
100 ng/µl Purified PCR product 4 
10X T4 DNA Polymerase Buffer 2  
25 mM dATP 2 
100 mM DTT 1 
Nuclease-free Water 10.6 
2.5 U/ml T4 DNA Polymerase 0.4 
Total reaction volume 20 
 
The treated PCR product (1 µl) was added to the pET-41 Ek/LIC vector (2 µl) in order 
to perform the annealing reaction.  The reaction mix was incubated at room temperature 
for 5 minutes and finally, 1 µl of 25 mM EDTA was added to stop the reaction and 
preserve recombinant vector.  
 
2.9.4 Transformation into the cloning strain 
The vector that contained the cloned PCR product was transformed into NovaBlue 
GigaSingles
™
 Competent Cells which harbor recA and endA mutations to increase the 
transformation efficiency and yield of recombinant plasmid DNA (Novagen, Cat# 
71086-5) as described in section  2.8.2.  The recombinant vector was purified as 
described in section  2.7.2. 
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2.9.5 Transformation into the expression strain 
The BL21 (DE3) pLysS Competent Cells (Novagen, Cat# 69451) were used to 
overexpress GlpX and Fbp proteins. The transformation was carried out as described in 
the instructions of the competent cell kit. The tube that contained the competent cells 
was taken from the -70°C freezer and immediately placed on ice for 5 minutes to thaw.  
Then 1 µl of purified plasmid (10 ng/μl) was added to the cells, mixed gently and placed 
on ice.  The tube was incubated on ice for 5 minutes, and the heated in a water bath at 
42°C for 30 seconds, returned to ice for 2 minutes and then 250 µl of S.O.C medium 
was added. The tube was incubated at 37°C for 1 hour at 200 rpm in the shaking 
incubator, and then 100 μl of the mixture was plated on a selective medium which 
contained (+Kan), and incubated overnight at 37°C.  
 
2.9.6 PCR Screening 
PCR screening was conducted as per Section  2.7.1 to verify whether the plasmid was 
transferred to the BL21 (DE3) pLysS Competent Cells.  
 
2.9.7 Expression of the Fbp and GlpX proteins  
After the fbp and glpX genes were identified as being cloned correctly in the Pet-41 
Ek/LIC plasmid, the Fbp and GlpX proteins were expressed as His tagged proteins 
using Overnight Express
TM
  Instant LB media (Novagen, Cat# 71757).  The procedure 
for the Fbp and GlpX proteins expression are summarized as follows. 
 
A colony of recombinant BL21 cells containing either fbp or glpX gene was transferred 
using a sterile toothpick into 10 ml LB Broth (+Kan) and was incubated overnight with 
shaking at 200 rpm at 37°C.  The overnight culture (1 ml) was transferred into 500 ml 
of Overnight Express
TM
 Instant LB media, and incubated overnight with shaking at 200 
rpm at 37°C. After induction, cells were centrifuged at 20000 xg at 4°C for 10 minutes.  
The supernatants were discarded and the pellets were washed by resuspending in 
distilled water, and a second centrifugation was carried out at 2700 xg at 4°C for 20 
minutes and finally the supernatants were discarded and the cell pellets were 
resuspended in Ni-Nitrilotriacetic acid (NTA) His•Bind Matrix buffer (3 ml for each 1 g 
of cell pellet) [50 mM NaH2PO4, pH 8.0; 300 mM NaCl; 10 mM imidazole].   
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The suspended cells were lysed using a French Pressure Cell Press
®
 under 1000 PSI 
twice and then the lysates were centrifuged at 2700 xg at 4°C for 20 minutes to separate 
the soluble fraction from  insoluble material.  
2.9.8 Purification of protien under native conditions using immobilizing metal-
affinity chromatography (IMAC)   
This purification system is based on a separation technique which uses chelating 
compounds with immobilized metal ions that covalently bind to amino acid residues 
exposed on the surface of the target protein (Gaberc-Porekar and Menart, 2001).  This 
purification system uses nitrilotriacetic acid (NTA) as the chelating compound, Ni
2+
 as 
the immobilized metal ion and the hexahistidine tags as amino acid residues exposed on 
the surface of the target protein (Figure ‎2.1).  
 
 
Figure ‎2.1: Schematic‎ illustration‎of‎a‎protein‎with‎a‎His•Tag‎attached‎at‎ the‎N-
terminal binding to a metal-chelated affinity support (NTA-Ni).  
 
Strong binding of a protein onto the IMAC matrix is achieved predominantly by multi-
point attachment of the engineered surface histidine tag which is located at the N- or 
and C-terminus of the protein.  Figure adapted from Gaberc-Porekar and Menart, 
(2001). 
 
The His tagged Fbp and GlpX proteins were purified using BugBuster
®
 Ni-NTA 
His•Bind Purification kit (Novagen, Cat# 70751-3) under native conditions by 
following the manufacturer’s protocol with the modification of using 1 M imidazole in 
the third and fourth elutions and being left for 1 hour to collect the elution.   
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The 50% Ni-NTA His•Bind slurry that was provided with the kit (1 ml) was added to 4 
ml of 1X Ni-NTA Bind Buffer and mixed gently and left for 20 minutes to settle.  A 4 
ml of soluble lysate was added to the Ni-NTA His•Bind slurry and mixed gently and 
incubated 1 hour at 4°C.   
 
After incubation, the mixture was loaded into a column with the outlet capped and left 
for 20 minutes at room temperature and then the cap was removed and the flow-through 
was collected in a 15 ml tube.  The washing step was carried out twice by added 4 ml of 
1X Ni-NTA Wash Buffer [50 mM NaH2PO4, pH 8.0; 300 mM NaCl; 20 mM imidazole] 
and the washing fractions were collected.  Finally, 4 × 0.5 ml of Ni-NTA Elution Buffer 
[50 mM NaH2PO4, pH 8.0; 300 mM NaCl; 250 mM imidazole] was added to elute the 
His tagged protein and collected in four tubes.   
      
2.9.9 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
A 10 μl of both purified proteins were added to 10 μl of 2 × SDS protein samples 
loading buffer and heated in a heating block at 100°C for 10 minutes, then the mixtures 
were loaded on the gel.  Also 10 μl of insoluble fractions of the cell extract were 
removed and added to the separate volumes of 2 × SDS protein samples loading buffer 
and heated in a heating block at 100°C for 10 minutes, then the mixtures were also 
loaded on the gel.  The AE-6450 Dual Mini Slab Kit (ATTO, Cat# 2322222) cassette 
was assembled for mini gel as described in the manufacturer`s manual and the SDS-
PAGE gel was prepared with the stacking gel at the top and the running gel at the 
bottom.  A 7% and 4% (v/v) of acrylamide/bis-acrylamide (30%, Sigma) in buffer were 
used in making the stacking and running gel, respectively.   First, the running gel was 
prepared by loading around 4/5 of the cassette and then a layer of 98% (v/v) butanol 
was added above the running gel and left for 1 hour.  After the running gel had 
polymerized, the butanol was discarded and replaced by the stacking gel and left for 45 
minutes to polymerise.       
The 7% (v/v) running gel contained the following (30 ml): 15.3 ml of H2O, 7.5 ml of 
1.5 M Tirs-HCl (pH 6.8), 140 µl of 20% (w/v) SDS, 6.9 ml of acrylamide/bis-
acrylamide (30%, Sigma), 140 µl 10% (w/v) ammonium persulfate, 20 µl of 
Tetramethylethylenediamine (TEMED).   
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The 4% (v/v) stacking gel contained the following (5.05 ml): 3.075 ml of H2O, 1.25 ml 
of 1.5 M Tirs-HCl (pH 6.8), 25 µl of 20% (w/v) SDS, 670 µl of acrylamide/ bis-
acrylamide (30 %, Sigma), 25 µl 10% (w/v) ammonium persulfate and 5 µl of TEMED. 
After the 20 µl samples were loaded alongside 10 µl of HyperPage Prestained Protein 
Marker (Cat# 33066, Bioline), the gel was run in the SDS-PAGE tank containing a 
reservoir buffer [30.3 g Tris base; 144 g Glycine; 10 g SDS with 1L dH2O] at 200 V 
and left for 2 hours. The gel was then removed from the cassette and placed in a box 
containing Coomassie blue staining buffer [45% (v/v) methanol; 10% (v/v) acetic acid; 
0.2% (w/v) Comassie Brilliant Blue; 44.8% (v/v) water] to stain the gel and left for 1 
hour at 37°C, followed by overnight destaining at room temperature in the destaining 
buffer [60% (v/v) methanol; 10% (v/v) acetic acid; 30% (v/v) water].     
  
2.9.10  Dialyzing of the recombinant proteins 
The recombinant proteins were dialyzed by using Dialysis Cassette Slide-A-Lyzers (3 
ml) (Fisher Scientific, Cat# 66382).  Dialysis cassette is a single use, self-floating 
syringe-loadable unit. The dialysis cassette membrane is made from regenerated 
cellulose that allows a complete retention of proteins and macromolecules that are larger 
than 10 kDa, at the same time, allowing the removal of unwanted buffer.  These dialysis 
cassettes can be loaded with up to 3 ml of the sample needs to be dialyzed. 
 
The recombinant proteins were dialyzed as described in the manufacturer`s protocol.  A 
5 ml syringe was filled with the recombinant protein up to 3 ml and injected through the 
gasket of a needle port at the cassette’s corner by the needle.  After that, the needle was 
removed and the gasket resealed and the cassette corner was marked to note which 
needle port had been used.  The cassette was placed vertically with foam attached in 1 
litre of dialysis buffer and stirred gently, and was left to dialyze for overnight at 4°C. 
The dialysis cassette was removed from the dialysis buffer, and then the needle was 
inserted into an unused needle port to remove the dialyzed recombinant protein.  
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2.9.11 Cleaving the fusion protein with recombinant enterokinase 
The Enterokinase Cleavage Capture Kit from Novagen
 
(Cat# 69067) can be used in 
order to remove tags from proteins in the N-terminal (GST.Tag, His.Tag and S.Tag).  
Recombinant enterokinase (rEK) is a catalytic subunit of bovine enterokinase which 
cleaves after the C-terminal end of a lysine residue in the sequence Asp-Asp-Asp-Asp-
Lys↓-insert.  After the cleavage of the target protein, rEK is removed from the reaction 
by using affinity capture on EKapture
™
 Agarose and finally the agarose is removed 
using a spin-filtration tube.  First, small scale optimization is needed to estimate the 
appropriate amount of target protein Table  2.12. 
 
Table ‎2.12: Reaction components for small scale optimization incubated in room 
or 37°C temperature. 
Component Volume‎(μl) 
10X rEK Cleavage/Capture Buffer  5  
Target protein 20, 10  
Diluted rEK (1 unit/μl) 1, 2  
Deionized water Until the total volume reached 50  
 
2.10 Growth of C. acetobutylicum ATCC 842 for RNA extraction 
C. acetobutylicum ATCC 842 was kept as spores in the cold room 4°C in sterile water. 
Spore suspension (2 ml) was transferred into an empty sterile tube and heat shocked at 
80°C
 
for 10 minutes, and then transferred into 20 ml of Reinforced Clostridial Medium, 
(RCM, Oxoid) and incubated at 37°C for 2 days in the anaerobic cabinet (Forma 
Scientific, Marietta, Ohio) to prepare starter cultures. Starter culture (3 ml) was 
transferred into 100 ml of Clostridial Basal Medium (CBM) and incubated at 37°C
 
in 
the anaerobic cabinet overnight.  Overnight culture (1.5 ml) was transferred into a 
microcentrifuge tube, 1 ml of RNA Protect Bacteria Reagent (Qiagen, Cat# 76506) was 
added and incubated at room temperature for 10 minutes, and then centrifuged for 10 
minutes at 10600 x g.  The supernatant was discarded and the pellet was immediately 
frozen in liquid nitrogen and then stored at -70°C. 
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2.10.1 RNA extraction for C. acetobutylicum ATCC 824 
The RNA was extracted by using RNeasy Mini Kit as described in the manufacturer’s 
protocol (Qiagen, Cat# 76506).  A tube of cell pellet was transferred from the -70°C 
freezer into ice to thaw for 5 minutes, and then 200 µl of QIAGEN Proteinase K was 
added and the pellet was resuspended by pipetting up and down several times.  The 
mixture was mixed by vortexing for 10 seconds and then incubated at room temperature 
for 10 minutes, during this period of incubation, the sample was vortexed for 10 
seconds every 2 minutes.  The RLT Buffer (700 µl) was added to the mixture and mixed 
by vortexing then, 500 µl of ethanol (96%) was added to the sample and mixed by 
pipetting.  Lysate (700 µl) was transferred into an RNeasy Mini spin column and placed 
into a 2 ml collection tube, and centrifuged for 15 seconds at 10600 xg, and the flow-
through was discarded.  The Buffer RW1 (700 µl) was added to the RNeasy Mini spin 
column, and centrifuged for 15 seconds at 10600 xg to wash the membrane of the spin 
column and  the flow-through and the collection tube were discarded.  The RNeasy 
Mini spin column was placed in the top of a new 2 ml collection tube and 500 µl of 
Buffer RPE was added and centrifuged for 15 seconds at 10600 xg to wash the spin 
column, and again the flow-through was discarded.  Again 500 µl of Buffer RPE was 
added to the RNeasy Mini spin column and centrifuged for 15 seconds at 10600 xg to 
wash the spin column, and again the flow-through was discarded. The RNeasy Mini 
spin column was placed in a new 1.5 ml collection tube and 50 µl of RNeasy-free water 
was added, and centrifuged for 1 minute at 10600 xg to elute the RNA. 
 
2.10.2 Analysis of purified RNA 
The total purified RNA was separated using a 1% (w/v) agarose gel in 1 × MOPS 
(morpholinopropanesulfonic acid) buffer.  The MOPS stock buffer (10 × MOPS) 
contained: 50 mM sodium acetate, 200 mM MOPS, and EDTA at pH 7.0.  The RNA 
loading buffer consisting of 50% (v/v) formamide, 16% (v/v) formaldehyde, 10% (v/v) 
of 10 × MOPS buffer, 0.1 mg/ml ethidium bromide and 0.01% (w/v) bromophenol blue, 
was mixed with the purified RNA, denatured at 70°C for 10 minutes, placed on ice for 2 
minutes, and then the total RNA was separated by electrophoresis at 80 V for 1 hour.   
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2.10.3 Reverse transcriptase PCR 
RNA was prepared as described in section  2.10.1 and used for cDNA synthesis and then 
PCR amplification of two fragments, first one between glpX and hprK genes and second 
between a gene that encodes for 5-formyltetrahydrofolate cyclo-ligase and hprK gene 
using a QIAGEN
®
 One-Step RT-PCR Kit (Cat# 210210).  This kit contains a special 
blended enzyme mix for both reverse transcription and PCR amplification.  Omniscript 
and Sensiscript Reverse Transcriptases are responsible for generating cDNA from the 
RNA.  Omniscript Reverse Transcriptase is specially engineered for reverse 
transcription of RNA amounts greater than 50 ng.  However, Sensiscript Reverse 
Transcriptase is designed for use with very small amounts of RNA, less than 50 ng.  
HotStarTaq DNA Polymerase is needed to generate the PCR products from the cDNA 
and this enzyme does not interfere with the reverse-transcriptase reaction due to it only 
being activated when the enzyme is heated to 95°C for 15 minutes.  Details of the PCR 
reaction mix and PCR cycles are presented in Table  2.13 and Table  2.14 respectively. 
 
Table ‎2.13: Reaction mix for one-step RT-PCR 
Component  Volume‎(μl) 
5x QIAGEN OneStep RT-PCR Buffer 10  
dNTP Mix (containing 10 mM of each dNTP) 2  
100 pmol/μl RNAglpX or RNAhprK forward 
primer  
1  
100 pmol/μl RNAglpX or RNAhprK reverse 
primer  
1  
QIAGEN OneStep RT-PCR Enzyme Mix 2  
(4 U/μl) RNase inhibitor 2  
Template RNA Variable 
RNase-free water Variable 
Total volume 50  
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Table ‎2.14: RT-PCR Cycling steps (QIAGEN
®
 One-Step RT-PCR Kit) 
Cycling step Time (min) Temperature (°C) 
1-Reverse transcription step 30  50 
2-Initial PCR activation step  15  95 
3-Denaturation step 1  94 
4-Annealing step 1  Variable 
5-Primers extension step 1  72 
Repeats steps 3 to 5 for 40 cycles 
6-Final extension step 10 72 
 
Also, the One Step RT-PCR Master Mix Kit from Novagen
®
 was used to generate 
cDNA and then PCR product.  This kit utilizes an engineered Thermus thermophilus 
(rTth) DNA polymerase, which acts both as reverse transcriptase and DNA polymerase.  
Details of the PCR reaction mix and PCR cycles are presented in Table  2.15 and Table 
 2.16 respectively. 
 
Table ‎2.15: Reaction mix for one-step RT-PCR 
Component Volume‎(μl) 
2X One Step RT-PCR Master Mix 25  
50 mM Mn(OAc)2 2.5  
10 pmol/μl RNAglpX or RNAhprK 
forward primer 
1  
10 pmol/μl RNAglpX or RNAhprK 
reverse primer 
1  
Template RNA Variable  
RNAse-free water Variable 
Total volume 50  
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Table ‎2.16: RT-PCR Cycling steps (One Step RT-PCR Master Mix Kit Novagen
®
) 
Cycling step Time  Temperature (°C) 
1-Enzyme Activation step 30 s 90  
2-Reverse transcription step  30 min 60 
3-Denaturation step (enzyme) 1 min 94 
4-Denaturation step (DNA) 30 s 94 
5-Annealing step 30 s variable 
6-Extension step 1 min 72 
Repeat steps 4–6 for 40 cycles 
7-Final Extension 7 min 60 
 
2.11 Proteomic analysis 
A sample of crude extract of C. acetobutylicum grown on glucose minimal medium was 
obtained from Dr. Wilfrid J Mitchell and sent to Moredun Research Institute by Dr. 
Douglas Fraser-Pitt. The proteomic analysis was carried out by using liquid 
chromatography electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS).  
 
2.12 Bioinformatics analysis 
The National Centre for Biotechnology Information (NCBI) database was used to obtain 
the DNA and amino acid sequence of each gene and protein respectively: 
 http://www.ncbi.nlm.nih.gov/. 
Also, the Basic Local Alignment Search Tool (BLAST), which is one of the search 
tools in NCBI database, was used to determine the percent homology in sequence 
alignments: 
http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome.  
ClustalW2 on The European Molecular Biology Laboratory- European Bioinformatics 
Institute (EMBL-EBI) database was used to align multiple DNA or protein sequences 
and visualised via the programmes GeneDoc or TreeView:  
http://www.ebi.ac.uk/Tools/msa/clustalw2/.  
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3.1 Introduction 
FBPase is one of the main irreversible gluconeogenic enzymes and is involved in 
converting fructose 1,6-bisphosphate to fructose  6-phosphate and orthophosphate.  This 
protein has been characterised in many Gram positive and Gram negative bacteria such 
as B. subtilis and E. coli (Brown et al., 2009; Jules et al., 2009).  To date, there is no 
study reporting FBPase activity in the genus Clostridium.  Tangney et al, (2003) 
reported that there is an open reading frame that might encode for a FBPase enzyme in 
C. acetobutylicum ATCC 824.  Therefore, the aim of this chapter was to examine 
whether the open reading frame that has been reported does encode for FBPase and also 
to examine whether there is any other gene that might encode for FBPase enzyme.  This 
was investigated by bioinformatic analysis, genetic complementation and biochemical 
analysis (enzyme assay).  
3.2 Results  
 
3.2.1 Bioinformatic analysis 
The whole genome of C. acetobutylicum ATCC 824 has been sequenced and is 
accessible for analysis (Nölling et al., 2001; GenBank accession number AE001437 
http://www.ncbi.nlm.nih.gov/nuccore/AE001437). C. acetobutylicum like all other 
bacteria requires fructose-1,6-bisphosphatase activity to enable the organism to grow 
under gluconeogenic conditions.  The genome sequence of C. acetobutylicum was 
searched for potential homologues of fructose-1,6-bisphosphatase encoding genes using 
the NCIB database.  Two potential homologues were identified, cac1088 and cac1572. 
Phylogenetic analysis of cac1088 and cac1572 with both experimentally proven and 
putative FPBase proteins from diverse species including human, yeast, plants and 
bacteria revealed that cac1088 clusters with FBPase class II proteins (Figure 3.1). It 
appears that cac1088 is evolutionarily divergent from E. coli FBPase class II.  
Interestingly, cac1572 clusters with FBPase class III enzymes which including B. 
subtilis FBPase enzyme (Fujita et al., 1998).  
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  Figure ‎3.1: Unrooted phylogenetic tree of characterised FBPases and the two putative clostridial FBPases 
Class I
Class II
Class III
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Continuation of Figure 3.1.  Abbreviations for FBPases Class I: b.na fbp; Brassica 
napus (Rape), s.po fbp; Schizosaccharomyces pombe (Fission yeast), h.sa fbp; Homo 
sapiens (Human), e.co fbp; Escherichia coli fbp, s.el_fbp; Synechococcus elongatus 
PCC 7942 and p.sa fbp: Pisum sativum (Garden pea).  For FBPases Class II: s.el glpX; 
Synechococcus elongatus PCC 7942, c.gl glpX; Corynebacterium glutamicum, m.tu 
glpX; Mycobacterium tuberculosis, e.co glpX; Escherichia coli, cac1088; C. 
acetobutylicum glpX, b.su glpX; Bacillus subtilis.  For FBPases Class III: cac1572; C. 
acetobutylicum fbp, b.su fbp; Bacillus subtilis, s.au fbp; Staphylococcus aureus.               
 
3.2.2 The cac1088 gene 
The first gene identified cac1088, covers 975 bp and putatively encodes a class II GlpX-
like protein of 324 aa.  The estimated molecular weight of the protein is 34.81 kDa.  A 
BLAST search was conducted on the NCIB protein database using the deduced amino 
acid sequence of the putative GlpX protein; the results are presented in Table  3.1.  All 
of the top ten hits from the BLAST search were from the genus Clostridium.  The 
putative FBPase of C. botulinum A str. ATCC 3502 shares 78% identity with the 
putative C. acetobutylicum FBPase protein (cac1088). The cac1088 also shares 
similarity with putative FBPase of other Clostridium spp. 
 
The protein sequences of the top ten BLAST hits were then aligned in ClustalW2 
(www.ebi.ac.uk/Tools/msa/clustalw2/) together with the experimentally proven type II 
FBPase protein sequences such as E. coli and M. tuberculosis and then visualised in 
GeneDoc (www.nrbsc.org/gfx/genedoc/).  There are large areas of conservation 
throughout the length of the proteins (Figure ‎3.2). There are four blocks of conserved 
motifs (Brown et al., 2009) consisting of VIGEGE, APML, AVDPIDGT and DGDV in 
sequence block I, II, III and IV respectively (Figure ‎3.2). The amino acid residues 
AVDPIDGT conserved in motif III have been shown to be involved in metal ion 
binding and phosphatase catalytic activities by crystallographic and mutational analysis 
(Brown et al., 2009).  It is interesting to note that the presence of the conserved block 
III in proteins is not sufficient for identification of FBPase members (Brown et al., 
2009; York et al., 1995).  
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Table ‎3.1: BLAST homology results for the deduced amino acid sequence of the 
putative fructose 1,6-bisphosphatase II  (cac1088). 
Species 
 
Putative 
protein 
% Identity % Similarity Predicted 
molecular 
mass (Da) 
Accession 
number 
C. 
carboxidivorans 
P7 
Fructose 1,6-
bisphosphatase
, class II  
78 
 
89 34364 
 
ZP_05392
875 
 
C. sporogenes 
ATCC 15579 
Fructose 1,6-
bisphosphatase
, class II 
78 89 34306 ZP_02995
269 
C. botulinum A 
str. ATCC 3502 
 
Fructose 1,6-
bisphosphatase
, class II  
78 
 
89 
 
34304 
 
YP_00125
5113 
 
C. botulinum A3 
str. Loch Maree 
 
Fructose 1,6-
bisphosphatase 
II 
 
77 
 
89 
 
34304 
 
YP_00178
7935 
 
C. botulinum 
B1 str. Okra 
 
Fructose 1,6-
bisphosphatase 
II  
77 
 
89 
 
34286 
 
YP_00178
2231 
 
C. novyi NT 
 
Fructose 1,6-
bisphosphatase 
II 
77 
 
89 
 
34227 
 
YP_87773
6 
 
C. botulinum C 
str. Eklund 
 
Fructose 1,6-
bisphosphatase
, class II 
76 
 
90 
 
34281 
 
ZP_02621
295 
 
C. botulinum D 
str. 1873 
 
Fructose 1,6-
bisphosphatase
, class II 
75 
 
89 
 
34216 
 
ZP_04862
266 
 
C.  botulinum 
BKT015925 
Fructose 1,6-
bisphosphatase 
II 
75 
 
89 
 
34255 
 
YP_00439
5515 
 
C. tetani E88 
 
Fructose 1,6-
bisphosphatase 
II  
74 
 
87 
 
34339 
 
NP_78165
7 
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Continuation of Figure 3.2 
           
           
C.ace    : 
C.boA    : 
C.bo_BKT : 
C.bo_B1  : 
C.bo3    : 
C.sp     : 
C.nov    : 
C.bo_C   : 
C.bo_D   : 
C.car    : 
C.tet    : 
Mtb      : 
Eco      : 
           
                                                       
         *        20         *        40         *     
---------------MFDNDISMSLVRVTEAAALQSSKYMGRGDKIGADQAAVDG
---------------MLNTDIAMGLARVTEAAALSASKFMGRGDKNAADQAAVDG
---------------MKNLDVSMGLVRVTEAAALNGAKLMGRGDKNAADQAAVDG
---------------MLNTDIAMGLARVTEAAALSASKFMGRGDKNAADQAAVDG
---------------MLNTDIAMGLARVTEAAALSASKFMGRGDKNAADQAAVDG
---------------MLNTDIAMGLARVTEAAALSASKFMGRGDKNAADQAAVDG
---------------MNNLDVSMGLVRVTEAAALNGAKLMGRGDKNAADQEAVNG
---------------MNNLDVSMGLIRVTEAAALNGSKLMGRGDKNAADQEAVNG
---------------MKNLDVSMGLVRVTEAAALNGAKLMGRGDKNAADQAAVDG
---------------MLNTDIAMGLARVTEAAALCSSKFMGRGDKIAADQAAVDG
---------------MIKQDIAMGLVRVTEAAALCSSKYMGRGDKIAADQAAVDG
MASHDPSHTRPSRREAPDRNLAMELVRVTEAGAMAAGRWVGRGDKEGGDGAAVDA
----------------MRRELAIEFSRVTESAALAGYKWLGRGDKNTADGAAVNA
                                                       
      
      
 :  40
 :  40
 :  40
 :  40
 :  40
 :  40
 :  40
 :  40
 :  40
 :  40
 :  40
 :  55
 :  39
      
           
           
C.ace    : 
C.boA    : 
C.bo_BKT : 
C.bo_B1  : 
C.bo3    : 
C.sp     : 
C.nov    : 
C.bo_C   : 
C.bo_D   : 
C.car    : 
C.tet    : 
Mtb      : 
Eco      : 
           
                                                       
   60         *        80         *       100         *
MEKAFSFMPVRGQVVIGEGELDEAPMLYIGQKLGMGKDYMPEMDIAVDPLDGTIL
MHKAFQIMPIRGKVVIGEGELDEAPMLYIGEEVGIGAEDMVEMDIAVDPVDGTKL
MEKAFNMMPIRGKVVIGEGEMDEAPMLYIGQSVGVGEEKMPEMDIAVDPIDGTVL
MHKAFQIMPIRGKVVIGEGELDEAPMLYIGEEVGIGAEDMVEMDIAVDPVDGTKL
MHKAFQIMPIRGKVVIGEGELDEAPMLYIGEEVGIGAEDMLEMDIAVDPVDGTKL
MHKAFQIMPVRGKVVIGEGELDEAPMLYIGEEVGIGAEDMVEMDIAVDPVDGTKL
MEKAFNMMPIRGNVVIGEGEMDEAPMLYIGQKVGVGQEDMPEMDIAVDPIDGTVL
MEKAFNMMPIRGNVVIGEGEMDEAPMLYIGQKVGIGREDMPEMDIAVDPIDGTVL
MEKAFNMMPIRGRVVIGEGEMDEAPMLYIGQNVGVGEENMPEMDIAVDPIDGTVL
MEKAFAMMPVRGTVVIGEGELDNAPMLYIGQSVGVGSADMPEMDIAVDPLDGTIL
MEKAFSMLPIKGTVVIGEGEMDEAPMLYIGQKLGIGTDGMEEMDIAVDPLDGTVL
MRELVNSVSMRGVVVIGEGEKDHAPMLYNGEEVGNG--DGPECDFAVDPIDGTTL
MRIMLNQVNIDGTIVIGEGEIDEAPMLYIGEKVGTG--RGDAVDIAVDPIEGTRM
                                                       
      
      
 :  95
 :  95
 :  95
 :  95
 :  95
 :  95
 :  95
 :  95
 :  95
 :  95
 :  95
 : 108
 :  92
      
           
           
C.ace    : 
C.boA    : 
C.bo_BKT : 
C.bo_B1  : 
C.bo3    : 
C.sp     : 
C.nov    : 
C.bo_C   : 
C.bo_D   : 
C.car    : 
C.tet    : 
Mtb      : 
Eco      : 
           
                                                       
       120         *       140         *       160     
ISKGLPNAIAVIAMGPKGSLLH-APDMYMKKIVVGPGAKGAIDINKSPEENILNV
IAKGLENAIAVVAMGPKGSLFH-APDMYMKKIAVGAGAKGAIDINKSPKENILNV
IAKGLPNSIAVVAMGPKGSLLH-APDMYMQKIAVGPGARGSIDINKSPRENIINV
IAKGLENAIAVVAMGPKGSLFH-APDMYMKKIAVGAGAKGAIDINKSPKENILNV
IAKGLENAIAVVAMGPKGSLFH-APDMYMKKIAVGAGAKGAIDINKSPKENILNV
IAKGLENAIAVVAMGPKGSLFH-APDMYMKKIAVGSGAKGAIDINKSPKENILNV
IAKGLPNSIAVVAMGPKGSLLH-APDMYMKKIAVGPGAVGAIDINKSPKENIINV
IAKGLPNSIAVVAMGPKGSLLH-APDMYMKKIAVGPGAKGAIDINKSPKENIINV
IAKGLPNSIAVVAMGPKGSLLH-APDMYMQKIAVGPGAKGAIDINKSPKENIINV
IAKGLPNAIAVVAMGPKESLFH-APDMYMKKIAVGPGAKGAIDINKSPKENIINV
IAKGLPNAVSVMAMGPKGSLLN-APDMYMKKIAVGASAKGVIDINKTNKENIINV
MSKGMTNAISVLAVADRGTMFDPSAVFYMNKIAVGPDAAHVLDITAPISENIRAV
TAMGQANALAVLAVGDKGCFLN-APDMYMEKLIVGPGAKGTIDLNLPLADNLRNV
                                                       
      
      
 : 149
 : 149
 : 149
 : 149
 : 149
 : 149
 : 149
 : 149
 : 149
 : 149
 : 149
 : 163
 : 146
      
           
           
C.ace    : 
C.boA    : 
C.bo_BKT : 
C.bo_B1  : 
C.bo3    : 
C.sp     : 
C.nov    : 
C.bo_C   : 
C.bo_D   : 
C.car    : 
C.tet    : 
Mtb      : 
Eco      : 
           
                                                       
    *       180         *       200         *       220
AKALNKDISELTVIVQERERHDYIVKAAIEVGARVKLFGEGDVAAALACGFEDTG
ARALNKDVTELTVIVQERDRHDYIVKDAREVGARVKLFGEGDVAAVLACGFEDTG
AKALNKDIEDLTVIVQERERHNYIVEQAREVGARVKLFAEGDVAAILACGFENTG
ARALNKDVTELTVIVQERDRHDYIVKDAREVGARVKLFGEGDVAAVLACGFEDTG
ARALNKDVTELTVIVQERDRHDYIVKDAREVGARVKLFGEGDVAAVLACGFEDTG
ARALNKDVTELTVIVQERDRHDYIVKDAREVGARVKLFGEGDVAAVLACGFEDTG
AKALNKDIEDLTIIVQERERHDYIVEQAREVGARVKLFGEGDVAAILACGFENTG
AKALSKEIEDLTVIVQERERHDYIVEQAREVGARVKLFGEGDVAAILACGFENTG
AKALNKDIEDLTVIVQERERHNYIVEQAREVGARVKLFAEGDVAAILACGFENTG
SKALNKDITEMTVIVQERERHNYIVQAAREVGARVKLFGEGDVAAVLACGFENTG
AMALNKDVTELTIMVQERERHNDIIKDAREVGARVKLFSEGDVAAVLACGFESTG
AKVKDLSVRDMTVCILDRPRHAQLIHDVRATGARIRLITDGDVAGAISACRPHSG
AAALGKPLSELTVTILAKPRHDAVIAEMQQLGVRVFAIPDGDVAASILTCMPDSE
                                                       
      
      
 : 204
 : 204
 : 204
 : 204
 : 204
 : 204
 : 204
 : 204
 : 204
 : 204
 : 204
 : 218
 : 201
      
I
IV
II III
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Figure ‎3.2: Alignment of the putative C. acetobutylicum fructose 1,6-
bisphosphatase II  (cac1088) sequence with the closest homologues.   
The deduced amino acid sequence of the putative C. acetobutylicum fructose 1,6-
bisphosphatase II protein is aligned with the fructose 1,6-bisphosphatase protein 
sequences with the highest percentage identities from the BLAST output and 
experimentally verified FBPase II enzymes in M. tuberculosis (Mtb) and E. coli (Eco).  
Dashes within the sequences indicate gaps giving optimal alignment.  The amino acids 
are highlighted according to 90% or more (red), 80% (yellow), 60% (grey) and non-
highlighted less than 60% conservation. Abbreviations: C.ace, C. acetobutylicum ATCC 
824; 
 
 
 
           
           
C.ace    : 
C.boA    : 
C.bo_BKT : 
C.bo_B1  : 
C.bo3    : 
C.sp     : 
C.nov    : 
C.bo_C   : 
C.bo_D   : 
C.car    : 
C.tet    : 
Mtb      : 
Eco      : 
           
                                                       
         *       240         *       260         *     
IDILMGIGGAPEGVIAAAAIKCMGGEMQAQLIPHTQE-------------EIDRC
VDIMMGTGGAPEGVIAAAAIKCMGGEMQAQLCPTSQE-------------EIERC
IDLMIGTGGAPEGVIAAAAIKCMGGEIQAKLEPHTDE-------------ERERC
VDIMMGTGGAPEGVIAAAAIKCMGGEIQAQLCPTSQE-------------EIERC
VDVMMGTGGAPEGVIAAAAIKCMGGEMQAQLCPTSQE-------------EIERC
VDIMMGTGGAPEGVIAAAAIKCMGGEMQAQLCPTSQE-------------EIERC
IDLMIGTGGAPEGVIAAAAIKCMGGEMQAILEPHTEE-------------EIKRC
IDLMIGTGGAPEGVIAAAAIKCMGGEIQAILEPHTEE-------------EVRRC
IDLMIGTGGAPEGVIAAAAIKCMGGEIQAKLEPHTDE-------------ERERC
VDIFMGTGGAPEGVIAAAAIKCMGGDMQAKLEPHTDE-------------ERERC
VDMMMGTGGAPEGVIAAAAIKCMGGDMQAKLVPQNEE-------------EIRRC
TDLLAGIGGTPEGIIAAAAIRCMGGAIQAQLAPRDDA-------------ERRKA
VDVLYGIGGAPEGVVSAAVIRALDGDMNGRLLARHDVKGDNEENRRIGEQELARC
                                                       
      
      
 : 246
 : 246
 : 246
 : 246
 : 246
 : 246
 : 246
 : 246
 : 246
 : 246
 : 246
 : 260
 : 256
      
           
           
C.ace    : 
C.boA    : 
C.bo_BKT : 
C.bo_B1  : 
C.bo3    : 
C.sp     : 
C.nov    : 
C.bo_C   : 
C.bo_D   : 
C.car    : 
C.tet    : 
Mtb      : 
Eco      : 
           
                                                       
  280         *       300         *       320         *
HKMGIDDVNKIFMIDDLVKSDNVFFAATAITECDLLKGIVFSKNERAKTHSILMR
KTMGIKDHEAILYIDDLVKSDDVYFAATAITDCDLLKGVVYNRNEKAITNSIVMR
KLMGIEDIEKVLTMDDLVMSDDVYFAATALTDSDLLKGVIFSKGDVATTHSVVMR
KTMGIKDHEAILYIDDLVKSDDVYFAATAITDCDLLKGVVYNRNEKAITNSIVMR
KTMGIKDHEAILYIDDLVKSDDVYFAATAITDCDLLKGVVYNRNEKAITNSIVMR
KTMGIKDHEAILYIDDLVKSDDVYFAATAITDCDLLKGVVYNRNEKAITNSIVMR
KEMGIEDINKVLTTDDLVKSDDVYFAATALTDSDLLKGVVFSKNDMATTHSVVMR
KDMGIEDINKVLTMDDLVKSDDVYFAATALTDSDLLKGVVFSKNDVATTHSVVMR
KLMGIEDVEKVLTMDELVMSDDVHFAATALTDSDLLKGVVFSKGDMATTHSVVMR
KSMGISDLNKVLLINDLVKDDEVYFAATGITDCDLLRGVVFSKNDWATTHSVVMR
KSMGIENVEATLYINDLVKSDDIYFAATAVTDSDLLKGVVYSKNNWATTQSIVMR
LEAG-YDLNQVLTTEDLVSGENVFFCATGVTDGDLLKGVRYYPGG-CTTHSIVMR
KAMG-IEAGKVLRLGDMARSDNVIFSATGITKGDLLEGIS-RKGNIATTETLLIR
                                                       
      
      
 : 301
 : 301
 : 301
 : 301
 : 301
 : 301
 : 301
 : 301
 : 301
 : 301
 : 301
 : 313
 : 309
      
           
           
C.ace    : 
C.boA    : 
C.bo_BKT : 
C.bo_B1  : 
C.bo3    : 
C.sp     : 
C.nov    : 
C.bo_C   : 
C.bo_D   : 
C.car    : 
C.tet    : 
Mtb      : 
Eco      : 
           
                                     
       340         *       360       
SKTGTIRFVEAIHDLNK------------SKLVVE--
SKTGTIRFVKACHNLAK------------SAIVVE--
SKTRTIRFVEAVHCAEK------------SCLL----
SKTGTIRFVKACHNLAK------------SAIVVE--
SKTGTIRFVKACHNLAK------------SAIVVE--
SKTGTIRFVKACHNLAK------------SAIVVE--
SKTRTIRFVEAVHCAEK------------SCLL----
SKTRTIRFVEAVHCAEK------------SCLL----
SKTRTIRFVEAVHCAEK------------SCLL----
AKTGTVRFIEAHHDLKR------------SSLVVR--
SKTGTIRFVDAQHHLSR------------SNLVL---
SKSGTVRMIEAYHRLSKLNEYSAIDFTGDSSAVYPLP
GKSRTIRRIQSIHYLDR----------KDPEMQVHIL
                                     
      
      
 : 324
 : 324
 : 322
 : 324
 : 324
 : 324
 : 322
 : 322
 : 322
 : 324
 : 323
 : 350
 : 336
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C.car, C. carboxidivorans P7; C.sp, C. sporogenes ATCC 15579; C.boA, C. botulinum 
A str. ATCC 3502; C.bo3, C. botulinum A3 str. Loch Maree; C.bo B1, Clostridium 
botulinum B1 str. Okra; C.nov, C.  novyi NT; C.bo C, C. botulinum C str. Eklund; C.bo 
D, C. botulinum D str. 1873; C.bo BKT, C. botulinum BKT015925; C.tet, C. tetani E88; 
Mtb, M. tuberculosis and Eco, E. coli. 
 
3.2.3 The cac1572 gene 
Bioinformatic analysis of the locus tag cac1572 of the C. acetobulycum genome 
revealed the presence of a second putative fructose 1,6-bisphosphatase-like class III 
protein (Fbp) of 665 aa. A BLAST search using the deduced amino acid sequence of the 
putative C. acetobulycum Fbp protein revealed that cac1572 is closely related to 
FBPase_2 family of proteins (Pfam06874). This family consists of several bacterial 
fructose-1,6-bisphosphatase proteins (EC:3.1.3.11) belonging to the Firmicutes phylum. 
The Pfam06874 appears to be not structurally related to class II FBPase_GlpX enzymes 
(Pfam003320).  Also, the BLAST search results are presented in Table  3.2.  All of the 
top ten hits from the BLAST search are from the genus Clostridium. The putative 
FBPase of C. cellulovorans 743B shares 73% identity with the putative C. 
acetobutylicum FBPase protein (cac1572). The cac1572 also shares similarity with 
putative FBPases of other Clostridium spp.  The protein sequences of the top ten 
BLAST hits were then aligned in ClustalW2 together with the experimentally proven 
class III FBPases protein sequences of B. subtilis (Fujita et al., 1998) and then 
visualised in GeneDoc.  Several conserved motifs can be seen through the alignment 
result together with the B. subtilis enzyme indicating that putative C. acetobutylicum fbp 
gene (cac1572) is most likely to encode for a class III FBPase protein.    
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Table ‎3.2 BLAST homology results for the deduced amino acid sequence of the 
putative fructose 1,6-bisphosphatase III (cac1572). 
Species Putative 
protein 
% Identity % Similarity Predicted 
molecular 
mass (Da) 
Accession 
number 
C. 
cellulovorans 
743B 
Fructose 1,6-
bisphosphatase 
 
73 
 
87 
 
76707 
 
YP_00384
2980 
 
C. beijerinckii 
NCIMB 8052 
 
Fructose 1,6-
bisphosphatase 
 
73 
 
87 
 
76726 
 
YP_00130
9581 
 
C. botulinum D 
str. 1873 
 
Fructose 1,6-
bisphosphatase 
 
71 
 
83 
 
76535 
 
ZP_04863
125 
 
C. botulinum C 
str. Eklund 
 
Fructose 1,6-
bisphosphatase 
 
70 
 
84 
 
76294 
 
ZP_02620
031 
 
C. botulinum 
BKT015925 
 
Fructose 1,6-
bisphosphatase 
 
70 
 
83 
 
76412 
 
YP_00439
5366 
 
C. novyi NT 
 
Fructose 1,6-
bisphosphatase 
 
68 
 
83 
 
76286 
 
YP_87759
3 
 
C. ljungdahlii 
DSM 13528 
 
Fructose 1,6-
bisphosphatase 
 
68 
 
83 
 
77329 
 
YP_00378
1055  
 
C. botulinum 
A2 str. Kyoto 
 
Fructose 1,6-
bisphosphatase 
 
69 
 
85 
 
77256 
 
YP_00280
2849  
 
C. botulinum Bf 
 
Fructose 1,6-
bisphosphatase  
 
69 
 
85 
 
77257 
 
ZP_02616
118 
 
C. sporogenes 
ATCC 15579 
 
hypothetical 
protein 
 
68 
 
85 
 
77298 
 
ZP_02994
084  
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Continuation of Figure 3.3 
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
         *        20         *        40         *        
------MLLESNTKNEEIKD-----------NLKYLVLLSKQYPTINEAATEIINLQA
------MTFCDENNLDLIKR-----------DLRYLNLLSKQYPDISSASTEIVNLQA
------MTFCDENNLDLIKR-----------DLRYLKLLAKQYPDISSASTEIVNLQA
------MTFCDENNLDLIKK-----------DLRYLKLLANQYPNISSASTEIVNLQA
------MTFCDENNLDLIKK-----------DLRYLKLLANQYPNISSASTEIVNLEA
------MIFYDENNLDIIEK-----------DLRYLQLLSREYPTISSASTEIINLQA
------MTLYDENNLHIIKD-----------NLRYLKLLSKQYPSISSASSEIINLQA
------MTLYDENNLHIIKD-----------NLRYLKLLSKQYPSISSASSEIINLQA
------MSIHKELNELDVEK-----------DLRYLNLLSKEYSTINSVCTEFINLQS
-------MKKYDLSTNEISD-----------NLRYLELLSKQYPTINEASTEIINLQA
MFKNNVILLNSPYHAHAHKEGFILKRGWTVLESKYLDLLAQKYDCEEKVVTEIINLKA
                                                          
      
      
 :  41
 :  41
 :  41
 :  41
 :  41
 :  41
 :  41
 :  41
 :  41
 :  40
 :  58
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
60         *        80         *       100         *      
ILNLPKGTEHFLSDVHGEYEQFIHVLKNASGVIKRKIDDIFGNRLMQSEKKSLATLIY
ILNLPKSTEHFLSDIHGEYESFTHVLKNASGVIKRKIDDVFGNSLRDSEKLTLATVIY
ILNLPKSTEHFLSDIHGEYESFTHVLKNASGVIKRKIDDVFGNSLRDSEKLTLATVIY
ILNLPKSTEHFLSDIHGEYESFTHVLKNASGVIKRKIDDVFGNSLRDSEKLTLATVIY
ILNLPKSTEHFLSDIHGEYESFTHVLKNASGVIKRKIDDVFGNSLRDNEKLTLATVIY
ILNLPKATEHFISDIHGEYESFTHMLRNASGVIKRKIDDVFGNSLREEQKASLATLVY
ILNLPKGTEHFISDVHGEYESFTHMLKNASGVIKRKIDDVFGTSLRECDKKNLATLIY
ILNLPKGTEHFISDVHGEYESFTHMLKNASGVIKRKIDDVFGTSLRECDKKNLATLIY
ILNLPKGTEHFLTDIHGEYEQFNHVLKNASGVIKRKIEDIFGNTLRQNEKKSLATLIY
ILNLPKGTEHFLTDIHGEYEPFIHVLKNASGVIKRKIEDLFGNSLMQSEKKSLATLIY
ILNLPKGTEHFVSDLHGEYQAFQHVLRNGSGRVKEKIRDIFSGVIYDREIDELAALVY
                                                          
      
      
 :  99
 :  99
 :  99
 :  99
 :  99
 :  99
 :  99
 :  99
 :  99
 :  98
 : 116
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
 120         *       140         *       160         *    
YPEQKLDIILK---QEKNIDDWYKITLYRLIEVCRNVSSKYTRSKVRKALPKEFSYII
YPEQKLELIKQ---SEKDLSDWYKITLYRLIELCRVVSSKYTRSKVRKALPHDFAYII
YPEQKLELIKQ---CEKDLSDWYKITLYRLIELCRAVSSKYTRSKVRKALPHDFAYII
YPEQKLELIKQ---SEKDLSDWYKITLYRLIELCRVVSSKYTRSKVRKALPHDFAYII
YPEQKLELIKQ---SEKDLSDWYKITLYRLIELCRVVSSKYTRSKVRKALPHDFAYII
YPERKIELIKE---KEHNLEEWYRISLYQLIELCKNVSSKYTRSKVRKALPSDFSYII
YPEQKLDLIKK---SEKNLEDWYKITLYRLIRLCQIVSSKYTRSKVRKSLPSDFAYII
YPEQKLDLIKK---SEKNLEDWYKITLYRLIRLCQIVSSKYTRSKVRKSLPSDFAYII
YPEQKLDIVLK---EEENINDWYTITLYRLIEICRHVSSKYTRSKVRKALPKDFAYII
YPEQKLEIVLK---QEENIDDWYKINLYRLIEICRYVSSKYTRSKVRKALPKDFTYII
YPEDKLKLIKHDFDAKEALNEWYKETIHRMIKLVSYCSSKYTRSKLRKALPAQFAYIT
                                                          
      
      
 : 154
 : 154
 : 154
 : 154
 : 154
 : 154
 : 154
 : 154
 : 154
 : 153
 : 174
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
   180         *       200         *       220         *  
EELLHEQPKGVDKQEYYDEIIKTIISIDRAKEFITAISKLIQRLVVDRLHIIGDIFDR
EELLHEHDGAFNKQEYYNGIVSTIIDIDRAPEFITAISKVIQRLVVDRLHIIGDIYDR
EELLHEHDGTINKQEYYNGIISTIIDIDRAPEFITAISKVIQRLVVDRLHIIGDIYDR
EELLHEHDGTINKHEYYNGIISTIIDIDRASEFITAISKVIQRLVVDRLHIIGDIYDR
EELLHEHDGTINKHEYYNGIVSTIIDIDRAPEFITAISKVIQRLVVDRLHIIGDIYDR
EELLHDQDDKVDKQAYYNGIIKTIIDINRAPEFIIAISNVIQRLVVDRLHIIGDIYDR
EELLNEQGDRVDKQEYYNSIIETIIDIDRASEFIIAISNVIQRLVVDKLHIIGDIYDR
EELLNEQGDRVDKQEYYNSIIETIIDIDRASEFIIAISNVIQRLVVDKLHIIGDIYDR
EELLHEYPESLDKHGYYGEIVKTIVAIDRAREFIMALSNLIQRLVIDRLHIIGDIFDR
EELLHEQPKGIDKYEYYEQIIRTIIDTDRSKEFIVALSKLIQRLVIDRLHILGDIFDR
EELLYKTEQAGNKEQYYSEIIDQIIELGQADKLITGLAYSVQRLVVDHLHVVGDIYDR
                                                          
      
      
 : 212
 : 212
 : 212
 : 212
 : 212
 : 212
 : 212
 : 212
 : 212
 : 211
 : 232
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
     240         *       260         *       280         *
GPRADIIMDKLEEYHAVDIQWGNHDILWMGAASGSSVCMANVIRISARYANLSTIEDG
GPGAEIILEALMKHHSVDIQWGNHDILWMGAAAGSEACICNVLRISLRYANLNTIEDG
GPGAEIILEALMKHHSVDIQWGNHDILWMGAAAGSEACICNVLRISLRYANLNTIEDG
GPGAEIIMEELMKHHSVDIQWGNHDILWMGAAAGSEACICNVLRISLRYANLNTIEDG
GPGAEIIMEELMKHHSVDIQWGNHDILWMGAAAGSEACICNVLRISLRYANLNTIEDG
GPGAEIIMDALMKHHSVDIQWGNHDMLWMGAAAGCEACIANVLRISLRYANLHTIEDG
GPGAEIIIEALSKHHSIDIQWGNHDIVWMGAAAGCEACIANVIRISLRYANLSTLEDG
GPGAEIIIEALSKHHSIDIQWGNHDIVWMGAAAGCEACIANVIRISLRYANLSTLEDG
GPGAEIILDTLKNYHSVDIQWGNHDVLWMGACAGSKACIANVIRISARYSNLDTIEDG
GPGADIIMDTLVEYHSVDIQWGNHDILWMGAACGSDVCIANVIKNSLKYANLDTLENG
GPQPDRIMEELINYHSVDIQWGNHDVLWIGAYSGSKVCLANIIRICARYDNLDIIEDV
                                                          
      
      
 : 270
 : 270
 : 270
 : 270
 : 270
 : 270
 : 270
 : 270
 : 270
 : 269
 : 290
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C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
       300         *       320         *       340        
YGINLLPLATFAMDFYGNDKCKNFEPKIESDKSYTVKEIELIGKMHKAIAIIQFKLEG
YGINLLPLATFAMDIYENDPCNSFIPKT-INKELTQNEINLISKMHKAIAIIQFKLQG
YGINLLPLATFAMDIYENDPCNSFIPKT-INKELTQNEINLISKMHKAISIIQFKLQG
YGINLLPLATFAMDVYENDPCNSFIPKT-INKELTQNELNLISKMHKAIAIIQFKLQG
YGINLLPLATFAMDVYENDPCNSFIPKT-INKELTQNELNLISKMHKAIAIIQFKLQG
YGINLLPLATFALEFYKDDPCKNFIPKT-LNKDISKNELNLLAKMHKAIAIMQFKLEA
YGINLLPLATFAMDFYKEDNCENFKPRT-IDKNLNETDIKLLSKMHKAISIIQFKLEG
YGINLLPLATFAMDFYKEDNCENFKPRT-IDKNLNETDIKLLSKMHKAISIIQFKLEG
YGINLLPLATFALDFYKEDPCTGFFPKFDAEKNYSVTEIELIAKMHKAIAIIQFKLEG
YGINLLPLATFSMDFYKDHPCNIFLPKMDCDKKYSINEINLIAQMHKAIAIILFKLEG
YGINLRPLLNLAEKYYDDNP--AFRPKA--DENRPEDEIKQITKIHQAIAMIQFKLES
                                                          
      
      
 : 328
 : 327
 : 327
 : 327
 : 327
 : 327
 : 327
 : 327
 : 328
 : 327
 : 344
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
 *       360         *       380         *       400      
EAIKRHPEFKMEHRMLLNKINFEDSTIELDGKKYKLNDTSFPTIDKNDPYKLIDEERE
QIIKNHPEFKMDDQLLLDKINYEKGTINLDGNVYKLNDTIFPTINPKDPYTLSPREND
QIIKNHPEFKMDDQLLLDKINYEKGTISLDGNIYKLNDTVFPTIDPKNPYTLTPGEDD
QIIQNHSEFKMDDQLLLDKIDYEKGTINLSGKIYKLNDTYFPTIDPKNPYKLTESEDD
QIIKNHPEFKMDDQLLLDKINYEKGTIDLDGHIYKLNDTFFPTVDPKDPYKLTENEDD
EIIKRHPEFKMDDRLLLDKIDIEKWEIDIYGHNYKLNDSKFPTIDWNDPYKLTDREQE
KIIKRRPEFKMEERLLLDKINIKEGTLNLNEKIYKLIDTNFPTLDKENPYELNERERD
KIIKRRPEFKMEERLLLDKINIKEGTLNLNEKIYKLIDTNFPTLDKENPYELNERERD
EIINRRPGFNMDDRLLLNKINFEAGTIELDGKTYKLNDTYFPTIDPKDPYKLLKEEQE
QVILRHPEFNMNHRLLLNKINYAEGTINLNGKTHKLKDSFFPTIDPKNPYELTYDEKE
PIIKRRPNFNMEERLLLEKIDYDKNEITLNGKTYQLENTCFATINPEQPDQLLEEEAE
                                                          
      
      
 : 386
 : 385
 : 385
 : 385
 : 385
 : 385
 : 385
 : 385
 : 386
 : 385
 : 402
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
   *       420         *       440         *       460    
VVEKLRSSFVNSEKLNRHVRFLFSHGNLYLKFNSNLLYHGCIPLNEDGTFKEVLIGSH
LIRKLTKSFVNSEKLQRHIRFLYSKGSMYLIYNSNLLYHGCIPLNEDGTFKEVTIDGK
LIKKITKSFVNSEKLQRHIRFLYSKGSMYLIYNSNLLYHGCIPLNEDGTFKEVTIDGK
LIKKLARSFVNSEKLQRHIRFIYSKGSMYLVYNSNLLYHGCIPLNEDGTFREISINGT
LIKKLTRSFVNSEKLQRHIRFMYSKGSMYLVYNSNLLYHGCVPLNEDGTFKEITIDGV
LIEKLTSSFVNSEKLQRHIKFLYGKGSIYLVYNSNLLYHGCIPLNKDGSFREVKIGKI
LVEKLTNSFINSEKLQRHIKFLYSNGSLYLKYNSNLLYHGCIPLNEDGSLKEVTLCKE
LVEKLTNSFINSEKLQRHIKFLYSNGSLYLKYNSNLLYHGCIPLNEDGSLKEVTLCKE
LVEKLRSSFMNSDKLNKHVRFLFANGSIYLKYNSNLLYHGCIPMNENGTFKKVRLRDK
LIDKLKTSFINSDKYNKHVRFLYSNGSLYLKFNSNLLYHGFIPLNEDGSFKKVKIADK
VIDKLLFSVQHSEKLGRHMNFMMKKGSLYLKYNGNLLIHGCIPVDENGNMETMMIEDK
                                                          
      
      
 : 444
 : 443
 : 443
 : 443
 : 443
 : 443
 : 443
 : 443
 : 444
 : 443
 : 460
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
     *       480         *       500         *       520  
KYKGKALLDKLDVLARKSFFYEENSKNSKYENDMIWYLWSGPFSPLFGKEKMTTFERY
KYWGKSLLDKFDCLAREAFFFKEDSKIKKFAMDMVWYLWCGPNSPEFGKYRMTTFERY
KYFGKSLLDKFDCLAREAFFFKEDSRLKKFAMDMVWYLWCGPNSPEFGKYKMATFERY
RYKGKSLLDKFDSLARESFFFKKGSKAKKFALDMVWYLWCGPNSPEFGKLRMTTLERY
RYSGKSLLDKFDSLAREAFFFKNGSSAKRFALDMMWYLWCGPNSPEFGKLRMTTLERY
SYSGRELLDRYDRLARDAFFFKNNTNSKKYGMDMMWYMWCGEDSPVFGKVRMTTFERY
TLKGKSLLDKLDRLAREAYFFKKDPESKLYGMDMMWYLWCGPNSPLFGKKKMTTFERY
TLKGKSLLDKLDRLAREAYFFKKDPESKLYGMDMMWYLWCGPNSPLFGKKKMTTFERY
EYNGKSLLDRLEILAREGYFHEDNPAAKLFGTDIMWYLWTGPYSPLFGKEKMTTFERY
EYKGKELLDKLDMLAREAYFSKDKDDSDNK-KDIMWYLWCGASSPLFGKDRMTIFEQY
PYAGRELLDVFERFLREAFAHPEET--DDLATDMAWYLWTGEYSSLFGKRAMTTFERY
                                                          
      
      
 : 502
 : 501
 : 501
 : 501
 : 501
 : 501
 : 501
 : 501
 : 502
 : 500
 : 516
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
       *       540         *       560         *       580
FIDDKKTHYEKKDPYYHYRDDEDICINILREFGLDSEQAHIINGHVPVESKNGENPIK
FIDNEGTHIEYRNPYYKYRSDEKIVINILKEFGLDPNCSHIINGHIPVKTKAGENPIK
FIDNEGTHIEYRNPYYKYRSNEKVVINILKEFGLDPNCSHIINGHIPVKTKAGENPIK
FIDDKGTHIEYRNPYYKYRSNEDVVINILKEFGLDPDCSHIINGHIPVKTKAGENPIK
FIDDKGTHIEYRNPYYKYRSNEKVVTNILKEFGLDPDCSHVINGHIPVKTKAGENPIK
FIDDKIAHYEKKNYYYQYRDDENVCKNILAEFNLPPESSHIINGHIPVKTKEGESPIK
FLDDKNTHKEQKNPYYKYRNDEKMCTMIFEEFELDADNSHIINGHIPVKTKEGENPIK
FLDDKNTHKEEKNPYYKYRNDEKMCTMIFEEFELDADNSHIINGHIPVKTKEGENPIK
FIDDKKTHIEKKDPYYNFRDKEEVYDNIFSEFGLDPNESHIVNGHVPVEKKKGESPIK
FIEEKETHYEKKDPYFSLRDNEDICKKILKEFGLSSPESHIINGHMPVEEKNGESPIK
FIKEKETHKEKKNPYYYLREDEATCRNILAEFGLNPDHGHIINGHTPVKEIEGEDPIK
                                                          
      
      
 : 560
 : 559
 : 559
 : 559
 : 559
 : 559
 : 559
 : 559
 : 560
 : 558
 : 574
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Continuation of Figure 3.3 
 
Figure ‎3.3: Multiple alignment of the putative C. acetobutylicum fructose 1,6-
bisphosphatase (cac1572) sequence with the top 10 results from the BLAST search.   
The deduced amino acid sequence of the putative C. acetobutylicum fructose 1,6-
bisphosphatase protein is aligned with the fructose 1,6-bisphosphatase protein 
sequences with the highest percentage identities from the BLAST output.  Dashes 
within the sequences indicate gaps giving optimal alignment. The amino acids are 
highlighted according to 90% or more (red), 80% (yellow), 60% (grey) and non-
highlighted less than 60% conservation.  Abbreviations: C.acet, C. acetobutylicum 
ATCC 824; C.cell, C. cellulovorans 743B; C.beij, C. beijerinckii NCIMB 8052; C.bot, 
C. botulinum D str. 1873; C.bot C, C. botulinum C str. Eklund; C.bot BKT, C. 
botulinum BKT015925; C.novy, Clostridium novyi NT; C.botA2, C. botulinum A2 str. 
Kyoto; C.botB, C. botulinum Bf; C.ljun, C. ljungdahlii DSM 13528 and B.sub, B. 
subtilis str. 168. 
  
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                          
         *       600         *       620         *       6
ANGKLIVIDGGFSKAYQSKTGIAGYTLIYNSFGLQLVSHELFETTEKAIKEETDIISS
ANGKLLVIDGGFCRAYQPETGIAGYTLIYNSYGLLLSSHEPFSSIRKAIEEEKDILSS
ANGKLLVIDGGFCRAYQPETGIAGYTLIYNSYGLLLSSHEPFSSIRKAIEEEKDILSS
ANGKLLVIDGGFCRAYQPETGIAGYTLIYNSYGLLLSSHEPFSSIRKAIDEEKDILSS
ANGKLLVIDGGFCRAYQPETGIAGYTLIYNSYGLLLSSHEPFSSIRKAIEEEKDILSS
ANGRLLVIDGGFCKAYQPETGIAGYTLIYNSYGLLLTSHEPFGAIKNAIEEDKDILSS
ANGKLLVIDGGFCKAYQPQTGIAGYTLIYNSYGLLLTSHEPFSSIHKAIVEGNDILSS
ANGKLLVIDGGFCKAYQPQTGIAGYTLIYNSYGLLLTSHEPFSSIHKAIVEGNDILSS
AKGKLLVIDGGFSKAYQGKTGIAGYTLIYNSFGLQLVSHEPFQSTEKAIKEETDILSS
ANGTLLVIDGGFSKAYQPKTGLAGYTLIYNSFGLQLVSHQPFESTEAAIKEETDILST
ANGKMIVIDGGFSKAYQSTTGIAGYTLLYNSYGMQLVAHKHFNSKAEVLSTGTDVLTV
                                                          
      
      
 : 618
 : 617
 : 617
 : 617
 : 617
 : 617
 : 617
 : 617
 : 618
 : 616
 : 632
      
            
            
C.acet    : 
C.bot     : 
C.bot_BKT : 
C.bot_C   : 
C.novy    : 
C.ljun    : 
C.botA2   : 
C.botBf   : 
C.cell    : 
C.beij    : 
B.sub     : 
            
                                                   
40         *       660         *       680         
TVIFEKSVRRKRVGDTDIGKDLKKQLYELNLLLLAYKKGLIKEFVKS----
TIILEQVVSRKRVADTDIGKALKKQIRELEMLLIAYRKGLIKEQTSKI---
TIILEQVVSRKRVSDTDIGKNLKKQIRELEMLLIAYRKGLIKEQNSEK---
TIILEQVVSRKRVADTDIGKDLKKQIEELEMLLIAYRKGLIKEQDSKS---
TIILEQVVSRKRVADTDIGKELKKQIAELKMLLIAYRKGLIKEQDSKS---
TVILEHVTKRKRVEDTDIGKDLTKQIADLEKLLIAYRKGLIKEDNNQIE--
TTILEHVSSRKRVLDTDSGEEIKKQIHDLEMLLVAYRKGLIKEENEANIRF
TTILEHVSSRKRVLDTDSGEEIKKQIHDLEMLLVAYRKGLIKEENEANIRF
TVILEHSMVRKKVADTDVGAILQEQIKNLKMLLIAYRTGLIKEKNSI----
TLLLEQVVNRKRVEDTDVGVTLKQQIDDLKMLLNAYRKGLIKQQNKI----
KRLVDKELERKKVKETNVGEELLQEVAILESLR-EYR--YMK---------
                                                   
      
      
 : 665
 : 665
 : 665
 : 665
 : 665
 : 666
 : 668
 : 668
 : 665
 : 663
 : 671
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3.3 Cloning glpX and fbp genes using TOPO cloning system 
 
3.3.1 Cloning of the C. acetobutylicum class II glpX gene 
The putative class II glpX-like gene (cac1088) was amplified by PCR using the 
TOPOglpX reverse and forward primers (Table ‎2.5: Primer details with annealing 
temperture 52°C and the purified genomic DNA of C. acetobutylicum as template, to 
produce a PCR product of about 1.1 kbp (Figure 3.1). This fragment which contains a 
single deoxyadenosine (A) at the 3´ ends was then cloned into the pCR2.1-TOPO vector 
(Appendix  7.4) that contains single 3´-thymidine (T) overhangs allowing the PCR 
product to ligate easily with the vector. Also, this vector contained the lacZα gene 
encoding for α part of beta-galactosidase, an enzyme that converts the colourless X-gal 
(5-bromo-4-chloro-3-indolyl-[beta]-D-galactopyranoside) modified galactose sugar into 
a coloured product (blue). In the pCR2.1-TOPO vector, the cloning site is located 
within the lacZα gene (Appendix  7.4).  When the foreign gene is cloned into that site, 
this results in disturbing the lacZα gene which in turn cannot produce the beta-
galactosidase peptide.  Therefore, the colonies that contain the foreign gene would be 
white and this is the foundation of the blue/white screening technique.  The recombinant 
plasmids were transformed into two chemically competent strains of E. coli Mach1
™
-
T1R and TOP10F`.  The Mach1
™
-T1R is a genetically modified E. coli strain which 
harbours a gene (tonA) confering resistantce to T1 phage.  However, TOP10F` is a 
genetically modified E. coli strain which harbours the lacIq repressor gene, hence, 
reduces the background expression of the cloned gene.  Different amounts of both 
transformed cells (25, 50, 75, 100, and 125 µl) were plated on five different LB plates 
(+Amp) for plasmid selection and X-gal for white/blue screening.  The efficiency of 
transformation was poor and the plates had 1, 6, 14, 49, and 74 white colonies, 
respectively.  These colonies were transferred onto fresh plates and given reference 
numbers.  Six colonies were selected (five white and one blue) for PCR screening to 
check whether these colonies contained the insert or not.  PCR screening was carried 
out using the same TOPOglpX reverse and forward primers and the DNA template 
which was the recombinant plasmid extracted using the boiling method.  Four colonies 
out of 6 were positive (contained the cloned glpX gene), 3 were white colonies and 1 
was blue (Figure 3.1).  These colonies were named and numbered based on two factors; 
competent cells in which the gene was transformed (M for Mach1™-T1R and T for 
TOP10F`) and colony colour (W for white and B for blue). 
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Table ‎3.3: Locations of TOPOglpX primers on the sequence of cac1088 (glpX 
gene). 
Bases underlined represent the location of TOPOglpX primers.  Bases highlighted in 
green, red and gray represent the start codon, stop codon and the hindIII cutting site 
respectively.  Obtained from Genome Information Broker.  
http://gib.genes.nig.ac.jp/single/index.php?spid=Cace_ATCC824 
 
 
 
ACTTTAGGACACTATAGCGCATATATAAATTTTTATGGTTGCAATGTGTTTATAAACAAATGTTTAATAT
AATCAAGGAGGGAAATTCATGTTTGATAATGATATATCCATGAGTTTAGTAAGAGTAACAGAAGCAGCAG
CACTACAATCTTCAAAGTATATGGGAAGAGGAGATAAAATTGGAGCTGATCAAGCAGCAGTAGATGGAAT
GGAGAAGGCATTTAGTTTTATGCCAGTAAGAGGCCAGGTTGTAATAGGAGAGGGAGAACTTGATGAAGCT
CCTATGCTTTATATAGGTCAAAAGCTTGGTATGGGAAAAGACTATATGCCTGAAATGGATATAGCAGTAG
ATCCTTTAGATGGAACGATTTTAATTTCTAAGGGACTACCTAATGCAATAGCAGTAATAGCAATGGGACC
AAAAGGAAGTTTACTTCATGCCCCAGATATGTATATGAAGAAAATTGTTGTGGGACCTGGAGCAAAAGGT
GCTATAGATATAAATAAATCTCCTGAAGAGAATATTTTAAATGTAGCAAAGGCATTAAACAAGGACATAT
CTGAATTAACAGTTATAGTTCAAGAAAGAGAAAGACATGACTACATAGTAAAAGCAGCTATAGAAGTTGG
AGCAAGAGTTAAGCTATTTGGTGAGGGCGATGTTGCAGCTGCACTTGCTTGTGGTTTTGAAGATACTGGA
ATAGACATACTTATGGGAATTGGAGGAGCTCCAGAAGGAGTTATAGCCGCAGCAGCTATCAAGTGCATGG
GCGGAGAAATGCAGGCTCAGCTTATACCTCATACTCAGGAAGAAATAGATAGATGTCACAAAATGGGAAT
AGATGATGTAAATAAAATTTTCATGATAGATGATTTAGTTAAAAGTGATAATGTGTTTTTTGCAGCTACA
GCAATAACAGAATGTGATCTTCTTAAGGGCATAGTATTTTCTAAAAATGAACGTGCAAAAACCCATTCCA
TATTAATGAGATCTAAAACTGGTACAATAAGATTTGTTGAAGCTATTCATGACTTGAATAAAAGTAAATT
AGTGGTAGAATAAAA 
TTAAAATGTTCGATTTACGGCGAAGGGGGATAGTAAATGCAGGTAA 
  
TOPOglpX forward primer    
TOPOglpX reverse primer  
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Therefore, for example the number one blue Mach1
™
-T1R colony on the plate is 
referenced as M1B.  White and blue colonies were tested for the presence of the insert 
using the same TOPOglpX primers which were used to amplify the gene from 
chromosomal DNA of C. acetobutylicum.  Also the blue colony, considered to be 
lacking an insert, was tested as a control.  Surprisingly, the blue colony was positive 
(contained an insert) and was termed M1B.  Moreover, the 3 white colonies, T1W, M1W, 
and M2W were positive, while the other two white colonies, M3W and T2W were 
negative (no insert).    
                                                                                     
 
 
Figure ‎3.4:  Two agarose gels of PCR amplification and screeing of glpX gene.  
(A) Amplification of C. acetobutylicum putative class II FBPase gene (glpX) using 
TOPOglpX primers forward and reverse as indicated by lanes 2 and 3.  (B) PCR 
screening of 6 colonies as indicated by lane 2, T1W strain, lane 3, M1W strain, lane 4, 
M2W, lane 5, M1B strain, lane 6, T2W strain, and lane 7, M3W strain.  Lane 1, 
represents molecular weight makers (hyperladder I) from Bioline. 
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3.3.2 Determination of the orientation of the insertion using PCR analysis 
In the pCR2.1-TOPO vector, the cloned gene can be placed under the control of the lac 
or T7 promoter (appendix ‎7.4).  Therefore, the orientation of the insert needs to be 
determined using PCR and restriction digest analysis.  After testing for the presence of 
the glpX gene, the orientation of the insert (glpX) was determined by PCR using one of 
the TOPOglpX primers (forward or reverse) along with the T7 promoter primer.  For a 
gene under the control of the lac promoter, the result will be a fragment of about 1.2 
kbp generated by the TOPOglpX forward and T7 promoter primers and there will be no 
product from the TOPOglpX reverse and T7 promoter primers.  However, for a gene 
under the control of the T7 promoter, the result will be a fragment of about 1.2 kbp 
generated by the TOPOglpX reverse and T7 promoter primers, with no product for the 
TOPOglpX forward and T7 promoter primers (Figure  3.5). Only one from the 6 
colonies tested gave a product by using the TOPOglpX forward and T7 promoter 
primers and this colony was the blue one (M1B) suggesting that the glpX gene was 
under the control of lac promoter, and hence, it was selected for further analysis.  
Strains T1W, M1W, and M2W contained inserts under the control of the T7 promoter. 
surprisingly, even though they were white colonies in the plate; M3W and T2W did not 
give any product using either combination of the TOPOglpX forward and T7 promoter 
primers or the TOPOglpX reverse and T7 promoter primers (Figure  3.6).   
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Figure ‎3.5: Illustration of the strategy to determine the orientation of the insert in 
the pCR2.1-TOPO vector.  
The TOPOglpX reverse, TOPOglpX forward and T7 promoter primers were used in this 
strategy.  (A) When the insert is under the control of lac promoter and (B) when the 
insert is under the control of T7 promoter. P in blue indicates the location of the 
promoter that controls expression of the PCR product.     
  
PCR Product
P
TOPOglpX reverse primer 
TOPOglpX forward primer T7 promoter primer 
(B)
PCR ProductP
TOPOglpX forward primer 
TOPOglpX reverse primer T7 promoter primer 
(A)
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Figure ‎3.6: Agarose gel of PCR analysis to to determine the orientation of the glpX 
gene in the vector.  
The lanes A show amplification of the insert under the control of T7 promoter using the 
TOPOglpX reverse and T7 promoter primers.  The lanes B show amplification of the 
insert under the control of lac promoter using the TOPOglpX forward and T7 promoter 
primers. The lanes 2A and 2B for strain M1B, lanes 3A and 3B for strain T1W , lanes 4A 
and 4B for strain M3W (no insert), lanes 5A and 5B for strain T3W (no insert), lanes 6A 
and 6B for strain M1W and lanes 7A and 7B  for strain M2W. Lane 1, represents 
molecular weight makers (hyperladder I) from Bioline.     
 
Recombinant vectors from strains M1B, M1W, and M2W were purified using the Qiagen 
Plasmid Midi Kit as described in materials and methods section 2.7.2, and then again 
screened by PCR to check whether plasimds that harbour glpX were isolated or not.  All 
the purified plasmids gave positive results for inserts.  Restriction digestions were 
performed in order to reconfirm the orientation of the inserts.  These purified plasmids 
were used in the restriction digest reaction mixture as described in materials and 
methods section 2.7.4.  The size of the pCR2.1-TOPO vector is 3931 bp and PCR 
fragment is 1111 bp, hence, the total size of the recombinant plasmid containing glpX 
gene is 5042 bp.  
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The EcoRI enzyme has two restriction sites in the recombinant vector which can be 
found at 11 bp upstream and at 6 bp downstream of the PCR product (Figure  3.7).  
Therefore, after EcoRI digestion two fragments 1128 bp and 3914 bp should be formed.  
In the case of pM1B, pM1W, and pM2W plasmids, EcoRI gave two products, one was 
around 1000 bp which represents the insert and the second product was around 4000 bp 
and that represents the vector (Figure  3.8).  These results reconfirm that glpX was 
successfully cloned in the plasmid which is consistent with the PCR screening results 
 
However, HindIII restriction sites can be found 60 bp upstream from the insert and 302 
bp from the 5`end of the PCR product (Figure  3.7).  For the insert under control of the 
T7 promoter, products of 869 bp and 4173 bp should be formed, however, products of 
367 bp and 4675 bp should be formed for insert under the control of the lac promoter 
(Figure  3.7).  HindIII digestion of the plasmids pM1W and pM2W gave products of 
around 800 bp and 4,000 bp (Figure  3.8), which indicates that the glpX gene is under the 
control of the T7 promoter.  Whereas for pM1B plasmid, HindIII produces two 
products, one was around 5,000 bp and the second one around 400 bp which indicates 
that the glpX gene is under the control of the lac promoter (Figure  3.8). These results 
were consistent with the PCR screening. 
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Figure ‎3.7: Illustration of the strategy to determine the orientation of the insert in 
the vector by restriction enzymes.  
The blue circle represents the TOPO vector (3931 bp) and the white oblong represents 
the cloned PCR product (1111 bp).  (A) EcoRI cuts the TOPO vector 11 bp from the 5` 
end  and 6 bp from 3` end of the PCR product.  (B) When the insert is under the control 
of the lac promoter, HindIII cuts at 60 bp upstream of the 5` end and 307 bp 
downstream from the 5` end of the PCR product.  (C) when the insert is under the 
control of T7 promoter, HindIII cuts at 60 bp upstream from the 5` end and 809 bp 
downstream from 5` end of the PCR product.        
PCR Product
EcoRI EcoRI
TOPO Vector 
Digested fragment 1128 bp
11 bp 6 bp
(A)
PCR Product
HindIII HindIII
TOPO Vector 
Digested fragment 367 bp
60 bp 307 bp
(B)
PCR Product
HindIII HindIII
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Digested fragment 869 bp
60 bp 809 bp
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Figure ‎3.8: Agarose gel showing HindIII (A) and EcoRI (B) digests of purified 
plasmid.  
In the case of plasmid pM1B which, HindIII produced two products in lane 2A; one was 
around 5,000 bp and the second one around 400 bp. The HindIII digests of the plasmids 
pM1W (lane 3A), and pM2W (lane 4A) gave products of around 800 bp and 4 kbp, 
whereas, plasmid pM1B, pM1W, and pM2W, EcoRI digests produced two fragments, 
one around 4 kbp and the other around 1 kbp in lanes B2, B3 and B4 respectively.    
Lane 1, represents molecular weight makers (hyperladder I) from Bioline. 
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3.3.3 Growth of E. coli strains on different selective media for phenotype studies.  
The phenotypes of all the E. coli mutant strains needed to be checked before 
transferring the plasmids that harbour the glpX gene.  LB Agar plates (+Tet) were used 
to grow the E. coli strains JB103, JB108, JLD2402, JLD2403, and JLD2405.  All these 
strains are tetracycline resistant because they carry the Tn10 transposon (Donahue et al., 
2000).  Also, the E. coli strains JB103, JB108 and JLD2402 all lack a functional fbp 
gene and therefore cannot grow on gluconeogenic substrates such as glycerol.  The 
JB103 strain has multiple copies of the lac repressor gene which allows tight regulation 
of the recombinant gene expression (Lutz & Bujard, 1997).  Whereas, the JB108 strain, 
which also lacks fbp, can express T7 RNA polymerase when induced with Isopropyl β-
D-1-thiogalactopyranoside (IPTG) (Donahue et al, 2000), and therefore, genes under the 
control of the T7 promoter can be indirectly induced by the addition of IPTG to the 
medium.  Moreover, JB108 still has a functional glpX class II gene, but the expression 
level of this gene is very low, hence, it is not sufficient for growth on glycerol (Donahue 
et al., 2000).  However, the JLD2402 strain is a double mutant (∆fbp and ∆glpX) 
(Donahue et al., 2000).  The strains were streaked onto M9 minimal medium that 
contained 0.2% glucose or 0.4% glycerol (+Tet).  All mutants grew on the M9 glucose 
medium as expected.  Whereas, only two out of five strains were able to grow on 
glycerol, JLD2403 (fbp
+
, ∆glpX) and JLD2405 (glpX+, fbp+) (Figure  3.9), due to both 
strains harbouring a functional fbp gene which enables them to grow on gluconeogenic 
substrates such as glycerol (Table  3.4).  The strains JB103, JB108 and JLD2402 were 
unable to grow on glycerol due to the ∆fbp mutation (Table  3.4).  However, all the E. 
coli strains JB103, JB108, JLD2402, JLD2403, and JLD2405 were able to grow on LB 
(Table  3.4). These results indicate that JB103, JB108 and JLD2402 can be used for 
genetic complementation of the fbp mutation.   
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Table ‎3.4: Growth of the E.coli mutants on LB, glycerol and their phynotype.  
Plus sign (+) represents growth and minus sign represents no growth.          
Strain  Genotype  LB Glycerol 
JB103 ∆fbp, glpX+ and lacIq  + - 
JB108 ∆fbp , glpX+ and T7 RNA polymerase + - 
JLD2402 ∆fbp and ∆glpX + - 
JLD2403 fbp
+and ∆glpX + + 
JLD2405 glpX
+
and fbp
+
 + + 
 
 
 
 
 
Figure ‎3.9: Growth of E. coli strains on M9 minimal medium containing 0.4% 
glycerol.  
Each section represents, 1: JB103, 2: JB108, 3: JLD2403, 4: JLD2402, 5: JLD2405, 6: 
JB108. 
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3.3.4 Chemical transformation and complementation of different E. coli mutants. 
Since the PCR analysis of plasmids pM1B and pM1W matched the restriction analysis in 
term of insert orientation, the next stage was to transform selected E. coli mutant strains 
with these plasmids that contain glpX gene. The aim of this step was to investigate 
whether the C. acetobutylicum glpX gene does indeed encode for FBPase or not by 
genetic complementation. Therefore, different E. coli ∆fbp mutants (JB103, JB108 and 
JLD2402) were used to study various phenotypes exerted by the C. acetobutylicum glpX 
gene and then to select the best transformant for enzyme assay.  Purified plasmid pM1B 
containing the insert under the control of lac promoter was transformed into E. coli 
JB103 and JLD2402 mutants all of which lack a functional fbp gene.  However, the 
JB108 strain was transformed as described in section  2.6, using the pM1W plasmid 
containing the insert under the control of T7 promoter because it can express T7 RNA 
polymerase when induced with IPTG.  
 
Due to the vector pCR2.1-TOPO harbouring a gene that encodes for ampicillin 
resistantce, hence, transformants were spread out on LB plates containing ampicillin 
and tetracycline (all the E. coli mutant strains are resistant to tetracycline) to confirm the 
presence of plasmid in the transformants.  After that, each colony was given a name 
such as JB108/pM1W strain which indicates the host strain name and transformed 
plasmid.  Then colonies were transferred onto fresh LB plates (+Amp and +Tet), and to 
M9 glycerol plates (+Amp and +Tet) to observe the differences in the phenotype and 
whether the C. acetobutylicum glpX gene can complement the mutation or not.  
 
The JB108/pM1W strain was also transferred onto M9 glycerol plates (+Amp and +Tet) 
supplemented with IPTG to induce the expression of glpX. Surprisingly, the 
JB108/pM1W strain showed no growth on the M9 glycerol medium containing IPTG 
(Figure  3.10), whereas, in the absence of IPTG, a lot of colonies were formed.  This 
may be due to the cloned glpX gene harbouring an extra sequence upstream of the 
transcriptional start site that RNA polymerase might recognise as a promoter.  
Therefore, the cloned glpX gene would be expressed from that promoter rather than 
from T7 promoter which means that IPTG is not needed (Table  3.5).   
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Another possibility is that addition of IPTG will potentially result in stimulation of 
expression of the cloned DNA in both directions; and therefore a nonsense mRNA 
expressed from the lac promoter might interfere with translation of the mRNA derived 
from the T7 promoter.  
Alternatively, the reason why the IPTG inhibits growth on glycerol may be that the 
overproduction of the foreign clostridial GlpX protein is toxic to the E. coli JB108 strain 
grow on glycerol minimal medium (a poor medium).  Further investigations were 
carried out by streaking JB108/pM1W on LB agar (+Amp and +Tet) supplemented with 
IPTG (Figure  3.11) to test whether the effect of the overexpression of the GlpX protein 
was still present in rich media.  The growth on LB agar was not affected by the addition 
of IPTG and this might indicate that cells can tolerate a high level of GlpX protein when 
grown on rich medium such as LB (Figure  3.11 and Table  3.5) 
 
Figure ‎3.10: Growth of JB108/pM1W strains on two M9 glycerol plates.  
Plate (A) supplemented with IPTG (+Tet), and plate (B) without IPTG (+Tet).  Control 
is the mutant JB108 strain without the recombinant plasmid which harbours glpX. 
 
 
 
 
 
 
 
 
 
                                                                                          Characterisation of glpX gene 
87 
Table ‎3.5: Growth of different E. coli mutant strains in LB and glycerol medium 
supplemented with or without IPTG.   
Plus sign (+) represents growth and  minus sign represents no growth          
Strains/plasmids  LB LB (IPTG) Glycerol Glycerol (IPTG) 
JLD2402/pM1B (lac) + Not tested + + 
JB108/pM1W(T7) + + + - 
JB103/pM1B  (lac) + Not tested + Not tested 
 
 
 
 
Figure ‎3.11: Growth of JB108/pM1W strains on two LB plates.  
Plate (A) supplemented with IPTG (+Tet), and plate (B) without IPTG (+Tet). Control 
is the JB108 strain without the recombinant plasmid which harbours glpX.  
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The JB103/pM1B and JLD2402/pM1B strains in which the cloned glpX gene is under 
the control of the lac promoter, were tested on M9 glycerol medium (+Tet) together 
with their controls, the JB103 and JLD2402 mutants.  Only 15 colonies of JB103/pM1B 
and only one colony of JLD2402/pM1B grew (Table  3.5 and Figure  3.12).  Four out of 
15 colonies of JB103/pM1B were transferred onto another M9 glycerol plate (+Tet) for 
further confirmation (Figure  3.13).  All the four colonies were able to thrive on the 
glycerol plate.  This could be due to that the JB103 strain contains a lac repressor gene, 
which would lower the expression of the clostridial glpX gene that is under the control 
of the lac promoter, thus reducing toxicity and this would allow the cells to thrive and 
grow in poor media such as M9 glycerol.  These results are consistent with the previous 
finding that a high expression level of the clostridial glpX gene is toxic to the tested 
JB108 mutant strain under glycerol growth conditions.  However, poor growth was stil 
observed after transferring the JLD2402/pM1B strain onto another M9 glycerol plate 
(+Tet) (Table  3.5).     
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Figure ‎3.12: Growth of JB103/pM1W and JLD2402/pM1B on M9 glycerol plate.  
Controls represent the JB103 and JLD2402 strain without the recombinant plasmid 
which harbours glpX.  Only one colony of the JLD2402 strain grew and 15 colonies of 
JB103 grew on glycerol.  The controls, JB103 and JLD2402, were unable to grow on 
glycerol.  
 
 
 
Figure ‎3.13: Growth of JB103/ M1B on M9 glycerol plate (+Tet). 
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3.3.5 Fructose bisphosphatase assay 
Based on genetic complementation results, the JB108/pM1W strain was selected for 
assay analysis due to the fact that the strain can tolerate overexpressed GlpX protein and 
also was the only mutant available which harbours the T7 RNA polymerase to express 
the glpX gene under the control of T7 promoter.  A colony of the JB108/pM1W strain 
was inoculated into 10 ml of LB broth (+Amp and +Tet) and incubated overnight at 
37°C and then 5 ml was transferred into 500 ml  of Overnight Express
TM  
Instant LB 
medium and then incubated overnight at 37°C.  The cells were broken using a French 
Pressure Cell as described in the materials and methods section to produce a crude 
extract and then the activity was assayed using by Beckman Coulter DU 800 
spectrophotometer at 37°C.  The protein concentration in crude extract (12.3 mg/ml) 
was determined by the microbuiret assay, using bovine serum albumin as a standard. 
  
The crude extract was used in a spectrophotometric coupled enzyme assay to measure 
the FBPase activity by detecting the reduction of NADP
+
 to NADPH 
spectrophotometrically at 37°C and wavelength of 340 nm.  The activity of the coupling 
enzymes, glucose-6-phophatase dehydrogenase and phosphoglucose isomerase were 
confirmed using fructose 6-phosphate as substrate.  
 
The assay was initiated by adding FBP to the 1 ml mixture.  F-6-P will be formed as a 
result of the FBPase reaction and this was converted to glucose 6-phosphate and then to                               
6-phosphogluconate by coupling to phosphoglucoisomerase and glucose-6-
dehydrogenase.  As a result the NADP
+
 will be converted to NADPH which was 
followed at 340 nm.  All the reported classes of FBPase required divalent cations such 
as Mg
2+
, Mn
2+
, Fe
2+
, Cu
2+ 
or Zn
2+ 
to maximize the activity (Brown et al., 2009). 
Therefore, all these divalent cations were tested.  Maximum activity was obtained with 
10 mM Mn
2+
, whereas no activity was detected using Fe
2+
, Cu
2+
, Ca
2+
or Zn
2+
.  No 
activity was detected in the absence of a cation.  Replacing Mn
2+
 with 10 mM Mg
2+
 
reduced the activity about 75%.  The effects of 1 mM of ATP, ADP, AMP, PEP, and 
KH2PO4 on the FBPase activity were tested (Table  3.6). The optimal activity was 
achieved using fructose 1,6-bisphosphate as substrate at pH 8.0.  The FBPase activity of 
GlpX was completely inhibited by the addition of 1 mM inorganic phosphate. 
Moreover, 1 mM PEP reduced the activity by 16.5%, whereas, an increase in the 
activity about 20.5% was detected after the addition of 1 mM ADP.   
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Other metabolites that were tested, AMP and ATP at 1 mM, produced no significant 
effect on the FBPase activity of GlpX (Table  3.6).  These results are comparable to 
these obtained for GlpX proteins from M. tuberculosis and E. coli, except for the effect 
of ADP and PEP. Although strain JB108 has a functional glpX gene in the chromosome, 
it is not expressed at a sufficient level to enable grow on minimal medium 
supplemented with a gluconeogenic substrate such as glycerol. Therefore, the glpX gene 
in the chromosome is unable to compensate the loss of fbp gene (Donahue et al., 2000).  
Crude extracts from JB108 mutant strain (control) were tested to detect any FBPase 
activity of the chromosomal glpX in the extract and as expected no activity was 
detected.  Brown et al, 2009 reported that the E. coli GlpX enzyme is structurally 
related to the Lithium-sensitive phosphatases which are strongly inhibited by lower than 
0.3 mM Li
+
.  Also they found that GlpX and YggF (another class II) were not sensitive 
to lithium even at 10 mM Li
+
, hence, the class II FBPases in E. coli belong to the more 
resistant Li
+
-sensitive phosphatases such as the class IV bifunction IMPase/FBPase 
enzymes (Brown et al., 2009).  This encouraged the testing of Li
+
 as a potential 
inhibitor.   No effect was detected after the addition of 1 mM or even 10 mM Li
+
, which 
indicates that the C. acetobutylicum GlpX belongs to the more resistant Li
+
-sensitive 
phosphatases.  This assay again showed that glpX gene encodes for FBPase enzyme. 
 
Table ‎3.6: The effect of different metabolites (effectors) on the reaction rate of the 
crude GlpX enzyme compare to the control (no effector). 
Effectors(1 mM) Reaction rate % (-)Inhibition or  
(+)activation rate % 
FBPase specific activity 
(nmol/min/mg) 
None 100 0 18.51 ± 0.88 
ATP 93.7 -6.3 17.34 ± 0.04 
ADP 120.5 +20.5 22.30 ± 0.79 
AMP 93.1 -6.9 17.24 ± 0.11 
PEP 83.5 -16.5 15.45 ± 0.13 
Inorganic 
phosphate 
No activity No activity No activity 
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3.3.6 Analysis of sequenced recombinant plasmid      
The recombinant plasmid from the JB108/pM1W strain that contains the insert under the 
control of the T7 promoter was purified using a QIAGEN
®
 plasmid midi kit. The region 
that contains the insert was sequenced by Beckman Coulter Genomics using the T7 
promoter and M13 reverse primers. No mutations or mismatches were detected in the 
sequence analysis on comparision with the orginal putative C. acetobutylicum 
chromosomal glpX gene.  
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3.4 Cloning fbp gene using TOPO cloning system.  
Based on the BLAST search, the C. acetobutylicum fbp gene is an orthologue of the B. 
subtilis fbp gene which belongs to the class III FBPase enzymes.  The fbp gene was 
amplified using the TOPOfbp primers (Table ‎2.5 and Table ‎3.7) and C. acetobutylicum 
genomic DNA was used as a template with 49°C as annealing temperature.   Two PCR 
products were seen on an agarose gel, the first fragment was fbp with a size of around 2 
kbp and the second fragment was an unwanted band of a size around 800 bp (Figure 
 3.14).  Therefore, two different approaches were used to attempt to purify the fbp gene.  
The first approach was using different annealing temperatures (48, 50 and 51°C) to try 
produce a PCR product around 2 kbp without the unwanted fragment (Figure  3.14). 
However, the unwanted fragment was still present even after using various annealing 
temperatures.  Therefore, to overcome the problem, the target fragment was purified 
using a gel purification kit as described in materials and methods section  2.9.2.  After 
gel purification only the target gene of around 2 kbp was seen on agarose gel (Figure 
 3.14). The purified PCR product was cloned into the pCR2.1-TOPO vector and 
transformed into E. coli Mach1
™
-T1
R
 and TOP10F` which as mentioned before has the 
lacI
q
 repressor to reduce the background expression of the cloned gene.  After 
transformation, PCR screening was carried out using the same primers, however, after 
plating the transformants on LB agar supplemented with (+Amp and +Tet) and X-gal 
for blue white screening , all the colonies were blue which indicated that these 
transformants did not contain the fbp gene.  Further confirmation was carried out by 
PCR screening, however, no PCR product was detected on the agarose gel.  These steps 
were repeated several times with no success.  After the fbp gene was cloned and 
expressed using the Ligation Independent Cloning system (LIC) which will be 
explained later on in the next chapter, attampts to clone it using the TOPO system were 
discontinued.     
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Table ‎3.7: Locations of TOPOfbp primers on the sequence of cac1572 (fbp gene). 
Bases underlined represent the location of TOPOfbp primers.  Bases highlighted in 
green and red represent the start codon and stop codon respectively.  Obtained from                                                                                   
Genome Information Broker.  
http://gib.genes.nig.ac.jp/single/index.php?spid=Cace_ATCC824 
 
 
 
CCTTGAAAATGGCTATAAAGTTAAATTTGTTGACGGTAAAAGCATAATAATATAAAATACCATTAAGACA 
 
 
CAAACGACACACTGTATACGGAGGGTTAAAATTATTATGCTATTAGAAAGTAACACCAAAAACGAAGAAA 
TTAAGGACAATTTAAAGTACTTAGTTCTTCTTTCGAAACAGTACCCAACAATTAACGAAGCAGCTACGGA
AATAATCAATCTACAGGCTATTTTAAACCTACCTAAAGGAACGGAACACTTTTTATCAGATGTTCATGGG
GAATATGAACAATTCATACATGTACTTAAGAACGCCTCTGGAGTAATAAAAAGAAAAATAGACGATATTT
TCGGAAATAGACTTATGCAGAGTGAAAAGAAAAGTCTTGCTACGTTGATTTATTATCCGGAGCAGAAGCT
GGATATAATATTAAAGCAGGAAAAAAATATTGATGACTGGTATAAAATAACACTGTATAGGCTTATAGAG
GTTTGCAGGAATGTCTCCTCAAAGTATACTCGTTCTAAAGTAAGAAAAGCTCTTCCTAAAGAATTTTCGT
ATATAATTGAGGAGCTTTTGCATGAACAACCCAAGGGAGTAGATAAGCAGGAATATTATGACGAGATAAT
AAAGACTATTATAAGCATAGATAGGGCTAAGGAGTTTATAACTGCAATATCAAAGCTTATACAGAGGCTT
GTAGTAGATAGACTTCACATAATAGGTGATATCTTTGATAGAGGTCCAAGGGCGGATATTATAATGGATA
AGCTTGAAGAGTATCATGCGGTAGATATTCAATGGGGAAATCATGATATTTTATGGATGGGAGCTGCATC
CGGTTCTTCAGTATGCATGGCAAATGTAATAAGAATTTCTGCAAGATATGCAAATCTGTCAACTATAGAA
GATGGTTACGGAATTAATTTGTTGCCATTAGCCACTTTTGCTATGGACTTTTACGGAAACGATAAGTGCA
AGAATTTTGAACCTAAGATAGAATCTGATAAAAGTTATACAGTCAAGGAAATTGAACTTATAGGTAAAAT
GCATAAGGCTATTGCGATAATACAGTTTAAGCTTGAAGGAGAAGCTATAAAAAGACATCCTGAGTTTAAG
ATGGAACATAGGATGCTTCTAAACAAAATCAACTTTGAAGACAGTACCATAGAATTGGATGGTAAAAAGT
ATAAATTAAATGATACAAGCTTTCCAACTATAGATAAAAATGATCCATATAAACTTATAGATGAGGAGAG
GGAGGTAGTTGAAAAATTAAGATCTTCATTTGTAAATAGTGAGAAACTAAACAGGCATGTAAGGTTTTTA
TTTTCTCATGGAAATCTGTACCTAAAATTTAACTCTAATTTGTTATACCATGGCTGTATACCTTTAAATG
AGGACGGAACCTTTAAAGAGGTGTTAATAGGAAGTCATAAGTATAAGGGAAAGGCACTTTTAGATAAACT
TGATGTTTTAGCTAGAAAAAGCTTTTTTTATGAAGAAAATTCTAAAAACAGTAAGTATGAGAATGATATG
ATATGGTATCTTTGGTCAGGCCCTTTTTCGCCACTTTTTGGTAAAGAAAAAATGACAACATTTGAAAGAT
ATTTTATTGACGATAAGAAGACACATTATGAAAAGAAAGACCCATATTATCATTACAGAGATGATGAAGA
TATATGTATCAATATTTTAAGGGAATTTGGACTTGATTCTGAGCAAGCTCATATTATAAATGGGCATGTT
CCTGTAGAAAGTAAAAATGGAGAAAATCCAATAAAGGCAAATGGGAAATTAATAGTTATTGATGGAGGGT
TTTCAAAGGCATATCAAAGTAAAACTGGAATCGCTGGATATACCTTAATATATAACTCTTTTGGACTTCA 
ACTTGTATCACATGAACTGTTTGAAACAACTGAAAAAGCAATAAAAGAAGAAACAGATATAATATCTTCT 
 
 
 
 
 
 
TOPOfbp forward primer   
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ACTGTTATATTTGAAAAATCGGTAAAAGAAAAAGAGTAGGAGATACTGATATAGGGAAAGATTTGAAAAA
GCAGCTCTATGAGTTGAACCTATTGTTTTAGCTTATAAGAAGGGGCTTATTAAGGAATTTGTAAAAAGTT
AAGATTATGTACAAAAAAA 
 
 
GAGAGATTTTATGTCCTCT 
 
 
 
  
TOPOfbp reverse primer  
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Figure ‎3.14: Two agarose gels of PCR amplification and purification of fbp gene.  
(A) amplification of C. acetobutylicum putative class III FBPase gene (fbp) without 
purification using TOPOfbp primers forward and reverse and the unwanted fragment as 
indicated by Lane 2.  Lane 1, molecular weight makers (hyperladder I) from Bioline. 
(B) Purified PCR product (fbp) indicated by lane 2.  Lane 1, molecular weight makers 
(hyperladder I) from Bioline. 
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3.5    Discussion 
3.5.1 Cloning of glpX gene using TOPO cloning system 
The bifunctional HPr kinase/phosphorylase is the most important element of carbon 
catabolite repression in low GC Gram positive bacteria.  It requires fructose 1,6-
bisphosphate for activation of kinase activity, however, inorganic phosphate is required 
for activation of phosphorylase activity (Kravanja et al., 1999; Jault  et al., 2000).  
Genome sequence analysis and experimentation on C. acetobutylicum ATCC 824 have 
revealed the presence of a HPr kinase/phosphorylase gene, hprK, which encodes a 
protein of 304 amino acids and a molecular mass of around 34.5 kDa.  Moreover, this 
solventogenic organism shows a unique gene arrangement in which the HPr 
kinase/phosphorylase gene (hprK) is followed by a gene encoding a putative class II 
FBPase (glpX), hence, this gene might have a role in carbon catabolite repression 
(Tangney et al., 2003).  Until now, five classes of FBPase have been reported, and that 
includes the class I, encoded by fbp which plays an essential role in the gluconeogensis 
pathway and is found in almost all organisms (Sato et al., 2004).  A class II enzyme was 
first described in E. coli (Hines et al., 2006), whereas, class III was firstly reported in B. 
subtilis (Fujta et al., 1998).  The class V enzyme was found in archaea, and the class IV 
enzyme was discovered in thermophilic prokaryotes of both domains (Brown et al., 
2009). 
 
In E. coli, the class I FBPase is the main FBPase which is involved in gluconeogenesis. 
Hence, a ∆fbp strain cannot grow on gluconeogenic substrates such as glycerol. 
The glpFKX operon was found in E. coli and Shigella flexneri, encoding a glycerol 
kinase (glpF), glycerol facilitator (glpK) and a gene of unknown function (glpX) 
(Donahue et al., 2000; Truniger et al., 1992).  The protein encoded by glpX was almost 
identical in these two organisms (Truniger et al., 1992).  Donahue et al, (2000) reported 
that the GlpX protein had FBPase activity by overexpressing the glpX gene in a fbp 
mutant to complement growth on glycerol.  This protein has a molecular weight around 
40 kDa and a dimeric structure (Donahue et al., 2000).  Brown et al, (2009) reported 
that another gene encodes for a FBPase class II enzyme (yggF).  Therefore, there are 
three genes (fbp, glpX and yggF) which encode for FBPase activity in E. coli; however, 
the functions of glpX and yggF are still unkown (Donahue et al., 2000; Brown et al, 
2009).  
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Several studies reported that M. tuberculosis can use fatty acids as a carbon source, 
however, there was no gene assigned to encode for class I FBPase activity in the 
genome sequence of M. tuberculosis.  The Rv 1099c gene encodes a GlpX-like class II 
FBPase that shares 43% identity to the E. coli class II FBPase (Movahedzadeh et al., 
2004).  This gene complemented E. coli fbp mutants lacking FBPase activity indicating 
that Rv 1099c is the main and only gene in M. tuberculosis that encodes for the missing 
FBPase which is the key enzyme in the gluconeogenesis pathway (Movahedzadeh et al., 
2004).  Also, another bacterium C. glutamicum, has only one main class II FBPase 
enzyme, hence a fbp mutant cannot grow on gluconeogenic substrates (Rittmann et al,. 
2003).   The clostridial glpX gene encodes a protein showing 45% identity to the E. coli 
class II GlpX and also has a molecular weight of 40 kDa.  It was the aim of this study to 
show that the clostridial GlpX protein has FBPase activity, which may be involved in 
regulating the FBP levels in the cell, hence, regulating the important element in CCR 
which is the bifunctional HPr kinase/phosphorylase activity and thus the phosphorylated 
state of HPr on the serine-46 site.    
   
E. coli mutant strains that lack the class I FBP were grown on Nutrient Agar and 
minimal media to ensure the stable phenotype which was described by Donahue et al., 
(2000).  As expected, all the strains matched the phenotype, being unable to grow on 
glycerol due to lacking a functional class I fbp gene.  It is important to test these 
mutants on a gluconeogenic substrate, as a mutation that restored the growth on a 
gluconeogenic substrate such as glycerol would give false results when cells are 
transformed with the putative clostridial glpX gene. 
 
This clostridial glpX gene was amplified from genomic DNA of the C. acetobutylicum 
ATTC 824.  Using a TOPO TA Cloning
®
 Kit from Invitrogen, the PCR product was 
ligated into the pCR2.1-TOPO vector and then transformed into E. coli Mach1
™
-T1
R 
and TOP10F` cells. The transformation efficiency was poor, with a total of 14 white 
colonies that may have the insert, many fewer than expected.  However, this was a 
sufficient number of clones to undertake the next stage of screening. The PCR 
fragments can be inserted into the pCR2.1-TOPO vector in one of two orientations, 
under the control of the T7 or lac promoter.  
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The desirable orientation is that the glpX gene would be placed in the pCR2.1-TOPO
 
vector under control of the lac promoter, as this would allow direct control of the glpX 
expression in strains such as JLD2402 and JB103 that lacked both class I and II 
FBPases. However, for the JB108 strain the glpX gene may be under the control of the 
T7 promoter, due to this strain having T7 RNA polymerase which can be induced by 
IPTG to express the glpX gene.  Therefore, the JB108 strain was transformed with the 
pCR2.1-TOPO vector containing the glpX gene under the control of the T7 promoter.      
 
PCR screening was carried out to verify the orientation of the inserts using the 
TOPOglpX forward and reverse primers along with the T7 promoter primer.  Only one 
PCR product should be produced, when the combination of TOPOglpX forward and T7 
promoter primers was used for the inserts under the control of lac promoter. However, 
when a combination of TOPOglpX reverse and T7 promoter primers was used, one 
product which is under the T7 promoter would be given and no product for TOPOglpX 
forward and T7 promoter primers.  All the strains (T1W, M1W and M2W) produced 
fragments from the combination of TOPOglpX reverse and T7 promoter primers 
indicating that the insert was under the control of T7 promoter.  Except one strain 
termed M1B which produced a fragment from the combination of TOPOglpX forward 
and T7 promoter primers, indicating that the insert was under the control of lac 
promoter.  This indicated that something was powerfully discriminating against an 
insert under the control of the lac promoter.  Surprisingly, the strain M1B produced blue 
colonies when plated on a medium containing X-gal, even though an insert was present 
in the pCR2.1-TOPO vector. 
 
Restriction analysis of the recombinant plasmids from the strains M1B, M1W, and M2W 
also indicated that the inserts in both M1W, and M2W were under the control of the T7 
promoter.  However, the glpX gene in strain M1B was under the control of the lac 
promoter.  Therefore, these results were consistent with PCR screening.  Two fbp 
mutant strains JB103 and JLD2402 were transformed with the M1B plasmid in which 
the insert was under the control of lac promoter.  Also the JB108 strain was transformed 
with the M1W plasmid in which the insert was under the control of T7 promoter.  The 
main purpose of using different E. coli mutant strains to test genetic complemenation 
was to investigate the phenotypes that were exereted by GlpX in order to find out what 
is the best E. coli mutant that could be used in FBPase assay analysis.  
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 All the JB103, JB108 and JLD2402 mutants were successfully transformed and able to 
grow on LB (+Amp and +Tet).  The mutant strain JLD2402 carries deletions in both the 
fbp and glpX genes, which allows testing of the putative clostridial glpX FBPase 
activity.  Therefore, the transformed JLD2402 strain was streaked onto M9 glycerol 
plates (+Tet).  Only one colony grew on the plate, but this was enough to prove that 
glpX encodes for an enzyme that has the FBPase activity.  Also the JB103 strain which 
contains a lac repressor allowing tight regulation of the insert under the control of the 
lac promoter was tested on M9 glycerol plates (+Tet).  Only 15 colonies were able to 
grow on the glycerol plate but growth of these colonies showed that glycerol could be 
used as a carbon source.  The JB108 strain contained the T7 polymerase which can be 
induced by IPTG to overexpress a cloned gene.  Transformants of JB108 were tested on 
two different glycerol plates, one with IPTG and the other one without IPTG.  The 
results were, no growth on the IPTG plate and a high level of growth on the plate 
without IPTG, which indicates that the E. coli cells cannot cope with the over 
expression of the foreign gene under poor growth conditions, which leads to inhibition 
of growth. 
   
Also, this strain was tested on LB plates one supplemented with IPTG and the other one 
without IPTG.  A high level of growth was seen on both plates, and a possible 
explanation of this was that on a rich medium such as LB, the cells may tolerate the 
high level of clostridial GlpX protein but, when transferred to poor environment such as 
glycerol minimal medium, transformants cannot withstand the overexpression, of the 
foreign protein and are hence unable to grow.  The JB108/pM1W strain was selected for 
FBPase assay analysis due to the fact that the GlpX protein can be overexpressed by 
Overnight Express
 TM
 Instant LB media with inhibiting the growth.  
  
 To assay the activity, the strain JB108/pM1W was grown on Overnight Express
 TM
 
Instant LB medium, to make crude extracts for testing the FBPase activity.  The enzyme 
activity was demonstrated using a coupled enzyme assay technique which linked the 
production of fructose 6-phosphate to the reduction of NADP
+
 to NADPH (Jules et al., 
2009; Brown, et al., 2009; Donahue et al.,2000).  The addition of cell extracts to the 
reaction mixture resulted in formation of NADPH which can be detected by an increase 
of the absorbance at 340 nm.   Crude cell extract from the mutant JB108 strain was also 
made to be tested as a control, and as expected no activity was detected for this mutant.  
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 Although as mentioned before, this strain does contain the glpX gene, the low level of 
expression of this gene cannot support growth on gluconeogenic conditions and enzyme 
activity cannot be detected by the coupled enzyme reaction (Donahue et al., 2000).   
 
 The GlpX activity was optimized using Mn
2+ 
as other reported FBPase enzymes such 
as class I, II, and III need divalent cations as such Mg
2+
, Zn
2+
, and Mn
2+ 
for maximium 
activity (Brown et al., 2009; Donahue et al.,2000 ).  Also other divalent cations 
including Fe
2+
, Cu
2+
, Ca
2+ 
and Ni
2+ 
were tested but no activity was detected.  The effects 
of AMP, ADP, ATP, and PEP (1 mM) on GlpX activity were tested.  ATP and AMP (1 
mM) had almost no effect on the activity of C. acetobutylicum GlpX enzyme (Table 
 3.8), whereas, in E. coli, the GlpX enzyme was not effected by AMP and ADP (1 mM).  
Moreover, ATP inhibited the activity only by 12%, but inorganic phosphate inhibited 
the E. coli GlpX activity completely (Table  3.8) (Brown, et al., 2009; Donahue et al., 
2000).  On the other hand, ATP and AMP (1 mM) had no effect on the C. glutamicum 
GlpX enzyme (Rittmann et al., 2003). Moreover, inorganic phosphate inhibited the 
activity completely, suggesting that phosphate may have a regulatory role on GlpX 
activity in C. acetobutylicum ATCC 824 (Table  3.8).  
 
PEP (1 mM) stimulated the GlpX activity in E. coli by 1.7-fold, however, no effect was 
detected in M. tuberculosis GlpX (Table  3.8).  But in B. subtilis, PEP (1 mM) inhibited 
the GlpX activity completely (Jules et al., 2009).  In this study, however, PEP inhibited 
the GlpX activity only by 16.5%.  However, ADP (1 mM) does not exert any effect on 
GlpX activity for any of the bacteria reported (Table  3.8).  Instead, in this study, GlpX 
activity was stimulated by 20.5% (Table  3.8).  The complete inhibition via inorganic 
phosphate was explained by solving the 3D structure of E. coli in which inorganic 
phosphate was shown to block the active site of the enzyme (Brown, et al., 2009).  This 
indicates that same mechanism might be responsible for complete inhibition by 
inorganic phosphate in C. acetobutylicum.  Also, C. acetobutylicum GlpX was shown to 
belong to resistant Li
+
-sensitive phosphatases such as E. coli GlpX due to the fact it was 
not completely inhibited by even 10 mM Li
+
.  Unlike the M. tuberculosis GlpX which is 
inhibited by by more than 90% at 2.5 mM.   
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Table ‎3.8: Comparision of the effect of various metabolites on the activity of different GlpX enzymes. 
microorganism Effectors (inhibit or stimulate FBPase activity of GlpX ) Source  
ATP ADP AMP PEP Phosphate  
E. coli Inhibited by 
12% (1 mM) 
No effect  
(1 mM) 
No effect  
(1 mM) 
Stimulate  by 1.7-fold 
(1mM) 
Inhibited completely  
(1 mM) 
Brown et al., 2009; 
Donahue et al., 2000 
M. tuberculosis Not tested No effect  
(1 mM) 
No effect  
(1 mM) 
No effect (1 mM) Not tested Movahedzadeh et al., 
2004 
C. glutamicum No effect  
(1 mM) 
No effect  
(1 mM) 
Inhibited 
completely 
(90 µM) 
Inhibited only by 50% 
(360 µM) 
Inhibited only by 50%  
(1.6 mM) 
Rittmann et al., 2003 
C. acetobutylicum Inhibited by 
6.3% (1 mM) 
Stimulated 
by 20.5%  
(1 mM) 
Inhibited by 
6.9% (1 mM) 
Inhibited by 16.5%  
(1 mM) 
Inhibited completely  
(1 mM) 
This study 
B. subtilis Not tested Not tested Not tested Inhibited completely  
(1 mM) 
Not tested Jules et al., 2009 
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3.5.2 Cloning of fbp gene using TOPO cloning system 
The putative fbp gene in C. acetobutylicum encodes for a class III Fbp enzyme. To date, 
this class has only reported in B. subtilis (Fujita et al., 1998; Jules et al., 2009).  Based 
on bioinformatic analysis the size of in C. acetobutylicum enzyme was 77.23 kDa which 
is almost twice the size of the GlpX class II enzyme (34.81 kDa). Therefore, this 
enzyme needs to be investigated as a second potential FBPase protein in C. 
acetobutylicum.  The assay results of B. subtilis class III FBPase enzyme indicate that 
PEP is needed for full activity and adding PEP (1 mM) to the assay reaction mix 
resulted in 30-fold stimulation compared to a control with no effector added to the assay 
reaction mix (Jules et al., 2009).  Also in B. subtilis, this gene enables the cell to grow 
on a gluconeogenic substrate such as glycerol even after disruption of the glpX gene 
which might imply that the fbp gene is the main FBPase enzyme in B. subtilis that is 
involved in the gluconeogensis pathway.  However, recent results revealed that glpX 
gene can substitute for the FBPase after fbp has been knocked out (Jules et al., 2009).  
 
Significant problems were encountered in cloning the C. acetobutylicum fbp gene using 
the TOPO cloning system.  After amplification of fbp, two PCR products were detected, 
the first fragment was the target which was around 2 kbp and the second fragment was 
small unwanted band of around 800 bp.  It was attempted to solve this problem by two 
different techniques, the first was changing the annealing temperature from 49 to 48, 50 
and 51°C with no sucess.  Secondly, the amplified fbp was purified using gel 
purification kit to ensure that only the target fragment which was fbp gene would be 
cloned into the vector.  After the transformation, no clones were detected that had the 
fbp gene which might indicate that the fbp gene was toxic to the E. coli host strain 
which would prevent the growth of the transformed cells.  Problems in cloning genes 
encoding an FBPase enzyme have been reported by Col, (2004).  He could not clone the 
yggF which is the third gene in E. coli that encodes FBPase enzyme, but he had no 
explanations for this problem.  However, this gene was cloned later (after 5 years) by 
Brown et al, (2009) using an expression vector obtained from the Genobase collection.    
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3.6 Conclusion 
In this chapter, the open reading frame cac1088 was investigated using bioinformatic 
analysis which showed that this open reading frame might encode for a class II FBPase 
enzyme (GlpX). The putative glpX gene was cloned using TOPO cloning technology, 
and transformed into an E. coli fbp mutant that cannot grow on glycerol.  As a result, 
the transformed cells were able to grow on glycerol which indicates that glpX does 
indeed encode for FBPase activity.  Different phenotypes were detected by growing the 
transformants which carry glpX on glycerol and LB agar with or without IPTG.  The 
JB108/pM1W strain could grow on LB agar with or without IPTG, but no growth was 
detected when the JB108/pM1W strain was streaked on glycerol agar supplemented with 
IPTG.  Instead, cells were able to grow on glycerol without IPTG.  This might imply 
that overpression of the C. acetobutylicum glpX gene is toxic to the E. coli mutant 
(JB108) on this medium.  FBPase activity was detected by assaying crude extract of the 
JB108/pM1W strain in the presence of 10 mM Mn
2+
.  The GlpX enzyme was 
completely inhibited by 1 mM inorganic phosphate and stimulated about 20.5% by 1 
mM ADP.  To date, this is the first study to report FBPase activity in clostridia.  
Attempts to clone the putative fbp gene, which might encode for Fbp class III were 
unsuccessful using TOPO cloning technology. 
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Chapter 4: 
4 GlpX and Fbp overexpression and 
purification  
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4.1 Gateway cloning system 
4.1.1 Introduction 
To assay FBPase activity of purified GlpX and Fbp enzymes, cloning, overexpression 
of both proteins and then purification needed to be carried out.  Different 
overexpreesion strategies were explored in order to obtain the possible highest 
expression and purity level without aggregation.  The first expression system that was 
explored was the Gateway expression system (Invitrogen
®
).  The Gateway
®
 Technology 
is based on two infectious stages of the bacteriophage lambda in E. coli. Bacteriophage 
lambda can enter the lysogenic pathway, in which it integrates itself into the genomic 
DNA of E. coli at a specific site or alternatively it releases active progeny viruses in a 
process called lytic pathway.  In the lysogenic pathway, the integrated phage can either 
be excised from the host genome and go back to lytic behavior or can be transferred to 
daughter cells.  There are four att binding sites, termed attP, attB, attL, and attR 
respectively, that govern the integration and excision process of the phage lambda DNA 
catalysed by integrase (Int) and excisionase (Xis) enzymes encoded by the phage 
lambda genome, and the E.coli integration host factor (IHF). The integration reaction, 
called the BP reaction (attB×attP) and the excision reaction, called the LR reaction 
(attL×attR).  The gene of interest can be integrated or excised in vitro by the BP or LR 
reactions, and this is the foundation of the Gateway
®
 cloning Technology. 
 
Attempts were made to express the fbp and glpX of C. acetobutylicum genes by the 
Gateway system, two reactions were applied by creating an entry clone for each gene 
with the Donor vector pDONR
™
221 (BP reaction) and then transferring each gene to 
the expression vector pET-60-DEST (LR reaction).  PCR primers were designed to 
amplify each gene flanked by two attB overhangs (attB1 and  attB2) to enable the 
recombination with two attP regions  (attP1 and  attP2) in the donor vector 
pDONR™221 (BP reaction)  to form an entry clone with two attL sites (attL1 and  
attL2) (Figure  4.1).  
 
After the integration reaction, the entry clone was mixed in the LR reaction with the 
expression vector (pET-60-DEST) (Appendix) that contains attR sites (attR1 and 
attR2), so that each gene was transferred from the entry clone (pDONR
™
221) 
(Appendix) to the expression vector (pET-60-DEST). 
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Figure ‎4.1: Illustration of the two BP and LR reactions of Gateway
®
 cloning 
Technology.  
(A) BP Reaction: Facilitates recombination of an attB substrate (attB-PCR product) 
with an attP substrate (donor vector) to create attL sites in the entry clone and this 
reaction is catalyzed by BP Clonase
TM
 II enzyme mix. (B) LR reaction: Facilitates 
recombination of an attL substrate (entry vector) to create attB sites in the expression 
clone and this reaction is catalyzed by LR Clonase
TM
 II enzyme mix.  Figure taken from 
Invitrogen Gateway manual, 2009. 
  
(A)
(B)
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4.1.3 Results  
4.1.3.1 Cloning of the glpX gene‎into‎the‎donor‎vector‎pDONR™221 
To clone the glpX gene into the donor vector pDONR
™
221 of the Gateway system, the 
GATEglpX primers (Table ‎2.5 and Table ‎4.1) were designed to amplify the glpX gene 
with the attB overhangs, with C. acetobutalicum genomic DNA used as template.  The 
amplified PCR product consisted of the 975 bp glpX gene, flanked by a 31 bp  attB site 
at the 5` terminus, and a 30 bp attB site at the 3` terminus. 
  
In the integration reaction (BP reaction), the two attB sites of the PCR products 
recognize the two attP sites in the pDONR
™
221 vector and are recombined by integrase 
enzyme to form the entry clone, in which the glpX gene was integrated into 
pDONR
™
221 vector.  The reaction mix was transformed into One Shot
®
 OmniMAX
™
 
2-T1R chemically competent E. coli and then plated on LB (+Kan) for screening 
(Section ‎2.8.2).  Cells that contain plasmid without the integrated glpX gene could not 
grow due to the presence of ccdB gene (Figure ‎4.1) which is lethal to E. coli by 
inhibiting gyrase which has the ability to relax the negative supercoiling DNA to allow 
replication (Bernard, 1996).  Therefore, makes the screening for transformants that 
contain the glpX gene straightforward.  Twelve Colonies out of over 300 resistant to 
(+Kan) were selected, and then PCR screening (Section ‎2.7) was carried out with the 
same primers that were used to amplify the glpX gene.  A product of around 1 kbp was 
observed (Figure ‎4.2).  Thus, indicated that the plasmid containing glpX has 
successfully transformed into E. coli.  The plasmids from three different selected 
isolates MAX-glpX-1, MAX- glpX-8, and MAX glpX-10 were purified (Figure ‎4.3) as 
described section ‎2.7.2.  These purified plasmids gave different sizes on the gel even 
though their size around 6 kbp due to the fact that the plasmid can exist in two forms; 
supercoiled and relaxed (Figure 4.3).         
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Table ‎4.1: Locations of GATEglpX primers on the sequence of cac1088 (glpX 
gene). 
Bases underlined represent the locations of GATEglpX primers.  Bases highlighted in 
green and red represent the start codon and stop codon respectively. Obtained from 
Genome Information Broker. 
     http://gib.genes.nig.ac.jp/single/index.php?spid=Cace_ATCC824 
  
 
 
 
ATCAAGGAGGGAAATTCATGTTTGATAATGATATATCCATGAGTTTAGTAAGAGTAACAGAAGCAGCAGC
ACTACAATCTTCAAAGTATATGGGAAGAGGAGATAAAATTGGAGCTGATCAAGCAGCAGTAGATGGAATG
GAGAAGGCATTTAGTTTTATGCCAGTAAGAGGCCAGGTTGTAATAGGAGAGGGAGAACTTGATGAAGCTC
CTATGCTTTATATAGGTCAAAAGCTTGGTATGGGAAAAGACTATATGCCTGAAATGGATATAGCAGTAGA
TCCTTTAGATGGAACGATTTTAATTTCTAAGGGACTACCTAATGCAATAGCAGTAATAGCAATGGGACCA
AAAGGAAGTTTACTTCATGCCCCAGATATGTATATGAAGAAAATTGTTGTGGGACCTGGAGCAAAAGGTG
CTATAGATATAAATAAATCTCCTGAAGAGAATATTTTAAATGTAGCAAAGGCATTAAACAAGGACATATC
TGAATTAACAGTTATAGTTCAAGAAAGAGAAAGACATGACTACATAGTAAAAGCAGCTATAGAAGTTGGA
GCAAGAGTTAAGCTATTTGGTGAGGGCGATGTTGCAGCTGCACTTGCTTGTGGTTTTGAAGATACTGGAA
TAGACATACTTATGGGAATTGGAGGAGCTCCAGAAGGAGTTATAGCCGCAGCAGCTATCAAGTGCATGGG
CGGAGAAATGCAGGCTCAGCTTATACCTCATACTCAGGAAGAAATAGATAGATGTCACAAAATGGGAATA
GATGATGTAAATAAAATTTTCATGATAGATGATTTAGTTAAAAGTGATAATGTGTTTTTTGCAGCTACAG
CAATAACAGAATGTGATCTTCTTAAGGGCATAGTATTTTCTAAAAATGAACGTGCAAAAACCCATTCCAT
ATTAATGAGATCT 
 
AAAACTGGTACAATAAGATTTGTTGAAGCTATTCATGACTTGAATAAAAGTAAATTAGTGGTAGAATAAA 
  
GATEglpX forward primer   
GATEglpX reverse primer  
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Figure ‎4.2: Agarose gel of PCR screening of the glpX gene in MAX-glpX isolates.   
Twelve different isolates (MAX-glpX) were used for PCR screening as indicated by 
lane 2 to 13.  Lane 1 represents molecular weight makers (hyperladder I) from Bioline. 
 
 
Figure ‎4.3: Agarose gel of the purified plasmids (pMAX-glpX).  
Three plasmids (recombinant pDONR
™
221 carrying glpX) were purified from different 
colonies.  Lane 2, 3, and 4 represent pMAX-glpX-1, pMAX-glpX-8, and pMAX-glpX-                            
10 plasimds respectively.  Lane 1, represents molecular weight makers (hyperladder I) 
from Bioline. 
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4.1.3.2 Transferring the glpX gene into the expression vector pET-60-DEST 
The glpX gene was transferred from the donor vector to the expression vector pET-60-
DEST by the LR reaction (excision reaction), in which the attL sites at each end of the 
glpX gene in pDONR
™
221 and the attR sites in the expression vector pET-60-DEST 
were recombined.  Thus, the lethal ccdB gene was replaced in the pET-60-DEST vector 
by the glpX gene (Figure ‎4.1).  The reaction mixture was transformed into the 
expression host, E. coli Rosetta
™
 2(DE3), and transformants were selected on LB plated 
agar (+Amp).  Twelve colonies out of over 300 were screened by PCR using the same 
cloning primers.  The PCR products from 12 (termed Rosetta-glpX-1-12) different 
isolates were around 1 kbp as expected (Figure  4.4).   
 
 
 
Figure ‎4.4: Agarose gel of PCR screening of the glpX gene in Rosetta-glpX isolates.   
Twelve Rosetta-glpX isolates were used for PCR screening as indicated by lane 2 to 13. 
Lane 1, represents molecular weight makers (hyperladder I) from Bioline. 
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Two colonies (Rosetta-glpX-6 and Rosetta-glpX-7) were selected for plasmid 
purification, and carried out as described in material and methods section ‎2.7.2.  After 
purification, the two plasmids pRosetta-glpX-6 and pRosetta-glpX-7 (recombinants 
pET-60-DEST carrying glpX) were examined via sequencing (Section ‎2.7.3) with 
GATEglpX primers by Beckman Coulter Genomics.  The sequencing result was a 
disappointment, with a lot of mismatching and unidentified bases, even although Easy-
A High-Fidelity PCR Cloning Enzyme had been used to amplify glpX for the cloning in 
the donor vector.  The same problem was found also with other students using this 
system to express different genes. 
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4.1.3.3 Cloning of the fbp gene into the donor vector pDONR™221 
To clone the fbp gene into the donor vector pDONR
™
221 of the Gateway system, the 
GATEfbp primers were designed to amplify the fbp gene with attB overhangs (Table 
‎2.5 and Table ‎4.2), and the C. acetobutylicum genomic DNA was used as template.  The 
amplified PCR products consisted of the 2000 bp fbp gene, flanked by a 31 bp  attB site 
at the 5` terminus, and a 30 bp attB site at the 3` terminus. 
  
The fbp gene was cloned in the same way as glpX (Section ‎0).  After transformation of 
the recombinant pDONR
™
221 into One Shot
®
 OmniMAX
™
 2-T1R chemically 
competent E. coli, transformants were plated on LB agar (+Kan) for screening.  Four 
colonies out of over 250 that were resistant to (+Kan) were isolated for potential 
insertion and then PCR screening was carried out with the same primers that used in 
clone fbp gene and the product of this pair was the same size as that one used in the 
cloning, around 2 kbp (Figure  4.5).  This Thus indicated the plasmid that contains fbp 
has successfully transformed into One Shot
®
 OmniMAX
™
 2-T1R Chemically 
Competent E. coli.  The plasmids from two different clones MAX-fbp-1 and MAX-fbp-
2 were purified as described in section ‎2.7.2 and their size was around 9 kbp (Figure 
‎4.6).  After purification, the two plasmids (pMAX-fbp-1, pMAX-fbp-2) were examined 
via sequencing (Section‎2.7.3) with same cloning primers (GATEfbp primers) by 
Beckman Coulter Genomics.  Again the sequencing result was a disappointment, with a 
lot of mismatching and unidentified bases. 
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Table ‎4.2: Locations of GATEfbp primers on the sequence of cac1572 (fbp gene). 
Bases underlined represent the locations of GATEfbp primers.  Bases highlighted in 
green and red represent the start codon and stop codon respectively.  Obtained from 
Genome Information Broker. 
http://gib.genes.nig.ac.jp/single/index.php?spid=Cace_ATCC824 
 
 
CAAACGACACACTGTATACGGAGGGTTAAAATTATTATGCTATTAGAAAGTAACACCAAAAACGAAGAAA 
 
TTAAGGACAATTTAAAGTACTTAGTTCTTCTTTCGAAACAGTACCCAACAATTAACGAAGCAGCTACGGA
AATAATCAATCTACAGGCTATTTTAAACCTACCTAAAGGAACGGAACACTTTTTATCAGATGTTCATGGG
GAATATGAACAATTCATACATGTACTTAAGAACGCCTCTGGAGTAATAAAAAGAAAAATAGACGATATTT
TCGGAAATAGACTTATGCAGAGTGAAAAGAAAAGTCTTGCTACGTTGATTTATTATCCGGAGCAGAAGCT
GGATATAATATTAAAGCAGGAAAAAAATATTGATGACTGGTATAAAATAACACTGTATAGGCTTATAGAG
GTTTGCAGGAATGTCTCCTCAAAGTATACTCGTTCTAAAGTAAGAAAAGCTCTTCCTAAAGAATTTTCGT
ATATAATTGAGGAGCTTTTGCATGAACAACCCAAGGGAGTAGATAAGCAGGAATATTATGACGAGATAAT
AAAGACTATTATAAGCATAGATAGGGCTAAGGAGTTTATAACTGCAATATCAAAGCTTATACAGAGGCTT
GTAGTAGATAGACTTCACATAATAGGTGATATCTTTGATAGAGGTCCAAGGGCGGATATTATAATGGATA
AGCTTGAAGAGTATCATGCGGTAGATATTCAATGGGGAAATCATGATATTTTATGGATGGGAGCTGCATC
CGGTTCTTCAGTATGCATGGCAAATGTAATAAGAATTTCTGCAAGATATGCAAATCTGTCAACTATAGAA
GATGGTTACGGAATTAATTTGTTGCCATTAGCCACTTTTGCTATGGACTTTTACGGAAACGATAAGTGCA
AGAATTTTGAACCTAAGATAGAATCTGATAAAAGTTATACAGTCAAGGAAATTGAACTTATAGGTAAAAT
GCATAAGGCTATTGCGATAATACAGTTTAAGCTTGAAGGAGAAGCTATAAAAAGACATCCTGAGTTTAAG
ATGGAACATAGGATGCTTCTAAACAAAATCAACTTTGAAGACAGTACCATAGAATTGGATGGTAAAAAGT
ATAAATTAAATGATACAAGCTTTCCAACTATAGATAAAAATGATCCATATAAACTTATAGATGAGGAGAG
GGAGGTAGTTGAAAAATTAAGATCTTCATTTGTAAATAGTGAGAAACTAAACAGGCATGTAAGGTTTTTA
TTTTCTCATGGAAATCTGTACCTAAAATTTAACTCTAATTTGTTATACCATGGCTGTATACCTTTAAATG
AGGACGGAACCTTTAAAGAGGTGTTAATAGGAAGTCATAAGTATAAGGGAAAGGCACTTTTAGATAAACT
TGATGTTTTAGCTAGAAAAAGCTTTTTTTATGAAGAAAATTCTAAAAACAGTAAGTATGAGAATGATATG
ATATGGTATCTTTGGTCAGGCCCTTTTTCGCCACTTTTTGGTAAAGAAAAAATGACAACATTTGAAAGAT
ATTTTATTGACGATAAGAAGACACATTATGAAAAGAAAGACCCATATTATCATTACAGAGATGATGAAGA
TATATGTATCAATATTTTAAGGGAATTTGGACTTGATTCTGAGCAAGCTCATATTATAAATGGGCATGTT
CCTGTAGAAAGTAAAAATGGAGAAAATCCAATAAAGGCAAATGGGAAATTAATAGTTATTGATGGAGGGT
TTTCAAAGGCATATCAAAGTAAAACTGGAATCGCTGGATATACCTTAATATATAACTCTTTTGGACTTCA 
ACTTGTATCACATGAACTGTTTGAAACAACTGAAAAAGCAATAAAAGAAGAAACAGATATAATATCTTCT
ACTGTTATATTTGAAAAATCGGTAAAAGAAAAAGAGTAGGAGATACTGATATAGGGAAAGATTTGAAAAA
GCAGCTCTATGAGTTGAACCTATTGT 
 
 
TTTAGCTTATAAGAAGGGGCTTATTAAGGAATTTGTAAAAAGTTAAGATTATGTACAAAAAAA 
 
 
 
GATEfbp forward primer   
      GATEfbp reverse primer  
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Figure ‎4.5: Agarose gel of PCR screening of the fbp gene in MAX- fbp isolates.  
Three isolates (MAX-fbp-1, 2, 3 and 4) were used for PCR screening as indicated by 
lanes 2, 3, 4 and 5.  Lane 1, represents molecular weight makers (hyperladder I) from 
Bioline. 
 
          
Figure ‎4.6: Agarose gel of the purified plasmids (pMAX-fbp).  
Two plasmids (recombinant pDONR
™
221 carrying fbp) were purified from different 
colonies (pMAX-fbp-1, pMAX-fbp-2) as indicated by lanes 2 and 3 respectively.     
Lane 1, represents molecular weight makers (hyperladder I) from Bioline. 
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4.2 Cloning and expression of the glpX and fbp genes using Ligation Independent 
Cloning system (LIC) 
 
4.2.1 Introduction 
To overcome the problem of unsatisfying cloning in the Gateway clonig system, another 
overexpression system was investigated which is the Ligation Independent Cloning 
system (LIC) from Novagen.  This system was developed for directional cloning of 
amplified PCR products with no need for restriction enzymes, DNA ligase or alkaline 
phosphatase (Aslanidis and de Jong 1990).   The system uses compatible 15 base single 
stranded overhangs, which are created in the amplified PCR product by the 3'
 
5' 
exonuclease activity of T4 DNA polymerase and anneal to the same complementary 15 
base single stranded overhangs in the vector (Figure ‎4.7). 
 
Figure ‎4.7: Diagram of the Ek/LIC strategy.  
After amplification with primers that include the indicated 5' LIC extensions, the PCR 
insert is treated with LIC-qualified T4 DNA Polymerase (+dATP), annealed to the 
Ek/LIC vector, and the resultant nicked, circular plasmid is transformed into competent 
E. coli.  Figure taken from Novagen
®
 LIC manual, 2010.  
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To create PCR products with the required overhangs, 15 extra bases is added to the 
primers at the 5` end.  The PCR products after the purification are treated by T4 DNA 
polymerase in the presence of dATP to create specific vector-compatible overhangs and 
then the treated PCR product is annealed to the pET-41 Ek/LIC vector.  To express glpX 
and fbp genes by the LIC system, the recombinant plasmid was transformed into the 
expression host BL21 (DE3) pLysS.  
 
4.2.2 Results 
4.2.2.1 Amplification and purification of the glpX and fbp PCR products 
To clone the glpX and fbp genes into the pET-41 Ek/LIC vector of the LIC system, the 
LICglpX primers (Table ‎4.3 and Table ‎2.5) were designed to amplify the glpX gene and 
also the LICfbp primers (Table  4.4 and Table ‎2.5) were designed (Section  2.1.2) to 
amplify the fbp gene with the extra 15 bases overhangs at each terminus, using the C. 
acetobutylicum genomic DNA as template.  For the glpX gene, the amplified PCR 
products consist of the 975 bp of the cloning sequence, flanked by the 15 extra bases at 
each terminus.  For the fbp gene, the amplified PCR products consist of the 1998 bp of 
the cloning sequence, flanked by the 15 extra bases at each terminus (Figure ‎4.8).   
           
 
 
Figure ‎4.8: Agarose gel of PCR amplification of the glpX and fbp genes.  
Lanes 2 and 3, represent amplified fbp and lanes 4 and 5, represent amplified glpX.  
Lane 1, represents molecular weight makers (hyperladder I) from Bioline. 
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Table ‎4.3: Locations of LICglpX primers on the sequence of cac1088 (glpX gene). 
Bases underlined represent the locations of LICglpX primers.  Bases highlighted in 
green and red represent the start codon and stop codon respectively.  Obtained from 
Genome Information Broker. 
http://gib.genes.nig.ac.jp/single/index.php?spid=Cace_ATCC824 
 
 
 
ATCAAGGAGGGAAATTCATGTTTGATAATGATATATCCATGAGTTTAGTAAGAGTAACAGAAGCAGCAGC
ACTACAATCTTCAAAGTATATGGGAAGAGGAGATAAAATTGGAGCTGATCAAGCAGCAGTAGATGGAATG
GAGAAGGCATTTAGTTTTATGCCAGTAAGAGGCCAGGTTGTAATAGGAGAGGGAGAACTTGATGAAGCTC
CTATGCTTTATATAGGTCAAAAGCTTGGTATGGGAAAAGACTATATGCCTGAAATGGATATAGCAGTAGA
TCCTTTAGATGGAACGATTTTAATTTCTAAGGGACTACCTAATGCAATAGCAGTAATAGCAATGGGACCA
AAAGGAAGTTTACTTCATGCCCCAGATATGTATATGAAGAAAATTGTTGTGGGACCTGGAGCAAAAGGTG
CTATAGATATAAATAAATCTCCTGAAGAGAATATTTTAAATGTAGCAAAGGCATTAAACAAGGACATATC
TGAATTAACAGTTATAGTTCAAGAAAGAGAAAGACATGACTACATAGTAAAAGCAGCTATAGAAGTTGGA
GCAAGAGTTAAGCTATTTGGTGAGGGCGATGTTGCAGCTGCACTTGCTTGTGGTTTTGAAGATACTGGAA
TAGACATACTTATGGGAATTGGAGGAGCTCCAGAAGGAGTTATAGCCGCAGCAGCTATCAAGTGCATGGG
CGGAGAAATGCAGGCTCAGCTTATACCTCATACTCAGGAAGAAATAGATAGATGTCACAAAATGGGAATA
GATGATGTAAATAAAATTTTCATGATAGATGATTTAGTTAAAAGTGATAATGTGTTTTTTGCAGCTACAG
CAATAACAGAATGTGATCTTCTTAAGGGCATAGTATTTTCTAAAAATGAACGTGCAAAAACCCATTCCAT
ATTAATGAGATCT 
 
AAAACTGGTACAATAAGATTTGTTGAAGCTATTCATGACTTGAATAAAAGTAAATTAGTGGTAGAATAAA
A 
 
 
  
LICglpX forward primer   
LICglpX reverse primer  
                                                                                          Characterisation of glpX gene 
119 
Table ‎4.4: Locations of LICfbp primers on the sequence of cac1572 (fbp gene). 
Bases underlined represent the locations of LICfbp primers.  Bases highlighted in green 
and red represent the start codon and stop codon respectively.  Obtained from Genome 
Information Broker. 
http://gib.genes.nig.ac.jp/single/index.php?spid=Cace_ATCC824 
 
 
CAAACGACACACTGTATACGGAGGGTTAAAATTATTATGCTATTAGAAAGTAACACCAAAAACGAAGAAA 
 
TTAAGGACAATTTAAAGTACTTAGTTCTTCTTTCGAAACAGTACCCAACAATTAACGAAGCAGCTACGGA
AATAATCAATCTACAGGCTATTTTAAACCTACCTAAAGGAACGGAACACTTTTTATCAGATGTTCATGGG
GAATATGAACAATTCATACATGTACTTAAGAACGCCTCTGGAGTAATAAAAAGAAAAATAGACGATATTT
TCGGAAATAGACTTATGCAGAGTGAAAAGAAAAGTCTTGCTACGTTGATTTATTATCCGGAGCAGAAGCT
GGATATAATATTAAAGCAGGAAAAAAATATTGATGACTGGTATAAAATAACACTGTATAGGCTTATAGAG
GTTTGCAGGAATGTCTCCTCAAAGTATACTCGTTCTAAAGTAAGAAAAGCTCTTCCTAAAGAATTTTCGT
ATATAATTGAGGAGCTTTTGCATGAACAACCCAAGGGAGTAGATAAGCAGGAATATTATGACGAGATAAT
AAAGACTATTATAAGCATAGATAGGGCTAAGGAGTTTATAACTGCAATATCAAAGCTTATACAGAGGCTT
GTAGTAGATAGACTTCACATAATAGGTGATATCTTTGATAGAGGTCCAAGGGCGGATATTATAATGGATA
AGCTTGAAGAGTATCATGCGGTAGATATTCAATGGGGAAATCATGATATTTTATGGATGGGAGCTGCATC
CGGTTCTTCAGTATGCATGGCAAATGTAATAAGAATTTCTGCAAGATATGCAAATCTGTCAACTATAGAA
GATGGTTACGGAATTAATTTGTTGCCATTAGCCACTTTTGCTATGGACTTTTACGGAAACGATAAGTGCA
AGAATTTTGAACCTAAGATAGAATCTGATAAAAGTTATACAGTCAAGGAAATTGAACTTATAGGTAAAAT
GCATAAGGCTATTGCGATAATACAGTTTAAGCTTGAAGGAGAAGCTATAAAAAGACATCCTGAGTTTAAG
ATGGAACATAGGATGCTTCTAAACAAAATCAACTTTGAAGACAGTACCATAGAATTGGATGGTAAAAAGT
ATAAATTAAATGATACAAGCTTTCCAACTATAGATAAAAATGATCCATATAAACTTATAGATGAGGAGAG
GGAGGTAGTTGAAAAATTAAGATCTTCATTTGTAAATAGTGAGAAACTAAACAGGCATGTAAGGTTTTTA
TTTTCTCATGGAAATCTGTACCTAAAATTTAACTCTAATTTGTTATACCATGGCTGTATACCTTTAAATG
AGGACGGAACCTTTAAAGAGGTGTTAATAGGAAGTCATAAGTATAAGGGAAAGGCACTTTTAGATAAACT
TGATGTTTTAGCTAGAAAAAGCTTTTTTTATGAAGAAAATTCTAAAAACAGTAAGTATGAGAATGATATG
ATATGGTATCTTTGGTCAGGCCCTTTTTCGCCACTTTTTGGTAAAGAAAAAATGACAACATTTGAAAGAT
ATTTTATTGACGATAAGAAGACACATTATGAAAAGAAAGACCCATATTATCATTACAGAGATGATGAAGA
TATATGTATCAATATTTTAAGGGAATTTGGACTTGATTCTGAGCAAGCTCATATTATAAATGGGCATGTT
CCTGTAGAAAGTAAAAATGGAGAAAATCCAATAAAGGCAAATGGGAAATTAATAGTTATTGATGGAGGGT
TTTCAAAGGCATATCAAAGTAAAACTGGAATCGCTGGATATACCTTAATATATAACTCTTTTGGACTTCA 
ACTTGTATCACATGAACTGTTTGAAACAACTGAAAAAGCAATAAAAGAAGAAACAGATATAATATCTTCT
ACTGTTATATTTGAAAAATCGGTAAAAGAAAAAGAGTAGGAGATACTGATATAGGGAAAGATTTGAAAAA
GCAGCTCTATGAGTTGAACCTATTGT 
 
 
TTTAGCTTATAAGAAGGGGCTTATTAAGGAATTTGTAAAAAGTTAAGATTATGTACAAAAAAA 
LICfbp forward primer   
 LICfbp reverse primer  
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In order to clone the glpX and fbp genes in the LIC system a large amount of ultra pure 
PCR products was needed.  Therefore, PCR amplification was carried out again to allow 
DNA purification from an agarose gel (Section  2.3).  After amplification, 60 µl of PCR 
products of both genes instead of 5 µl was loaded onto the agarose gel for DNA agarose 
gel purification procedure and purified as described in materials and methods section 
 2.9.2. This step is to ensure that only the band of interest is purified (Figure  4.9).  
 
 
Figure ‎4.9: Agarose gel of purified PCR products of the glpX and fbp genes using 
agarose gel purification (Ultrafree-DA).  
Lanes 2 and 3, represent glpX and lane 4, fbp. Lane 1, represents molecular weight 
makers (hyperladder I) from Bioline. 
 
  
1      2             3            4
1Kbp_
2Kbp_
10kbp_
0.4kbp_
                                                                                          Characterisation of glpX gene 
121 
Another purification step is also needed to remove dNTPs and residual enzyme and this 
was done by chloroform extraction and ethanol precipitation method.  The samples from 
the agarose gel purification were extracted with chloroform and DNA was precipitated 
with isopropanol as described in section  2.9.2 and again run in duplicate on an agarose 
gel to show purity (Figure  4.10). 
 
 
Figure ‎4.10: Agarose gel of purified PCR products of the glpX and fbp genes 
following chloroform extraction and ethanol precipitation.  
Lanes 2 and 3, represent glpX and lanes 4 and 5, represent fbp.  Lane 1, represents 
molecular weight makers (hyperladder I) from Bioline. 
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4.2.2.2 Cloning the glpX into the pET-41 Ek/LIC vector 
After purification of the PCR products, T4 DNA polymerase treatment was carried out 
to create compatible overhangs on the purified insert as described in section  2.9.3.  The 
treated insert was used in the annealing reaction with the pET-41 Ek/LIC vector.  The 
recombinant vector that contained glpX insert was transformed into NovaBlue 
GigaSingles
™
 Competent Cells (cloning host).  The transformants (Nova-glpX) were 
plated on LB (+Kan).  Seven colonies out more than 200 were selected for PCR 
screening using the same primers that were used in cloning glpX.  All the selected 
screened colonies contained the plasmid pET-41 Ek/LIC vector that harbour the glpX 
insert (Figure  4.11).   
 
 
Figure ‎4.11: Agarose gel of PCR screening of the glpX gene in Nova-glpX isolates. 
Seven isolates (Nova-glpX-1 to Nova-glpX-7) were PCR screened as indicated by lanes 
2 to 8.  Lane 1, represents molecular weight makers (hyperladder I) from Bioline. 
 
Two (Nova-glpX-3 and Nova-glpX-4) from the seven isolates that contain the insert 
were used for plasmid purification.  The recombinant pET-41 Ek/LIC vector was 
purified as described in section 2.7.2 and their sizes were around 7 kbp (Figure  4.12).  
The two purified plasmids, pNova-glpX-3 and pNova-glpX-4, were again screened by 
PCR using the cloning primers, and as expected both plasmids contained the glpX gene 
(Figure  4.13). 
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Figure ‎4.12: Agarose gel of the purified pNova-glpX plasmids.  
Two plasmids (pNova-glpX-3 and pNova-glpX-4) were purified from two different 
colonies (Nova-glpX-3 and Nova-glpX-4) as indicated by lanes 2 and 3.  Lane 1, 
represents molecular weight makers (hyperladder I) from Bioline. 
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Figure ‎4.13: Agarose gel of PCR screening of the glpX after purification from 
Nova- glpX-3 and Nova- glpX-4 isolates.   
Two purified plasmid (pNova-glpX-3 and pNova-glpX-4) were PCR screening as 
indicated by Lanes 2 and 3.  Lane 1, represents molecular weight makers (hyperladder I) 
from Bioline. 
 
The two purified plasmids pET-41 Ek/LIC containing the glpX gene (pNova-glpX-3 and 
pNova-glpX-4) were examined via sequencing with same cloning primers. The 
sequencing results indicate that the glpX gene was cloned into the pET-41 Ek/LIC 
vector. 
 
4.2.2.3 Expression of the glpX gene in the recombinant pET-41 Ek/LIC vector     
The purified plasmid pNova-glpX-3 was selected to be transformed into the expression 
host, BL21 (DE3) pLysS.  This strain contains an IPTG-inducible T7 RNA polymerase, 
and is designed for protein expression from a pET vector.  pLysS means that the strain 
carries a pACYC184-derived plasmid that encodes T7 lysozyme, which is an inhibitor 
of T7 RNA polymerase, and hence, represses basal expression of the target gene under 
the control of the T7 promoter to reduce possible toxicity.  Therefore, the plasmid 
pNova-glpX-3 was transformed into the BL21 (DE3) pLysS cells as described in section 
 2.9.5. The transformants (BL21/pNova-glpX-3) were plated on LB (+Kan).  To 
demonstrate that the pNova-glpX-3 we successfully transformed into the expression 
host, PCR screening (Section  2.9.6) was carried out for 4 selected isolates out of more 
than 200 using the same cloning primers (Figure  4.14).  
 
1      2       3
1Kbp_
10kbp_
0.2kbp_
                                                                                          Characterisation of glpX gene 
125 
 
Figure ‎4.14: Agarose gel of PCR sreening of the glpX gene in BL21/ pNova-glpX-3 
isolates.   
Four different isolates (BL211/pNova-glpX-3 to BL214/pNova-glpX-3) were PCR 
screened.  Lanes 2 to 5, represent amplified glpX.  Lane 1, represents molecular weight 
makers (hyperladder I) from Bioline. 
 
To express the glpX gene, 500 ml of Overnight Express
TM  
Instant LB medium (Section 
 2.9.7) was used to grow the transformant (BL211/pNova-glpX-3), and this was 
incubated overnight at 37°C.  The cells were harvested and a crude extract prepared 
using a French Pressure Cell Press
®
 as described in section ‎2.7.6.  The recombinant 
GlpX protein was purified under native conditions from the crude extract using the Bug 
Buster
®
 Ni-NTA His•Bind Purification kit as described in section ‎2.9.8, and then all the 
purified fractions collected were analyzed by SDS-PAGE method as described in 
section ‎2.9.9 (Figure ‎4.15).  The recombinant fusion GlpX was purified to homogeneity 
as estimated by SDS-PAGE with a molecular weight of about 73 kDa (Figure ‎4.15) 
which was as expected and is bigger than the native protein which is 34.81 kDa, due to 
the extra two His-Tags, GST-Tag, and S-Tag (appendix 7.1).   
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These tags are important for the expressed recombinant protein, since they increase the 
solubility, the efficiency of purification and prevent aggregation of the recombinant 
protein.  This was demonstrated by analysising the insoluble fraction of the GlpX crude 
extract togather with the 2X diluted insoluble fraction of the GlpX crude extract in 
SDS-PAGE gel in order to identify any aggregation, however, no sign of aggregation 
was detected (Figure ‎4.15).  The total molecular weight of all the tags in the 
recombinant fusion protein is about 37 kDa. Thus, the total expected molecular weight 
of the recombinant fusion protein is 37 + 34.81 = 71.81 kDa, which is very close to size 
of the GlpX (about 73 kDa) seen on the SDS-PAGE gel (Figure ‎4.15). 
   
 
 
Figure ‎4.15: SDS-PAGE of purified GlpX proteins in the eluted fractions after His-
tag purification under native conditions.  
Lanes 1 and 2, insoluble fraction of the crude extract and 2X diluted insoluble fraction 
of the GlpX crude extract respectively .  Lanes 5 to 8,  eluate fractions of GlpX.  Lane 4, 
HyperPage prestained protein marker (Bioline).  
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4.2.2.4 Cleavage of the recombinant fusion GlpX protein  
Before assay of the recombinant GlpX enzyme, attempts were made to cut the 
recombinant fusion tag part of GlpX using enterokinase.  This enzyme is able to remove 
all fused GST-Tag, His-Tag, and S-tag in the N-terminal from the recombinant fusion 
GlpX by cleaving at the C-terminal end of the lysine residue which is before the start 
codon site of the target gene (Figure  4.16). 
 
 
Figure ‎4.16: Illustration of GlpX protein attached to tagged proteins at the N- and 
C-terminus.  Enterokinase cleavage site is shown by the horizontal arrow.  
 
During purification, the recombinant GlpX protein was eluated using 1 M imidazole.  
Since the enterokinase enzyme is inhibited by imidazole, the recombinant protein was 
dialyzed against distilled water using a Dialysis cassette Slide-A-Lyzer as described in 
materials and methods section  2.9.10, and then the dialyzed recombinant GlpX was 
added to the reaction mix containing the enterokinase (Section  2.9.11).  The 
enterokinase enzyme appeared however to be unable to cut the tag region from the 
recombinant GlpX, despite various optimizations of the reaction mix such as increasing 
the amount of the recombinant protein from 10 to 20 μl, and changing the incubation 
temperature (room temperature to 37°C).  This might have been due to the inhibition of 
some remaining imidazole in the reaction mix. 
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4.2.2.5 Assay of the fructose 1,6 biphosphatase activity of the purified 
recombinant GlpX protein.  
The purified recombinant GlpX was dialyzed against 50 mM Tris-Cl (pH8) containing 1 
mM dithiothreitol (DTT) and 5 mM MgCl2.  The recombinant GlpX was assayed as 
described before in materials and methods section  2.7.6.  However, no activity was 
detected, a similar problem has also reported by  Movahedzadeh et al, (2004) in that the 
purification of recombinant GlpX from M. tuberculosis led to the loss of FBPase 
activity.  
 
4.2.2.6  Overexpression of the glpX gene in the mutant JB108     
As an alternative means of demonstrating FBPase activity associated with the GlpX 
enzyme, the purified plasmid pNova-glpX-3 containing the glpX gene was transformed 
into the expression host, the mutant E. coli JB108 strain which is the same strain used 
for genetic complementation in chapter 3.  The transformants (JB108/ pNova-glpX-3) 
were plated on LB (+Kan and +Tet) and more than 200 colonies were able to grow on 
the plate.  To demonstrate that the recombinant plasmid was successfully transformed, 
two colonies (JB1081/pNova-glpX-3 and JB1082/pNova-glpX-3) were PCR screened 
using the same cloning primers and both produced a PCR product of around 1 kbp 
(Figure  4.17).  
 
Figure ‎4.17: Agarose gel of PCR screening of the glpX gene in the JB108/ pNova-
glpX-3 isolates.  
Two different isolates JB1081/pNova-glpX-3 and JB1082/pNova-glpX-3 were PCR 
screened as indicated by lanes 2 and 3.  Lane 1, represents molecular weight makers 
(hyperladder I) from Bioline. 
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The same overexpression procedure that was used with BL21 (DE3) pLysS was applied 
to overexpress the GlpX protein from JB1081/pNova-glpX-3 strain to demonstrate 
whether overexpression was possible in the JB108 mutant.  The recombinant GlpX 
protein was purified under native condition from the crude extract by Bug Buster
®
 Ni-
NTA His•Bind Purification kit and then all the purified fractions were run in the SDS-
PAGE (Figure  4.18).  As expected, all the purified proteins were around 73 kDa which 
was consistent with the previous purification.   
 
 
 
Figure ‎4.18: SDS-PAGE of purified GlpX proteins in the eluted fractions after His-
tag purification under native conditions.  
Lanes 2 to 5, eluate fractions of GlpX.  Lane 1, represents the HyperPage prestained 
protein marker (Bioline). 
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4.2.2.7 Complementation of JB108 mutant 
Before assaying the enzyme, the JB1081/pNova-glpX-3 and JB1082/pNova-glpX-3 need 
to be tested via genetic complementation to know whether the recombinant fusion GlpX 
still has FBPase activity or not.  Therefore, two colonies of JB1081/pNova-glpX-3 and 
JB1082/pNova-glpX-3 grown on LB plate (+Kan and +Tet) which harbour plasmid 
pNova-glpX-3 were streaked on M9 glycerol plate (+Tet).  As expected no growth was 
detected due to the glpX gene being under the control of the T7 promoter, and the JB108 
strain does not express the T7 RNA polymerase without the presence of IPTG in the 
medium (Figure  4.19).  Therefore, 50 µl of IPTG (200 mg/ml) was spread onto a M9 
glycerol plate (+Tet), and the same two colonies were streaked onto it and then 
incubated overnight at 37°C.  The two colonies were able to grow on the medium, and 
this indicates that the cloned glpX gene is expressed and has an FBPase activity (Figure 
 4.19).     
     
 
 
Figure ‎4.19: Growth of JB1081/pNova-glpX-3 and JB1082/pNova-glpX-3 strain on 
two M9 glycerol plates.  
Plate (A) M9 glycerol medium (+Tet) without IPTG and plate (B) M9 glycerol medium 
(+Tet) supplemented with IPTG.  The JB1081/pNova-glpX-3 and JB1082/pNova-glpX-3 
that were tested are indicated by 1 and 2 respectively. 
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4.2.2.8 Assay the fructose 1,6-biphosphatase activity of the recombinant GlpX 
from JB1081/pNova-glpX-3  crude extract.   
The genetic complementation results shown that the recombinant fusion GlpX had 
FBPase activity.  This indicates that the recombinant fusion tag part did not affect the 
activity of GlpX enzyme.  This encouraged the testing of the FBPase activity of 
recombinant GlpX.  Therefore, the JB1081/pNova-glpX-3 strain was grown on the same 
overexpression media that used to grow the BL21 (DE3) pLysS strain and a crude 
extract was prepared as described in section ‎2.7.6.  The protein concentration of the 
crude extract was 23 mg/ml and the FBPase activity was assayed using fructose 1,6-
bisphosphate as substrate at pH 8.0 (Section ‎2.7.6).  The recombinant GlpX from 
JB1081/pNova-glpX-3 strain had FBPase specific activity of 29.70 ± 0.61 nmol/min/mg. 
Different divalent cations were tested (Mn
2+
, Ca
2+
, Zn
2+
, Ni
2+
, Cu
2+
 and Mg
2+
), and 10 
mM of Mn
2+ 
was found to support the activity of GlpX as also shown in section ‎3.3.5.  
No activity was detected when Mn
2+ 
was omitted from the reaction mix.  However, 
replacing Mn
2+
 with 10 mM of Mg
2+
 led to increase the activity about 2-fold compared 
to the 10 mM of Mn
2+
.  In contrast, no FBPase activity was detected when Mn
2+
 was 
replaced with 10 mM of Zn
2+
 or Ca
2+
.  Moreover, all divalent cations that inhibit the 
FBPase activity (Ca
2+
, Zn
2+
, Ni
2+
, Cu
2+
) were tested as a potential inhabitor for the 
coupling enzymes that are used in the assay reaction. Ca
2+
 and Zn
2+ 
did not inhibit the 
activity of the coupling enzymes, whereas, Ni
2+
, Cu
2+
 in inhibited the activity of these 
enzymes completely.   
 
The FBPase activity of GlpX was completely inhibited by the addition of 1 mM 
inorganic phosphate.  The PEP (1 mM) reduced the activity by about 26.5%.  Other 
metabolites (effectors) tested such as AMP, ADP and ATP, each at 1 mM each, 
produced no major effect on the FBPase activity of GlpX (Table ‎4.5).  These results are 
compatible to that obtained for GlpX protiens from M. tuberculosis, except for PEP 
(Movahedzadeh et al., 2004).  Also, Li
+
 was tested as a potential inhibitor.  No effect 
was detected after the addition of 1 mM Li
+
, on the other hand, only 21% inhibition was 
detected after the addition of 10 mM Li
+
, which reconfirms that the C. acetobutylicum 
GlpX belongs to the more resistant Li
+
-sensitive phosphatases.  
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Table ‎4.5: The effect of different metabolites (effectors) on the reaction rate of the 
crude recombinant GlpX enzyme compare to the control (no effector). 
Effector (1mM) Reaction rate (%) Inhibition rate (%) FBPase specific activity 
(nmol/min/mg) 
Control 100 0 29.70 ± 0.61 
ATP 93.7 6.3 28.83 ± 0.68 
ADP 100 0 29.70 ± 0.08 
AMP 100 0 29.70 ± 0.06 
PEP 73.5 26.5 21.74 ± 0.49 
Inorganic 
phosphate 
No activity No activity No activity 
 
  
                                                                                          Characterisation of glpX gene 
133 
4.2.2.9 Cloning and expression of the fbp gene  
After the second purification of the PCR product (Section  4.2.2.1), T4 DNA polymerase 
treatment was carried out to create compatible overhangs on the purified insert as 
described in section  2.9.3.  The treated insert was used in the annealing reaction, by 
adding the treated insert that contained the compatible overhangs to the pET-41 Ek/LIC 
vector.  The recombinant vector that contains fbp insert was transformed into NovaBlue 
GigaSingles
™
 Competent E.coli Cells (cloning host) and the transformants were plated 
on LB (+Kan).  Five different colonies (designated from Nova-fbp-1 to Nova-fbp-5) 
were PCR screened (Section  2.9.6) using the same primers that were used in cloning 
fbp.  All the selected screened colonies contained the insert (Figure  4.20).  Two isolates 
(Nova-fbp-3 and Nova-fbp-4) from the five were used for plasmid purification.  The 
recombinant pET-41 Ek/LIC vector was purified as described in section  2.7.2 and gave 
a band size of around 8 kbp (Figure  4.21).  The two purified plasmid (pNova-fbp-3 and 
pNova-fbp-4) were PCR screened using the same cloning primers and as expected both 
plasmid contain fbp gene (Figure  4.22).  These two purified plasmids were examined 
via sequencing with same cloning primers, and the sequencing results indicated that the 
fbp gene was perfectly cloned into the pET-41 Ek/LIC vector. 
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Figure ‎4.20: Agarose gel of PCR screening of the fbp gene in Nova-fbp isolates.  
Five isolates (Nova-fbp) were PCR screened as indicated by lane 2 to 6. Lane 1, 
represents molecular weight makers (hyperladder I) from Bioline. 
 
 
Figure ‎4.21: Agarose gel of the purified pNova-fbp plasmids. 
 Two plasmids (pNova-fbp-3 and pNova-fbp-4) were purified from two different 
colonies as indicated by lanes 2 and 3. Lane 1, represents molecular weight makers 
(hyperladder I) from Bioline. 
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Figure ‎4.22: Agarose gel of PCR screeing of the fbp gene after purification.  
Two purified plasmid (pNova-fbp-3 and pNova-fbp-4) were PCR screened as indicated 
by lanes 2 and 3 respectively.  Lane 1, represents molecular weight makers (hyperladder 
I) from Bioline. 
1      2     3
2Kbp_
10Kbp_
0.2Kbp_
                                                                                          Characterisation of glpX gene 
136 
4.2.2.10 Expression of the fbp gene in the recombinant pET-41 Ek/LIC vector 
The purified plasmid pNova-fbp-3 was selected to be transformed into an expression 
host, BL21 (DE3) pLysS.  The transformants (BL21/pNova-fbp-3) were plated on LB 
(+Kan).  To show that the recombinant plasmid was successfully transformed, PCR 
screening (Section  2.9.6) was carried out using the same cloning primers and a 2 kbp 
band was observed on the agarose gel (Figure  4.23).  
 
 
Figure ‎4.23: Agarose gel of PCR screening of the fbp gene in BL21/pNova-fbp-3 
isolates.  
Three different isolates (BL211/pNova-fbp-3, BL212/pNova-fbp-3 and BL213/pNova-
fbp-3) were used for PCR screening as indicated by lane 2 to 4.  Lane 1 represents 
molecular weight makers (hyperladder I) from Bioline. 
     
The fbp gene was expressed in BL211/pNova-fbp-3 and purified in the same way as 
glpX gene (Section  4.2.2.3).  The recombinant fusion Fbp was purified to homogeneity 
and estimated  by SDS-PAGE to have a molecular weight of about 115 kDa (Figure 
 4.24), bigger than the native protein which is 77.23 kDa, due to the extra His-Tag, GST-
Tag, and S-Tag.  The total molecular weight of all the tags in the recombinant fusion 
protein is about 37 kDa. Thus, the total expected molecular weight of the recombinant 
fusion protein is 37 + 77.23 = 114.23 kDa, which is very close to the Fbp size seen on 
the SDS-PAGE 115 kDa (Figure  4.24).  Also, no aggregation was detected in the 
insoluble fraction of the Fbp crude extract together with the 2X diluted insoluble 
fraction of the Fbp crude (Figure  4.24).  
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Attempts to cut the recombinant fusion tag from the recombinant Fbp using 
enterokinase enzyme was carried out (Section  2.9.11).  As expected, the fusion tag in 
the C-terminal was not removed.  Also, an attempt was made to assay the purified 
recombinant Fbp enzyme, however, no activity was detected. 
 
 
 
Figure ‎4.24: SDS-PAGE of the purified Fbp proteins in the eluate fractions after 
His-tag purification under native conditions.  
Lanes 1 and 2, insoluble fractions of crude extract and the 2X diluted insoluble fractions   
recepectively. The lane 3, empty and lane 4, HyperPage prestained protein marker 
(Bioline).  Lane 5 to 8, eluate fractions of Fbp.  
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4.2.2.11 Expression of the fbp gene in the mutant JB108     
The problem of unable to detect FBPase activity was solved by transforming, the 
purified plasmid pNova-fbp-3 into the E.coli JB108 mutant strain, the transformants 
(JB108/pNova-fbp-3) were plated on LB supplemented with (+Kan and +Tet).  To 
confirm that the purified plasmid was transformed into the JB108 mutant strain.  PCR 
screening (Section  2.9.6) was carried out using the same cloning primers (Figure  4.25).  
The fbp gene was shown to be expressed in JB1083/pNova-fbp-3 and purified in the 
same way as the glpX gene had been (Section  4.2.2.6) and then all the purified fractions 
were run in the SDS-PAGE to check whether Fbp was expressed or not (Figure  4.26).  
 
 
 
Figure ‎4.25: Agarose gel of PCR screening of the fbp gene in JB1083/pNova-fbp-3 
and JB1084/pNova-fbp-3 isolates.   
Two different isolates (JB1083/pNova-fbp-3 and JB1084/pNova-fbp-3) were used for 
PCR screening as indicated by lane 2 and 3, fbp fragments.  Lane 1, represents 
molecular weight makers (hyperladder I) from Bioline. 
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Figure ‎4.26: SDS-PAGE of the purified Fbp proteins in the eluate fractions after 
His-tag purification under native conditions.   
Lanes 2 to 5, eluate fractions of Fbp.  Lane 1 represents the HyperPage prestained 
protein marker (Bioline).   
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4.2.2.12 Complementation of JB108 mutant via fbp gene 
The transformants (JB1083/pNova-fbp-3 and JB1084/pNova-fbp-3) cells were plated on 
LB plate (+Tet and +Kan).  Then the two colonies were transformed onto M9 glycerol 
plate (+Tet).  As expected no growth was detected in the palte on M9 glycerol plate 
(+Tet) without IPTG (Figure  4.27).  However, the transformants (JB1083/pNova-fbp-3 
and JB1084/pNova-fbp-3) were able to on the M9 glycerol plate (+Tet) supplemented 
with IPTG, this implies that the cloned fbp gene has FBPase activity (Figure  4.27).   
 
 
Figure ‎4.27: Growth of JB1083/pNova-fbp-3 and JB1084/pNova-fbp-3 strains on 
two M9 glycerol plates.  
Plate (A) without IPTG (+Tet) and plate (B) with IPTG (+Tet).  The JB1083/pNova-fbp-
3 and JB1084/pNova-fbp-3 that were tested are indicated by 3 and 4 respectively. 
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4.2.2.13 Assay of the fructose 1,6 biphosphatase activity of the recombinant Fbp 
protein from a crude extract of the  JB1083/ pNova-fbp-3  
The protein concentration of the crude extract of JB1083/pNova-fbp-3 was17.2 mg/ml 
as assessed by the Biuret methond (Section ‎2.7.6.1) and FBPase activity in was assayed 
as mentioned in section ‎2.7.6.  The recombinant Fbp from JB1083/pNova-fbp-3 strain 
had FBPase specific activity of 747.67 ± 20.97 nmol/min/mg.  Different divalent cations 
were tested as metioned before (Mn
2+
, Ca
2+
, Zn
2+
, and Mg
2+
).  The divalent cations used 
that support the optimal activity of Fbp was Mn
2+
 (10 Mm) (Table ‎4.6).  No activity was 
detected when Mn
2+ 
was absent from the reaction mix.  However, replacing Mn
2+
 with 
10 Mm of Mg
2+
 or Ca
2+
 reduced the activity about 59% and 93% respectively, compares 
to the 10 Mm of Mn
2+
.  Instead, no FBPase activity was detected when Mn
2+
 was 
replaced with 10 mM of Zn
2+
.   
 
The FBPase activity of Fbp was completely inhibited by the addition of 1 mM inorganic 
phosphate.  However, 1 mM of PEP and ATP reduced the activity about 10%, whereas, 
1 mM of AMP reduce the activity about 16%.  Also    1 mM of ADP was tested which 
produced no major effect on the FBPase activity of Fbp (Table ‎4.6).  As C. 
acetobutylicum GlpX belongs to the more resistant Li
+
-sensitive phosphatases it was not 
completely inhibited by 1 mM or 10 mM Li
+ 
as mentioned before (Section  4.2.2.8) , 
hence, Li
+
 was tested as a potential inhibitor.  Only 27% reduction in the activity was 
detected after the addition of 1 mM Li
+
, however, a 45% reduction in activity was 
detected after the addition of 10 mM Li
+
, which indicates that the C. acetobutylicum 
Fbp also belongs to the more resistant Li
+
-sensitive phosphatases. 
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Table ‎4.6: The effect of different metabolites on the reaction rate of the recombinant 
Fbp enzyme compare to the control (no effector). 
Effector (1mM) Reaction rate (%) Inhibition rate (%) FBPase  specific  activity 
(nmol/ min/mg)  
None 100 0 747.67 ± 20.97 
ATP 90.6 9.4 677.33 ± 10.56 
ADP 95.3 4.7 712.21 ± 3.00 
AMP 84.4 15.6 630.81 ± 34.12  
PEP 90.5 9.5 680.23 ± 16.4 
Inorganic 
phosphate 
No activity No activity No activity 
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4.2.2.14   Comparision of the FBPase activities of recombinant GlpX (native and 
tagged) and recombinant Fbp proteins 
The recombinant fusion GlpX was more active (29.70 ± 0.61 nmol/min/mg) by 1.6 fold 
compared to the native GlpX (18.51 ± 0.88 nmol/min/mg) due to the recombinant 
fusion GlpX being more concentrated than the native GlpX based on SDS-PAGE. 
However, the recombinant fusion Fbp had activity (747.67 ± 20.97 nmol/min/mg) 
which was 25 fold higher than the recombinant fusion GlpX and around 40 fold higher 
than the native GlpX even though the concentration of the recombinant fusion GlpX 
was higher than Fbp based on SDS-PAGE. 
 
On the other hand, ADP had almost no effect on the activity of the recombinant fusion 
GlpX, in fact, ADP stimulated the activity of the native GlpX by 20.5%.  Also, the PEP 
inhibited the activity for both proteins, with more inhibition 10% for the recombinant 
fusion GlpX (Table  4.7).  Phosphate inhibited the activity completely of both enzymes 
which indicates that the active site is not affected by the presence of the N-terminal tags 
in these recombinant fusion proteins (Table  4.7).  In contrast, the ADP had no dramatic 
effect on the FBPase activity of the recombinant fusion Fbp protein, whereas, the AMP 
inhibited the activity by about 15.6%, however, only 9.4% and 9.5% inhibition were 
detect after adding the ATP and PEP respectively (Table  4.7). Moreover, ATP excerted 
similar inhibition rate on both native and recombinant GlpX enzymes. 
 
Table ‎4.7: Comparisons of different effectors on the FBPase activity of GlpX 
(native and tagged) and Fbp tagged of C. acetobutylicum.   
Effectors (1mM) Percentage of Activity of FBPase enzymes compare to their control 
(no effector) 
GlpX (native) GlpX (tagged) Fbp (tagged) 
ATP 6.3%  inhibition 6.3%  inhibition 9.4% inhibition 
ADP 20.5% stimulation no effect 4.7% inhibition 
AMP 6.9%  inhibition no effect 15.6% inhibition 
PEP 16.5% inhibition 26.5% inhibition 9.5% inhibition 
Phosphate Complete inhibition Complete inhibition Complete inhibition 
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The recombinant fusion GlpX was stimulated 2-fold when the Mn
2+
 was replaced by 
Mg
2+
 compared to about 75% inhibition for the native GlpX which might indicate that 
the GST•Tag, and S•Tag have more drastic effect on the activity toward divalent 
cations.  In contrast, Ni
2+
, Cu
2+
, Zn
2+
, Ca
2+
 were tested as potential divalent cations, no 
activity were detected (Table  4.8).  Also, the Ni2+, Cu2+, Zn2+, Ca2+  were test as 
potential inhibitors of the coupling enzymes in the assay reaction.  Ni
2+ 
and Cu
2+
 were 
found to inhibit the coupling enzymes, indicating that the Ni
2+
, Cu
2+
 most not used as 
potential divalent cations alongside with coupling enzymes in assay FBPase activity.   
 
Table ‎4.8: Comparisons of different divalent cations require for FBPase activity 
of GlpX (native and tagged) and Fbp tagged of C. acetobutylicum. 
Divalent cations 
(10 mM) 
Percentage of Activity of FBPase enzymes compare to control 
condition (10 mM of
 
Mn
2+
) 
GlpX (native) GlpX (tagged) Fbp (tagged) 
Mg
2+
 75% inhibition 200% stimulation 60% inhibition 
Ni
2+
 Inhibit the coupling 
enzymes 
Inhibit the coupling 
enzymes 
Inhibit the coupling 
enzymes 
Cu
2+
 Inhabit the 
coupling enzymes 
Inhabit the coupling 
enzymes 
Inhibit the coupling 
enzymes 
Zn
2+
 No activity No activity No activity 
Ca
2+
 No activity No activity Only 6% activity 
 
When the Mn
2+ 
was replaced by Mg
2+
, about 60% loss of the activity of the recombinant 
fusion Fbp was detected, compare to 2 fold increase in the activity of the recombinant 
fusion GlpX and about 75% inhibition for the native GlpX.  This might indicate that 
attached tags affect the metal bind site (Table  4.8). 
 
Moreover, a small activity 6% compare to control was detected when Mn
2+
 was 
replaced by Ca
2+
, to date this is the first study reported that Fbp class III has shown 
activity with Ca
2+
 as divalent cations that required for FBPases enzyme activity (Table 
 4.8).  On the other hand, the Zn2+, Ca2+ were test as potential divalent cations, no 
activity were detected. 
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These results shown that the N-terminal tags had only a very small effect on the activity 
of the target protein (GlpX) probably due to the fact that the tagged proteins was 
engineered on the surface of the target protein and away from the active site to reduce 
any effect in the activity of the target protein.  These small differences in the behaviour 
toward the effectors compare to the native GlpX due to the GST•Tag, and S•Tag have 
the ability to enhance the folding of the target protein which may contribute to very 
small increase or decrease on the activity in the presence of effectors.     
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4.3 Discussion 
4.3.1 Overexpression of GlpX and Fbp proteins by Gateway cloning system. 
This expression system was used in order to purify the recombinant GlpX and Fbp 
proteins and then assay these pure proteins. The Gateway technology is based on the 
specific-site recombination reactions catalyzed by the bacteriophage λ Integrase (Int) 
protein (Hartley et al., 2000). The Gateway cloning system consists of two 
bacteriophage pathways, the BP reaction is the first step that mediates by the 
bacteriophage λ Integrase (Int) and the E. coli Integration Host Factor (IHF) proteins 
and this mix of enzymes is termed BP Clonase
TM
 II enzyme mix and this step called 
lysogenic pathway.  The second step of this system is the LR reaction which is the lytic 
pathway catalyzed by the LR ClonaseTM II enzyme mix that consists of the 
bacteriophage λ Integrase (Int), Excisionase (Xis), and E. coli Integration Host Factor 
(IHF) proteins. The BP Clonase
TM
 II enzyme mix and LR Clonase
TM
 II enzyme mix 
recognise specific-sites (att-sites).  The GATEglpX and GATEfbp primers are designed 
to amplify glpX and fbp genes flanked with 31 bp attB sequences at both ends.  These 
PCR products are mixed together with the Donor vector (pDONR™221) which contains 
the attP sites, and BP Clonase
TM
 II enzyme mix in the first step of cloning reaction (BP 
reaction).  As a result, the entry clone was formed containing the gene of interest and by 
product. The entry clone was transformed into One Shot
®
 OmniMAX™ 2-T1R 
Chemically Competent E. coli.   
 
Transformed cells grew on the LB plates (+Kan) which indicated that an entry clone 
had successfully transformed. The transformed cells that contain the Donor vector 
(pDONR
™
221) without the cloned genes cannot grow due to the ccdB which a lethal 
gene which located at the cloning site.  Therefore only the transformed cells that 
harbour the entry clones with glpX or fbp genes grew.  Moreover, PCR screening 
reconfirmed these results by amplifying the glpX or fbp genes from the entry clones.  
These entry clones containing glpX or fbp genes were purified and the second step 
which is the lytic pathway (LR reaction) was conducted with the LR Clonase
TM
 II 
enzyme mix and the destination vector harbours the lethal gene (ccdB) that surrounded 
by attR sequences.   
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The expression clones were formed containing the glpX or fbp genes and by product 
vector which contains the lethal gene. These mixtures were transformed in Rosetta™ 
2(DE3) Competent Cells (expression strain).  Meanwhile, the purified entry clones 
containing the glpX or fbp genes were sent for sequencing and the results were 
disappointments due to a lot of mismatching and unidentified bases as mentioned 
before.  Although  the  glpX and  fbp genes were amplified using the Easy-A high 
fidelity PCR cloning enzyme which has a proofreading activity (3´- to 5´-exonuclease 
activity) that removes or excises the wrong base pair and replaced with a correct one 
(Newton and Graham, 1994). Moreover, this enzyme has a six fold lower error rate 
compared to Taq DNA polymerase and two to three fold lower than any proofreading 
archaeal DNA polymerases in the market (Strategene
® 
manual, 2009). Therefore, it is 
unlikely to have errors or mismatching in the PCR products.  Also, the same problem 
was seen with another student using different genes and due to these problems, we 
discontinued the use of the Gateway cloning system and switched to Ligation 
Independent Cloning system.       
 
4.3.2 Overexpression of GlpX and Fbp proteins by LIC system 
This expression system does not require T4 ligase or restriction enzymes, however, in 
order to clone a gene, primers were designed with an extra 15 bp at 5` ends. The 
amplified PCR product as a result, would include the gene of interest flanked with the 
extra 15 bp at the ends.  However, this system is based on the 3
'
5' exonuclease 
activity of T4 DNA Polymerase together with dATP which removes all the extra 13 bp 
(dGTP, dCTP, and dTTP) from 3
'
5' direction and stop at the 13 bp which is 
adenosine.  Therefore, the 5` compatible overhangs on the PCR product is generated, 
which anneals to the compatible overhangs on the the Ek/LIC vector.  The glpX and fbp 
genes were amplified using LICglpX and LICfbp primers respectively which contain 
compatible overhangs at 5` ends for easy cloning with no the needs of T4 ligase.  Two 
PCR products were detected on the agarose gel, a fragment about 1 kbp of the amplified 
glpX and the other fragment was round 2 kbp for amplifying fbp.  Moreover, the LIC 
system is sensitive to any nonspecific amplified fragments, remaining dNTPs and DNA 
polymerase from PCR and these reduce the efficiency of the cloning reaction.   
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Therefore, two purification procedures were used, the first one was the agarose gel 
purification to remove any unwanted PCR products and this step avoids any possibility 
of nonspecific cloning.  The second step was Chloroform: Isoamyl Alcohol (CIAA) 
extraction and isopropanol precipitation to inactivate DNA polymerase and remove the 
remaining dNTPs which prevented interference with T4 DNA Polymerase.  After 
purification, the glpX and fbp amplified PCR products were treated with T4 DNA 
Polymerase and dATP  to create compatible overhangs at 5` ends and  cloned  into pET-
41 Ek/LIC plasmid. 
 
In this plasmid, the protein encoded by the cloned gene is fused with N-terminal 
GST•Tag, His•Tag, S•Tag and also another His•Tag in C-terminal, these tags are to 
facilitate the purification and solubilization of recombinant protein.  The Glutathione S-
transferase (GST•Tag™) is a 211 amino acid protein with a molecular mass of 26 kDa 
which makes it the largest fused protein.  Moreover, the GST•Tag is often integrated 
with other tags such as His•Tag to increase the solubility of the recombinant protein and 
prevent aggregation.  However, some recombinant proteins may aggregate even though 
they contain a His•Tag fusion and this is why pET-41 Ek/LIC plasmid which harbours 
more than one tagged fusion protein was selected and also, to increase the purity of the 
target protein.  However, the disadvantage of using a large tag is that the fused protein 
has to be removed for some applications such as crystallization (Terpe, 2003).  
Meanwhile, the polyhistidine tag (His•Tag) is the smallest tag consisting of six histidine 
amino acids attached to the N-terminal of the recombinant protein and another one is 
attached to the C-terminal (Appendix  7.7).  The advantage of using small tags is that 
some applications such as crystallization can be conducted without interference (Brown 
et al., 2009; Terpe, 2003). 
   
After cloning, the plasmids that harboured the fbp and glpX genes were transformed into 
NovaBlue GigaSingles™ Competent E.coli Cells.  These were excellent cloning hosts 
with high transformation efficiency and this step was used to increase the yield of the 
plasmids containing fbp and glpX genes.  PCR screening was carried out using the same 
primers that have been used before in the amplification of fbp and glpX genes.  As 
expected, Two PCR products were detected on the agarose gel, a fragment about 1 kbp 
of the amplified glpX and the other fragment was round 2 kbp for amplifying fbp.   
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The plasmids were purified and then transformed into an expression host, BL21 (DE3) 
pLysS, a strain genetically engineered for expression vectors such as pET vectors.  Also 
this strain contains the T7 bacteriophage gene 1(DE3), encoding T7 RNA polymerase 
and harbours the pLysS plasmid, which carries the gene encoding T7 lysozyme that 
lowers the background expression of the target gene under the control of T7 promoter 
under uninduced conditions.  However, T7 lysozyme, under induced conditions, which 
was achieved by adding IPTG, does not interfere or lower with the expression level of 
the target gene (Davanloo et al., 1984).  This creates an excellent environment to 
increase the yield of target protein without killing the cells. After transformation to the 
expression host, PCR screening was conducted to confirm the presence of the plasmids 
that harbour the fbp or glpX genes. The cells were induced for glpX and fbp expression 
and the GlpX and Fbp proteins were purified using the Bug Buster
®
 Ni-NTA His•Bind 
Purification kit. 
  
As mentioned before, the expressed Fbp and GlpX were fused with two hexahistidine 
tags at N and C terminals.  Therefore, after loading the crude extract into the column, 
covalent bonds were formed between the two His•Tags on the surface of Fbp and GlpX 
proteins and Ni, whereas, the rest of the proteins that not did have His•Tags were among 
the flow through.  To elute the proteins, imidazole was added which competes with and 
replaces the tagged Fbp and GlpX proteins in attaching to the immobilized metal ion.  
As a result, the fused Fbp and GlpX proteins were purified to homogeneity estimated by 
SDS-PAGE, moreover, no aggregations were seen in the insoluble extracts for both 
proteins due to the presence of GST•Tag and S•Tag which their main functions were to 
prevent the aggregation and increase the solubility of Fbp and GlpX proteins.  
 
Based on calculation, the total expected molecular weight of the fusion proteins which 
consist of GST•Tag, S•Tag and two His•Tags together with the extra bases between the 
tagged proteins was 37 kDa.  The native GlpX molecular weight is around 34.81 kDa, 
hence, the expected size of the tagged GlpX is 71.81 kDa.  After purification, the tagged 
GlpX was about 73 kDa which very close to the expected size.  However, the native 
Fbp molecular weight is around 77.23 kDa, hence, the total expected size of tagged Fbp 
is 114.23 kDa.  After purification, the tagged Fbp was 115 kDa seen in SDS-PAGE and 
this also was very close to the estimated size. 
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4.3.3 Assay of the purified Fbp and GlpX recombinant fusion proteins 
Using the LIC cloning system, a specific cleavage site is engineered between the N-
terminal tags and the fused proteins. Hence, all N-terminal tags proteins (GST•Tag, 
His•Tag, and S•Tag) should be removed by treatment with enterokinase.  Several 
attempts to remove the tags from the dialyzed Fbp-fusion and GlpX-fusion proteins 
were carried out with various optimizations and conditions, but with no success.  
Although the reason is not clear, it might be due to remaining imidazole even after 
extensive dialysis. 
 
Both JB 108 strains which harbour the plasmids that have the fbp or glpX genes, were 
plated onto M9 glycerol (+Tet) plates, one with IPTG and the other one without IPTG. 
As expected no growth occurred on the glycerol plate without IPTG due to the fbp or 
glpX genes were under the control of the T7 promoter which only allows for expression 
after induction with IPTG.  However, the cells were able to thrive on the glycerol plate 
supplemented with IPTG, indicating that the fbp or glpX genes were able to complement 
the fbp mutation even though both the Fbp and GlpX enzymes were expressed as 
recombinant fusion proteins.  This provided confirmation that the tags on the fusion 
proteins do not interfere with the FBPase activity of the Fbp and GlpX enzymes. 
 
Also, both purified Fbp and GlpX were assayed the same way as described before in 
section  2.7.6, however no activity were detected for Fbp or GlpX.  A similar problem 
was also reported by  Movahedzadeh et al, (2004) who found that purification of the 
recombinant M. tuberculosis GlpX led to loss of FBPase activity.  This was due to 
nitrilotriacetic acid (NTA) may have the ability to absorb metals and therefore 
purification of a protein that is dependent on a metal for activity can result in loss of the 
activity (Terpe, 2003).  This problem was solved by transforming the expression vectors 
that contained the fbp or glpX genes into the strain JB108, allowing preparation of crude 
extracts, and assay of the enzymes as described previously in section  2.7.6.  Both 
recombinant tagged Fbp and GlpX proteins had FBPase activity indicating that the 
fusion tags did not inhibit FBPase activity.  However, there were small differences in 
the activity of the native and tagged GlpX toword the respond to the effectors and this 
was explained in section  4.2.2.14.          
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4.4 Conclusion 
The main goal of using Gateway expression system was to express and purify GlpX 
class II and Fbp class III.  The BP and LR reactions appeared to work successfully as 
mentioned before.  However, the sequence results were disappointments which resulted 
in a decision to stop using this expression system and alternative cloning strategies were 
being investigated at the same time and attention turned to one of them.  Although, this 
problem was reported by another student in the laboratory who was cloning different 
genes at the same time.  This problem was solved using LIC cloning system and both 
proteins were expressed and purified, but the purified GlpX and Fbp enzymes were not 
active.  It is presumed that purification system Bug Buster
®
 Ni-NTA His•Bind is not 
suitable for enzymes that depend on metal for their activity.  Genetic complementation 
results of both recombinant GlpX and Fbp enzymes confirm this hypothesis and both 
enzymes were able to complement the JB108 mutant.  Also, it was shown that Fbp 
protein encodes for FBPase and this is first study reported Fbp class III enzyme in 
clostridia. Moreover, the enzymes assay results were consistent with genetic 
complementation that both proteins indeed encode for FBPase activity, despite the large 
tag protein attached in the N-terminal.  The native GlpX and recombinant fusion GlpX 
assay results were almost alike.  However, it seems that the large tag protein does affect 
the metal bind site.  Further analysis needed to be carried out in order to determine the 
physiological function of glpX using RT-PCR and proteomics analysis.     
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Chapter 5: 
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5.1 Reverse transcriptase- Polymerase chain reaction (RT-PCR) 
 
5.1.1 Introduction 
The RT-PCR reaction consists of two amplification steps.  The first one is reverse 
transcription of RNA which can be performed by a primer that anneals to the RNA 
template to create a complementary DNA (cDNA) by using the reverse transcriptase 
(RT) enzyme, hence, this reaction is termed the RT reaction.  The second step is PCR 
amplification which can be performed by using any DNA polymerase enzyme (Newton 
and Graham, 1994). 
 
5.1.2 Results 
5.1.2.1 Determination the expression of glpX and hprK 
The unique gene arrangement that has been proposed in C. acetobutylicum by Tangney 
et al, (2003) in which glpX is linked to hprK, is not found in other low GC Gram-
positive bacteria. In all the other bacteria, the identified hprK genes are linked to an lgt 
gene that codes for a prolipoprotein diacylglyceryl transferase enzyme (Tangney et al., 
2003; Boel et al., 2003).  Also the hprK gene overlaps with a gene that encodes for 5-
formyltetrahydrofolate cyclo-ligase, an enzyme that forms ADP, phosphate, and 5,10 
methenyltetrahydrofolate via the hydrolysis of ATP and 5-formyltetrahydrofolate as per 
the reaction equation (Greenberg et al., 1965).   
 
ATP + 5-formyltetrahydrofolate  ADP + phosphate + 5,10 methenyltetrahydrofolate. 
 
In C. acetobutylicum FBP is needed for the activity of HPr kinase/phosphorylase which 
phosphorylates HPr at the Ser-46 site and GlpX hydrolyses FBP.  Therefore, GlpX 
might be involved in regulating the kinase activity of HPrK/P which in turn would 
regulate carbon catabolite repression (Tangney et al., 2003).  It is very important to 
prove this unique gene arrangement by experimental evidence.  Therefore, an RT-PCR 
was carried out using RNAglpX primers (Table ‎2.5 and Table ‎5.1) which amplify a 
fragment of 369 bp between the 3` end of glpX and the 5` end of hprK genes.  Also, 
another RT-PCR was carried out using RNAhprK primers (Table ‎2.5 and Table ‎5.2) 
which amplify the overlap fragment of 316 bp between hprK and the gene that encodes 
for 5-formyltetrahydrofolate cyclo-ligase (Figure ‎5.1). 
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Table ‎5.1: Locations of RNAglpX primers on the sequences of cac1088-cac1089 
(glpX-hprK genes). 
Bases underlined represent the locations of RNAglpX primers.  Bases highlighted in 
green and red represent the start and stop codon respectively.  Obtained from National 
Center for Biotechnology Information. 
http://www.ncbi.nlm.nih.gov//nuccore/NC_003030.1?report=fasta&from=1257296&to
=1258210 
 
glpX start codon 
ATGTTTGATAATGATATATCCATGAGTTTAGTAAGAGTAACAGAAGCAGCAGCACTACAATCTTCAAAGT
ATATGGGAAGAGGAGATAAAATTGGAGCTGATCAAGCAGCAGTAGATGGAATGGAGAAGGCATTTAGTTT
TATGCCAGTAAGAGGCCAGGTTGTAATAGGAGAGGGAGAACTTGATGAAGCTCCTATGCTTTATATAGGT
CAAAAGCTTGGTATGGGAAAAGACTATATGCCTGAAATGGATATAGCAGTAGATCCTTTAGATGGAACGA
TTTTAATTTCTAAGGGACTACCTAATGCAATAGCAGTAATAGCAATGGGACCAAAAGGAAGTTTACTTCA
TGCCCCAGATATGTATATGAAGAAAATTGTTGTGGGACCTGGAGCAAAAGGTGCTATAGATATAAATAAA
TCTCCTGAAGAGAATATTTTAAATGTAGCAAAGGCATTAAACAAGGACATATCTGAATTAACAGTTATAG
TTCAAGAAAGAGAAAGACATGACTACATAGTAAAAGCAGCTATAGAAGTTGGAGCAAGAGTTAAGCTATT
TGGTGAGGGCGATGTTGCAGCTGCACTTGCTTGTGGTTTTGAAGATACTGGAATAGACATACTTATGGGA
ATTGGAGGAGCTCCAGAAGGAGTTATAGCCGCAGCAGCTATCAAGTGCATGGGCGGAGAAATGCAGGCTC
AGCTTATACCTCATACTCAGGAAGAAATAGATAGATGTCACAAAATGGGAATAGATGATGTAAATAAAAT 
 
 
TTTCATGATAGATGATTTAGTTAAAAGTGATAATGTGTTTTTTGCAGCTACAGCAATAACAGAATGTGAT
CTTCTTAAGGGCATAGTATTTTCTAAAAATGAACGTGCAAAAACCCATTCCATATTAATGAGATCTAAAA 
            glpX stop codon 
CTGGTACAATAAGATTTGTTGAAGCTATTCATGACTTGAATAAAAGTAAATTAGTGGTAGAATAAAATTA 
hprK start codon 
AAATGTTCGATTTACGGCGAAGGGGGATAGTAAATGCAGGTAAGTATTGAAGATATAATAGAAAATCTCG 
ATTTAGAGGTCTTGGTTAAGGGGAAAGATGGAATAAAACTGGGGTTAAGTGATATAAA 
 
 
CAGACCAGGACTACAGTTTG 
RNAglpX forward primer  
 and GATEfbp reverse primer 
 
RNAglpX reverse primer 
 and GATEfbp reverse primer 
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Table ‎5.2: Locations of RNAhprK primers on the sequences of cac1089-cac1090 
(hprK-5-formyltetrahydrofolate cyclo-ligase genes). 
Bases underlined represent the locations of RNAhprK primers.  Bases highlighted in 
green and red represent the start and stop codon.  The overlap region is in bold. 
Obtained from National Center for Biotechnology Information. 
http://www.ncbi.nlm.nih.gov//nuccore/NC_003030.1?report=fasta&from=1257296&to
=1258210 
 
 
hprK strat codon 
ATGCAGGTAAGTATTGAAGATATAATAGAAAATCTCGATTTAGAGGTCTTGGTTAAGGGGAAAGATGGAA
TAAAACTGGGGTTAAGTGATATAAACAGACCAGGACTACAGTTTGCCGGATTCTATGATTATTTTGGCAA
TGAAAGAGTGCAGGTTATAGGAAAGGCTGAGTGGAGTTTTCTAAATGCAATGCCTCCAGAAATAAGAGAA
AAAAGAATTAGAAAATATTTTCAATTTGAAACACCATGTATTGTTCTTGCAAGAGGATTGAAACCACAAA
AGGAACTTCTTGATTGTTCCAAAGAGTACAATAGGTGGCTTTTAAGGTCAAAGGCTCAAACTACTAGATT
TATAAATAAAATAATGAACTATCTTGATGACAAGCTGGCTCCTGAAACAAGAATTCATGGAGTGTTAGTT
GATATCTATGGATTAGGTATACTAATCACTGGAGAAAGTGGAATCGGAAAAAGTGAAACTGCACTTGAGC
TCATAAAAAGAGGGCATAGATTGGTTGCAGATGATGCTGTAGATATAAAAGAAATTGAATCAGTTCTTGT
TGGAAAATCACCATACATAACTTCTGGTATGCTTGAGGTTAGAGGAATGGGAATAATAGATGTTCCAGCA
CTTTATGGTCTTAGTTCTGTTTTGTCAGAAAAGAATATAAATCTTGTAATATACCTTGAACAATGGAAAG
AGGGAAGAGACTACGATAGACTTGGTACAGAT 
 
GATGAACACATAAAAATTTTAAATATTCCTGTGAGAAAAATGACGCTGCCTATACGTCCAGGGAGGAATG
TTGCTGTTATAATAGAGGCAGCAGCTGCTAATTATAGATATAATTTAAGCAGTAAAATATCTCCTGTAGA      
      
TACTATTAATAAGAGAATTGAAGAGTCTACAAATTATGATTAATAGTAAAAAAGAACTTAGGAAAAATA 
TGGTTTTAAAAAGGGATTCTTTAGAGCCAGATTTAAAATCAATAAAGGATAATATGATTTATAATAAAGT
CATAAATAGCATACAATATAAAAGTGCTAATAATATATTTGTGTTCGTTAGTTACAAAAGTGAAGTTGAT
ACTCATAATATAATAAG 
 
AACAGCAATTGCAGATGGAAAAAAAGTTTTTGTGCCGAAGGTTATTTCCAAGG 
 
 
         RNAhprk forward primer  
 and GATEfbp reverse primer 
 
RNAhprk reverse primer 
 and GATEfbp reverse primer 
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Figure ‎5.1: Illustration of glpX, hprK and 5-formyltetrahydrofolate cyclo-ligase 
gene arrangement.  
The blue box is an open reading frame located between glpX and hprK genes that would 
be amplified by RNAglpX primers, the red box is an overlap region located between 
hprK and 5-formyltetrahydrofolate cyclo-ligase genes that would be amplified by 
RNAhprK primers. 
 
First, normal PCR using a DNA template was carried out using the reverse and forward 
RNAglpX primers and reverse and forward RNAhprK primers to check their ability to 
amplify the right fragments and the best annealing temperatures (Figure ‎5.2). Three 
different annealing temperatures were tested for each gene; for the RNAglpX primers 
51, 53 and 55°C were tested, only 53 and 55°C were able to anneal the primers and 
amplify the fragment between the the 3` end of glpX and the 5` end of hprK genes to 
give a product of 369 bp (Figure  5.2).  However, for the RNAhprK primers 53, 55 and 
57°C were tested, and only 53 and 57°C were able to anneal and amplify the overlap 
fragment between hprK and the 5-formyltetrahydrofolate cyclo-ligase gene to give a 
product of 316 bp (Figure  5.2).  The agarose gel showed that both annealing 
temperatures for each fragment can be used in the cDNA amplification step of the RT-
PCR (Figure  5.2).  Also, the primer dimers issue needed to be solved to prevent 
interference with the results due to them being are very close in size to the PCR product 
(Figure  5.2). 
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Figure ‎5.2: Agarose gel electrophoresis of PCR amplification of fragments between 
hprK, glpX and a gene that encodes for 5-formyltetrahydrofolate cyclo-ligase.   
The RNAglpX primers amplify a fragment between the 3` end  of glpX and the 5` end 
of hprK genes and the size of the PCR product was around 369 bp (lane 2 for 53°C and 
lane 3 for 55°C).  The RNAhprK primers which amplify the overlap fragment between 
hprK and a gene that encodes for 5-formyltetrahydrofolate cyclo-ligase and the PCR 
product was around 316 bp (lane 4 for 55°C and lane 5 for 57°C).  The lane 1 represents 
Hyperladder I (Bioline).              
  
1       2     3      4       5
0.4kbp_
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5.1.2.2 QIAGEN® One-Step RT-PCR Kit 
The RNA template was purified as described in materials and methods section ‎2.10.1, 
from C. acetobutylicum grown in glucose minimal medium (Figure ‎5.3).  Several 
attempts were made to amplify these fragments using the QIAGEN
®
 One-Step RT-PCR 
Kit, such as different amount of RNA template (1, 2, and 4 µl) (Figure  5.4), adding 
RNase inhibitor into the reaction mix to protect from degradation and extend the life 
time of the RNA template.  Also the same different annealing temperatures that were 
used before to amplify each fragment were tested for the cDNA amplification step of 
the RT-PCR.  Despite these various optimisations, no products were obtained from the 
RT-PCR reaction and only primer dimer was observed (Figure ‎5.4). Moreover, the 
QIAGEN
®
 One-Step RT-PCR Kit does not come with a control reaction to test the 
efficiency of the kit. 
 
 
Figure ‎5.3: Agarose gel of purified total RNA from a culture of C. acetobutylicum 
grown in glucose minimal medium.  
Lane 1 and 2 represent duplicate sample of the total purified RNA. 
 
  
1               2
16S rRNA-
23S rRNA-
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Figure ‎5.4: Agarose gel electrophoresis of RT-PCR attempt to amplify fragments 
between hprK, glpX and a gene that encodes for 5-formyltetrahydrofolate cyclo-
ligase.  
Attempt to amplify fragment between the downstream of glpX and the upstream of hprK 
genes using these different amounts of RNA template, 1µl for the lane 2, 2µl for the 
lane 3, and 4µl for the lane 4.  Lanes 5 to 7, represent the attempt to amplify the overlap 
fragment between hprK and a gene that encodes for 5-formyltetrahydrofolate cyclo-
ligase using the same different amounts of RNA template.  The lane 1 represents the 
Hyperladder (Bioline).   
1         2      3      4       5        6        7              
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5.1.2.3 One Step RT-PCR Master Mix Kit from Novagen® 
Therefore, another kit, the One Step RT-PCR Master Mix Kit from Novagen
®
 was used 
to generate cDNA and then PCR product as described in the materials and methods 
section ‎2.10.3.  This kit comes with a control reaction to test the efficiency of the kit 
and also it can detect very small amounts of RNA, less than 2 ng, which makes it more 
sensitive.  First, a control reaction to test the kit was carried out using the RT-PCR 
control primers and a positive RNA control transcribed product from the human gene 
G3PDH (glyceraldehyde 3-phosphate dehydrogenase) which is a housekeeping gene in 
human tissue (Barber et al., 2005).  The reaction mix was set up as described in 
materials and method section ‎2.10.3.  A positive RNA control (2 µl) and 16.5 µl RNAs-
free water to reach the reaction total volume of 50 µl.  As expected a RT-PCR product 
of 450 bp was detected in the agarose gel (Figure ‎5.5).   
 
To prove the unique gene arrangement, two RT-PCR reactions were then carried out 
using RNAglpX primers which amplify a fragment between 3` end  of glpX and the 5` 
end of hprK genes, and RNAhprK primers which amplify the overlap fragment between 
hprK and the 5-formyltetrahydrofolate cyclo-ligase gene.  The reaction mix was 
prepared as described in the materials and methods section ‎2.10.3, however, to 
overcome the primer dimer issue, primer concentrations were diluted to 10 pmol/µl (10 
-fold) and the amount of RNA template used was 9 µl.   A PCR product of size around 
300 bp was detected in the agarose gel for each of the reactions, which indicates that 
glpX and hprK are expressed on one polycistronic m-RNA and also the same results 
were seen for hprK and the 5-formyltetrahydrofolate cyclo-ligase gene.  Therefore, all 
these glpX, hprK and 5-formyltetrahydrofolate cyclo-ligase genes are expressed as an 
operon.   Also, a control reaction was carried out with normal PCR reaction (no reverse 
transcriptase step) using the same primers (RNAglpX) to detect any trace of DNA in the 
purified RNA.  However, no amplification was detected indicating that no DNA was 
present in the purified RNA (Figure ‎5.6).   
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Figure ‎5.5: Agarose gel electrophoresis of a control RT-PCR reaction from the 
Novagen
®
 One Step RT-PCR Master Mix Kit.  
The lanes 2, 3 represent two control RT-PCR products of size 450 bp.  Lane 1, 
represents the Hyperladder I (Bioline). 
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Figure ‎5.6: Agarose gel electrophoresis of RT-PCR reaction to amplify fragments 
between hprK, glpX and a gene that encodes for 5-formyltetrahydrofolate cyclo-
ligase.   
The lane 2, and 3 represent amplified fragments between the 3` end  of glpX and the 5` 
end of hprK genes (300 bp).  Lanes 4 and 5 represent the amplified the overlap fragment 
between hprK and a putative gene that encodes for 5-formyltetrahydrofolate cyclo-
ligase and the control reaction mix (normal PCR), respectively.  The lane 1 represents 
the Hyperladder I (Bioline). 
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5.2 Discussion  
The kinase activity of the bifunctional HPr kinase/phosphorylase is dependent on FBP. 
HPrK/P is phospholyrates the HPr at serine-46 site in an ATP dependant manner to 
participate in carbon catabolite repression.  However, the putative hprK gene in C. 
acetobutylicum is located downstream of a gene that encode for GlpX which is a class II 
FBPase enzyme (Tangney et al., 2003).  This gene arrangement is exclusive to C. 
acetobutylicum which might indicate the unique role of GlpX in regulating the activity 
of HPr kinase, and this in turn would effect carbon catabolite repression.  To confirm 
how the expression of the genes is organised, RT-PCR analysis was carried out using 
specific primers as mentioned previously.  The RNA was extracted and purified from C. 
acetobutylicum grown on glucose minimal medium conditions in which it would be 
expected that HPrK would be expressed.  Several attempts to amplify these fragments 
using QIAGEN
®
 One-Step RT-PCR, a kit that can detect amounts of RNA less than 50 
ng, however no PCR products were seen on the gel.  Therefore, RT-PCR analysis was 
done using another kit, the One Step RT-PCR Master Mix Kit from Novagen
®
 which 
can detect very small amounts of RNA, less than 2 ng.  The results showed that both 
regions were amplified and detected on agarose gel, indicate that GlpX, HPr kinase and 
the gene that encodes for 5-formyltetrahydrofolate cyclo-ligase were expressed under 
glucose condition.   
 
In B. subtilis the hprK was reported to be weak constitutive expressed gene that does 
not depend on the growth condition (Hanson et al., 2002).  Therefore, Northing blotting 
cannot be used due to the fact that this technique is not sensitive enough to detect a 
weak gene expression (Rapley and Manning, 1998).  This might explain why m-RNA of 
hprK-glpX cannot be detected by standard RT-PCR kit such as QIAGEN
®
 One-Step 
RT-PCR and was only detected by very sensitive RT-PCR kit which was One Step RT-
PCR Master Mix Kit from Novagen
®
.  Moreover, these results shown, glpX, hprK and 
the 5-formyltetrahydrofolate cyclo-ligase gene were expressed together in one 
polycistronic m-RNA.  In prokaryotes genes that are functionally related are usually 
expressed as a polycistronic m-RNA as seen for the E. coli lac operon in which all the 
three genes that responsible for uptake and utilization of lactose are expressed as one 
polycistronic m-RNA (Vilar et al., 2003).   
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Therefore, the RT-PCR results imply that the unique gene arrangement of the C. 
acetobutylicum glpX, hprK and 5-formyltetrahydrofolate cyclo-ligase genes might 
indicate that they have a related function in regulating carbon catabolite repression in 
this industrial important strain.  The physiological function of 5-formyltetrahydrofolate 
cyclo-ligase is still unknown in prokaryotes.  However, a recent study indicates that this 
protein is necessary in thiamine (Vitamin B1) metabolism (Pribat et al., 2011).  Also, 
the expression of glpX in cells grown in glucose minimal medium indicates that this 
gene is not simply an enzyme of the gluconeogensis pathway which enables cells to 
grow on gluconeogenic substrate such as glycerol as reported by others (Rittmann et al., 
2003; Movahedzadeh et al., 2004; Jules et al., 2009).  Instead, glpX in C. 
acetobutylicum can be suggested to have a specific role in regulating the activity of HPr 
kinase.  Also, proteomic analysis was carried out in order to confirm whether glpX is 
expressed or not when the cells are grown on glucose as a sole carbon source.   The 
results showed that liquid chromatography electrospray ionization tandem mass 
spectrometry was able to detect 439 proteins and GlpX was among the proteins which 
indicate that glpX gene is expressed during growth on a glycolyte substrate such as 
glucose which is consistent with the RT-PCR result.  However no Fbp was detected 
under these conditions and this indicates that Fbp might have role gluconeogenic 
pathway.  
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5.3 Conclusion 
C. acetobutylicum total RNA was purified from a culture grown on glucose minimal 
medium.  Then two RT-PCR reactions were carried out using RNAglpX and RNAfbp 
primers to amplified regions between the 3` end  of glpX and the 5` end of hprK genes 
and the overlap region between hprK and the 5-formyltetrahydrofolate cyclo-ligase 
gene. The RT-PCR results indicate that GlpX is expressed under glucose growth 
conditions and expressed as a polycistronic m-RNA together with hprK and the 5-
formyltetrahydrofolate cyclo-ligase gene which also imply that these genes are 
expressed as an operon.  Furthermore, proteomic analysis was compatible with RT-PCR 
results.  Based on these results, GlpX seems to be expressed constitutively due to it 
linked to hprK which is constitutive expressed gene that does not depend on the growth 
condition and needed for CCR.  Therefore, GlpX might play a vital role in CCR. 
                                                                                                               General discussion 
166 
 
 
 
 
 
 
 
 
 
Chapter 6: 
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6.1 The importance of intracellular FBP levels in CCR and strain improvements  
In this project the glpX and fbp genes of C. acetobutylicum were shown by genetic 
complementation and enzyme assay to encode for FBPase enzymes.  Both GlpX and 
Fbp protiens were inhibited by 1 mM inorganic phosphate and the recombinant tagged 
Fbp had 25 fold higher activity than the recombinant tagged GlpX.   To investigate this 
further, proteomic and RT-PCR analyses were carried out.  In proteomic analysis, the 
Fbp protein was not found under glucose growth conditions, but, GlpX was detected.  
RT-PCR results showned that glpX does indeed express on one polycistronic m-RNA 
together with hprK and 5-formyltetrahydrofolate cyclo-ligase genes under glucose 
growth conditions.  These results are consistent with the GlpX would appear to have a 
different role, whereas, the Fbp enzyme appear to involve in utilizing gluconeogenic 
substrates, Given the position of the glpX gene in C. acetobutylicum genome, proteomic 
and RT-PCR analyses which work towards a role in regulating intracellular FBP 
concentration.     
As mentioned before, FBP is a key metabolite effector that can enhance binding of the 
CcpA-HPr-P-Ser complex to a cre site which in turn results in repression or activation 
of an operon or gene (Henkin, 1996; Presecan-Siedel et al., 1999; Schumacher et al., 
2007; Antunes et al., 2010).  In B. subtilis, disruption of the gene encoding 
phosphofructokinase, which prevented the production of FBP, resulted in no CCR and 
the growth was impaired (Nihashi and Fujita, 1984).  These results indicated how FBP 
is important in mediating the level of CCR in Gram positive bacteria.  Intracellular FBP 
concentration has vital role in regulating the activity of HPr kinase and in turn CCR in 
low GC Gram positive bacteria such as B. subtilis (Singh et al., 2008; Deutscher et al., 
2006).  In this microorganism the highest FBP concentration was detected in vivo when 
cells were grown on glucose which is the preferable sugar that exerts the strongest CCR 
effect (Singh et al., 2008; Nihashi and Fujita, 1984).  
Singh et al, (2008) have tested the effects of many different substrates on CCR.  These 
tested substrates such as ribose, sucrose, glucose, and fructose have the ability to exert 
CCR and the repression caused by these substrates was quantified using the activity of 
β-xylosidase (XynB) which is involved in xylose utilization.  In the absence of xylose, a 
very low β-xylosidase activity was detectable (14 U/mg), however, in the presence of 
xylose, a high β-xylosidase was detectable (945 U/mg) demonstrating that the synthesis 
of the enzyme was induced.  
 
                                                                                                               General discussion 
168 
In the quantitative analysis, cells were grown on xylose together with a repressing sugar 
to find out how XynB synthesis was affected, and intracellular FBP concentration was 
also measured.  Glucose exerted the strongest repression on XynB activity which was 
reduced to about 7 U/mg.   However, maltose, sucrose and ribose repressed the activity 
to about 437, 126 and 497 U/mg respectively which was very weak repression 
compared to glucose.  These results, however, indicated that not only glucose, but also 
other substrates, can exert CCR (Singh et al., 2008).  Moreover, the amount of 
intracellular FBP during growth in the presence of glucose, maltose, sucrose and ribose 
were around 14.1, 10.7, 11.5, 6.5 mM respectively (Singh et al., 2008).  By comparison, 
under gluconeogenic growth conditions such as on malate intracellular FBP in B. 
subtilis was found to be very low (around 1.5 mM) (Kleijn et al., 2009).  The 
implication of the results is that a higher FBP concentration increases the activity of 
HPr kinase which phosphorylates more HPr protein at the serine 46 site to cause CCR, 
while substrates which generate a low level of intracellular FBP do not exert CCR 
(Carlos et al, 2003; Singh et al., 2008).  
For developing a successful industrial strain, clarification is needed on metabolic and 
regulatory networks of this strain (Dobson et al., 2011).  Although several attempts to 
control metabolic pathway in C. acetobutylicum in order to increase solvent production 
were carried out.  Recently, the ack gene which encodes for acetate kinase that involve 
in acetate formation was disrupted using the ClosTron system with the aim to increase 
the butanol production by reducing acetate and acetone formation (Kuit et al., 2012).  
Although, acetate production in the mutant strain was reduced by more than 80% 
compare to the wild type, however, the acetone production was not effected in the 
mutant strain.  This indicates that another acetate producing pathway might be operated 
in C. acetobutylicum (Kuit et al., 2012).             
Therefore intracellular FBP concentration might be used as an important global 
regulatory signal to control CCR in   Gram positive bacteria such as C. acetobutylicum, 
in which a similar regulatory mechanism appears to be present.  It has been reported that 
C. acetobutylicum and C. butyricum AKR102a are able to grow on crude glycerol 
derived from biodiesel (Carlos et al., 2003; Ringel et al., 2011).   
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As mentioned before, cloning and overexpression of either the fbp or glpX gene of C. 
acetobutylicum allowed an E. coli fbp mutant to thrive in glycerol minimal media. 
Therefore, overexpression of either Fbp or GlpX in C. acetobutylicum might lead to an 
increase in growth rate and the utilization efficiency of crude glycerol and thus increase 
butanol production.  At the same time, overexpression of either gene might also result in 
a drop in the intracellular FBP concentration which would most likely relieve CCR 
when the cells grow on multiple carbon sources and increase the ability of the cells to 
utilize multiple carbon sources. Therefore, this might solve the problem of CCR 
excreted via using fermentation substrates that contain mixture of several carbon 
sources concurrently.   
Also, this metabolic engineered strain probably can be used in the current biodiesel 
industry not only to increase the profit but solve the excessive crude glycerol formed 
from the production of biodiesel.  Although genomic DNA of the recently isolated C. 
butyricum AKR102a strain has not been sequenced yet, this strain might contain genes 
encoding fbp in order to grow on glycerol.  Therefore, the same proposed metabolic 
engineering techniques mentioned above for C. acetobutylicum might be used to 
increase the utilization efficiency of crude glycerol and production of 1,3-PD. The 
availability of genomic DNA sequence may assist in confirming these hypotheses by 
allowing characterization of the genes that encode for FBPase activity in this strain and 
identifying the locations of those genes. 
It has been reported that knockout of the hprK gene in Gram positive bacteria such as 
Streptococcus mutans and B. subtilis led to impaired growth even though the CCR was 
relieved (Deutscher et al., 1994; Zeng et al., 2010).  Also a knockout of ccpA in C. 
acetobutylicum apparently had the same result (Ren et al., 2010).  These effects are 
presumably due to several genes being positively regulated by these CCR elements and 
any mutations introduced to these elements may lead to a defect in the growth.  An 
alternative way to relieve CCR in Gram positive bacteria without disturbing growth rate 
may be to reduce the intracellular FBP concentration by overexpressing a gene that 
encodes for FBPase to mimic the conditions when the bacteria are grown on unpreferred 
substrates such as glycerol.  Knockout of a gene that encodes FBPase might result in 
several phenotypes, depending on how many genes encode for FBPase enzyme in the 
bacterium.   
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For example, in a bacterium that has only one gene that encodes for FBPase is most 
likely to involve in gluconeogenesis pathway and the knockout of this gene would be 
expected to result in the mutant strain being unable to grow on gluconeogenic substrate 
such as glycerol.  This phenomenon was reported in C. glutamicum and M. tuberculosis 
in which there is only one gene that encodes for FBPase enzyme (Movahedzadeh et al., 
2004; Rittmann et al., 2003).  However, if the bacteria contain two genes or more 
encoding for FBPase enzyme, one of these genes may encode for the major FBPase 
involved in the gluconeogenesis pathway and the others might have different 
physiological functions.  In E. coli for example, knockout of the major fbp gene which 
encodes for the class I FBPase enzyme created the ∆fbp strain which is unable to grow 
on gluconeogenic substrates such as glycerol, whereas the glpX mutant do not show any 
change in the phenotype (Donahue et al., 2000).  Therefore, it is most likely that 
knockout of the fbp gene in C. acetobutylicum would result in a strain that is unable to 
grow on a gluconeogenic substrate, while, disrupting of the glpX gene might generate a 
strain with very tight CCR due to high level of intracellular FBP concentration.           
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6.2 Conclusions and future work 
This study has demonstrated that C. acetobutylicum contains two genes encoding for 
class II and III FBPase enzymes.  In order to confirm their physiological functions, 
three mutants need to be constructed, ∆fbp, ∆glpX, and a double mutant (∆fbp and 
∆glpX) and tested with different carbon sources to detect any variations in the growth 
phenotype.  Also the intracellular FBP concentration of these mutants together with the 
wild type strain need to be tested to determine whether this is affected by growth with 
various carbon sources or not.  These experiments would shed some light on how GlpX 
can interfere with CCR and also confirm the proposed function of Fbp.  These findings 
could form the basis of constructing strains that would show optimum performance in 
fermentations using a range of substrates and conditions.   
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7.1 Sequence of the recombinant fusion tags 
Obtained from Novagen (2010) LIC

 Cloning User Manual. 
 
His-tag sequence: (molecular weight = 900 Da) HHHHHH. 
S-tag sequence: (molecular weight = 4500 Da) LGTAAALPGAGHMAS. 
GTS-tag sequence: (molecular weight = 26 KDa) 
MKLFYKPGACSLASHITLRESGKDFTLVSVDLMKKRLENGDDYFAVNPKGQVP
ALLLDDGTLLTEGVAIMQYLADSVPDRQLLAPVNSISRYKTIEWLNYIATELHK
GFTPLFRPDTPEEYKSTVRAQLEKKLQYVNEALKDEHWICGQRFTIADAYLFTV
LRWAYAVKLNLEGLEHIAAFMQRMAERPEVQDALSAEGLK 
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7.2 Bioline Hyperladders  
DNA molecular weight markers obtained from: 
http://www.bioline.com/h_ladderguide.asp 
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7.3 HyperPAGE Prestained Protein Marker  
 
Prestained protein markers obtained from Bioline: 
http://www.bioline.com/documents/product_inserts/HyperPAGE.pdf#zoom=130 
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7.4 pCR 2.1 TOPO Cloning Vector  
Obtained from Invitrogen (2006) TOPO TA

 Cloning User Manual.  
http://www.invitrogen.com/content/sfs/manuals/topota_man.pdf 
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7.5 The‎donor‎vector‎pDONR™221. 
Obtained from Invitrogen (2009) cloning user manual. 
http://tools.invitrogen.com/content/sfs/manuals/gateway_pdonr_vectors.pdf 
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7.6 The Gateway® Nova pET-60-DEST™‎vector 
Obtained from Novagen (2009) Gateway

 Cloning User Manual. 
http://www.merck-chemicals.com/united-kingdom/life-science-research/gateway-nova-
pet60destexpressionsystem/EMD_BIO71863/p_C3Ob.s1OvmAAAAEjEhx9.zLX;sid=l
qvX0FI_JYLd0B0mb5O6h_r_ESjFINyxuku9d2oR9QHR7kIjlXIq6Hs4t1_OlJ7vpTHHz
FHmESjFINW8hFvHzFHm?attachments=USP  
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7.7 The pET-41 Ek/LIC vector 
Obtained from Novagen (2010) LIC

 Cloning User Manual. 
http://www.merck-chemicals.com/united-kingdom/life-science-research/pet-41-ek-lic-
vector-kit/EMD_BIO-71071/p_BICb.s1O130AAAEj5Rt9.zLX?attachments=USP 
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7.8 Amino acids abbreviation  
Obtained from the LabRat.com (2005). 
http://www.thelabrat.com/protocols/aminoacidtable.shtml 
 
Name Abbreviation  
3-Letter 1-Letter 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamic Acid Glu E 
Glutamine Gln Q 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
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7.9 Calibration curve of protein 
Typical calibration curve for estimation of concentration of protein. 
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7.10 FBPase enzyme assay curve  
Typical FBPase enzyme assay curve for calculating the FBPase specific activity. 
 
 
 
 
  
                                                                                                                             Appendix  
183 
7.11 Proteomic analysis of FBPase class II (GlpX) protein  
Typical output from liquid chromatography electrospray ionization tandem mass 
spectrometry (LC/ESI-MS/MS).  
 
 
Match to: gi|15894373 (glpX) Score: 92 
fructose 1,6-bisphosphatase II [Clostridium acetobutylicum ATCC 824] 
Found in search of DATA.TXT 
 
Nominal mass (Mr): 35015; Calculated pI value: 5.08 
NCBI BLAST search of gi|15894373 against nr 
Unformatted sequence string for pasting into other applications 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 7% 
 
Matched peptides shown in Bold Red 
 
     1 MFDNDISMSL VRVTEAAALQ SSKYMGRGDK IGADQAAVDG MEKAFSFMPV  
    51 RGQVVIGEGE LDEAPMLYIG QKLGMGKDYM PEMDIAVDPL DGTILISKGL  
   101 PNAIAVIAMG PKGSLLHAPD MYMKKIVVGP GAKGAIDINK SPEENILNVA  
   151 KALNKDISEL TVIVQERERH DYIVKAAIEV GARVKLFGEG DVAAALACGF  
   201 EDTGIDILMG IGGAPEGVIA AAAIKCMGGE MQAQLIPHTQ EEIDRCHKMG  
   251 IDDVNKIFMI DDLVKSDNVF FAATAITECD LLKGIVFSKN ERAKTHSILM  
   301 RSKTGTIRFV EAIHDLNKSK LVVE 
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